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Multiple sclerosis (MS) is an immune-mediated prevalent chronic demyelinating 
and neurodegenerative disease of the central nervous system that begins with an abrupt 
onset during early adulthood.  MS is idiopathic, but many factors are thought to 
influence the pathogenesis of the disease, which include genetic, gender and 
environmental factors.  To date, there is much evidence that suggest that both the onset 
and progression of MS is facilitated by both viral infections and stress.  Theiler’s murine 
encephalomyelitis virus (TMEV) is a picornavirus that upon inoculation into susceptible 
strains of mice (i.e. SJL and CBA) causes a persistent infection which, in turn, results in 
an early acute encephalomyelitis followed by a late chronic immune-mediated 
demyelinating and neurodegenerative disease that pathologically resembles MS.  In 
contrast, resistant mice (i.e C57BL/6 and BALB/c) are able to clear the virus from the 
CNS, and consequently do not develop chronic demyelination.   Previous studies 
indicated that stress during early infection of susceptible mice can increase CNS viral 
titers and alter dissemination of TMEV, decrease early cytokine and chemokine 
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expression in the spleen and CNS, and result in an exacerbated late demyelinating 
disease.  The studies herein, focused on the hypothesis that chronic stress during early 
infection with TMEV infection would lead to drastic immunosuppression of both innate 
and adaptive arms of immunity, and that this immunosuppression may overcome the 
genetically controlled resistance of C57BL/6 mice to Theiler’s virus-induced 
demyelination.  In these series of studies, we were able to show that stress, regardless of 
mouse strain susceptibility, decreases NK cell activity, and increased viral titers at day 1 
p.i.  Furthermore, after seven days of stress, susceptible mice demonstrated decreased 
virus specific T-cell effector function in both the CNS and spleens as indicated by a 
globalized reduction in type 1 and type 2 cytokines, as well as transcription factors.  
Importantly, these decreased responses were, in part, attributable to the actions of 
glucocorticoids.  However, stress during early infection of C57BL/6 mice did not alter 
resistance to demyelination.  These results begin to shed light on how stress, infection, 
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I  INTRODUCTION 
 
1.  Multiple sclerosis 
1.1  History and prevalence of multiple sclerosis 
Multiple sclerosis (MS) is a chronic inflammatory, neurodegenerative and almost 
always debilitating disease that is confined to the central nervous system (CNS) and 
thought to be mediated by autoimmune processes.  Charcot is credited with the initial 
description of the disease in 1868 although others, in particular Carswell  and Cruveiller, 
twenty years ealier described a similar disorder (Morales et al., 2006).  While the disease 
was only first recognized as a specific entity approximately 170 years ago, it is most 
likely not a new disease, as historical records may provide evidence of its existence 
among the Vikings during the 14th century (Morales et al., 2006).  Despite the fact that 
MS has been around for centuries, there is a general consensus that its incidence is, in 
fact, increasing (Noseworthy et al., 2000; Noonan et al., 2002; Hauser and Oksenberg, 
2006).   
 Indeed, a recent worldwide assessment of the most common diseases of the CNS, 
which included MS, as well as others, indicated that MS had an incidence of 4.1 per 
100,000 and a prevalence of 0.9 per 1000 (nearly 0.1% of the world population) (Hirtz et 
al., 2007).  When considering these statistics, it is important to keep in mind that both 
the incidence and prevalence of MS is influenced greatly by latitude.  This observation 
has recently been confirmed by an analysis of the incidence and prevalence of MS in  
____________ 
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Europe, where, for example, the authors demonstrate that the prevalence for Northern  
Scotland are 168 and 186 per 100,000 respectively, but only 50 and approximately 45 
(32-58) for France and Spain (Pugliatti et al., 2006).  In the United States (US) there also 
exists a gradient of MS prevalence that is dependent on latitude where the prevalence of 
MS is generally higher in northern states compared to southern states (Kurtzke, 1980).  
Nevertheless, the overall prevalence of MS worldwide is estimated at over 2.5 million 
(Compston and Coles, 2002) and the prevalence of MS in the US is estimated between 
250,000 to 350,000 (Anderson et al., 1992; Hirtz et al., 2007).  Even though the 
incidence and prevalence of MS is lower than other neurological diseases (Hirtz et al., 
2007), the age of onset and debilitating nature of the disease ensure a high cost to the 
patient as well as society.  For instance, MS has an estimated medical cost of over $2 
billion per year in the UK (Homes et al., 1995) and $6.8 billion per year in the US 
(Whetten-Goldstein et al., 1998). 
 The onset of multiple sclerosis usually occurs between the ages of 15 and 40 
(Kantarci and Weinshenker, 2005) although in rare cases individuals have certainly been 
diagnosed with MS before and after this timeframe.  MS, like other autoimmune diseases 
including lupus, and rheumatoid arthritis, has a predilection for females rather than 
males which is illustrated by the fact that the odds ratio of being diagnosed with MS is 
2:1 female to male (Noseworthy et al., 2000; Hirtz et al., 2007).  However, males, for 
reasons unknown, present with a more exacerbated disease than females (Kantarci and 
Weinshenker, 2005).  
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1.2  Natural history of multiple sclerosis 
For each case of MS, the natural history is extremely heterogeneous in nature 
(Noseworthy et al., 2000; Pugliatti et al., 2006).  The initial symptoms at onset generally 
include, but are not limited to, optic neuritis, L’hermitte symptom, involuntary limb 
movement, ataxia, fatigue, incontinence, and vertigo (Noseworthy et al., 2000).  As the 
disease progresses, patients may experience cognitive difficulty, sexual dysfunction, 
paralysis, gait ataxia, incontinence, pain, depression and fatigue (Noseworthy et al., 
2000).  Typically, the disease will take on a relapsing remitting (RRMS) course where 
the patient will experience a neurological symptom lasting 24 hours or more in duration, 
followed by nearly complete remission (Wingerchuk et al., 2001).  This type of MS 
occurs in approximately 85% of patients (Kantarci and Weinshenker, 2005).  During 
RRMS, relapses are associated with the appearance of hyperintensive T2-weighted 
lesions of the white matter in the CNS indicating edema and tissue damage, as well as 
hypointensive T1-weighted lesions indicating atrophy, and hyperintensive gadolinium 
(Gd) enhancing T1 weighted lesions indicating disruption of the blood-brain barrier 
(BBB) (Neema et al., 2007).  These inflammatory events that occur during relapse are 
mirrored by the pathological findings within the lesion which include microgliosis 
(hypercellularity), activated macrophages, both lipid and myelin-laden macrophages, the 
presence of CD4+ and CD8+ T-cells, plasma cells, antibody and complement (Frohman 
et al., 2006).  A heterogeneity between lesions of different MS patients has been 
described, and potentially characterizes patients into four groups based on the 
occurrence or absence of macrophage, T-cell, antibody, complement and apoptosis 
 4
within the lesion (Luccinetti et al., 1999; 2000).  This heterogeneity between patients 
may suggest four distinct types of disease, but these findings await conformation as 
several groups have now demonstrated that more than one category of lesion can appear 
in one patient at the same time, which indicate that the results observed by Luccinetti 
may be attributable to the evolution of the lesion over time (Barnett and Prineas, 2004; 
Breij et al., 2008).  
After a time, most patients will continue to develop secondary progressive 
multiple sclerosis (SPMS) which is characterized as a slow continuing progression of 
symptoms with few or no relapses and is generally unresponsive to treatment (Kantarci 
and Weinshenker, 2005).  During this phase of the disease, it is believed that the 
symptoms progress due almost exclusively to neurodegenerative processes, which is 
apparent by the decreases in N-Acetylaspartate levels, a neuronal cell marker, by 1H-
MRS and by apparent “black holes” by T1-weighted MRI which correspond to increases 
in cerebral atrophy (Neema et al., 2007).  Unfortunately, there is currently no apparent 
reason for the switch from RRMS to SPSM, although some indicators such as age, 
gender, and the appearance of more than one lesion at onset, can predict a more rapidly 
advance to SPMS (Kantarci and Weinshenker, 2005).  
 Interestingly, not all patients will progress in the above-mentioned natural 
history.  Instead, about 10-15% will develop a primary progressive form of the disease 
(PPMS) in which the relapsing remitting phase is seemingly skipped (Miller and Leary, 
2007).  PPMS is thought to differ from RRMS in that patients generally have a later 
onset (40 years of age), coinciding with the time in which RRMS patients normally 
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progress to SPMS, and experience more symptoms consistent with motor impairment of 
the spinal cord rather than sensory impairment (Miller and Leary, 2007).  Peculiarly, 
unlike RRMS, there is no gender predilection in PPMS (Miller and Leary, 2007).   
Benign MS is characterized by a failure to exhibit clinical MS symptoms for 
decades, and in some cases the patients will never experience a secondary symptom 
(Ramsaransing and Keyser, 2006).  The incidence of this disease varies widely 
depending on the geographic location studied (Ramsaransing and Keyser, 2006).  
Interestingly, these patients have shown to possess the same T2-lesion volume, but at the 
same time demonstrate almost no decreases in markers of neuronal loss (Ramsaransing 
and Keyser, 2006).  The progression of multiple sclerosis is currently measured by the 
expanded disability status score (EDSS) designed by John Kurtzke (Kurtzke, 1983), and 
by MRI – the latter being more indicative of cognitive dysfunction.   
 
1.3  Diagnosis of multiple sclerosis 
For the clinician the diagnosis of MS is difficult for several reasons.  First, the 
symptoms at onset are similar to other idiopathic disorders of the CNS.  A perfect 
example is the presentation of optic neuritis (ON).  While approximately 38% of patients 
with an initial presentation of ON will develop MS within ten years, some will develop 
neuromyelitis optica, but most will keep the diagnosis of ON, which is itself considered 
a separate idiopathic disease (Kantarci and Winshenker, 2005).  Secondly, there are 
currently no disease markers available to test exclusively for MS.  For instance, even 
though it is known that the occurrence of oligoclonal bands in the cerebral spinal fluid 
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(CSF) are indicative of MS and are, incidentally, used in the diagnosis of MS, these 
banding patterns are also present in virally-induced meningitis and as such cannot be 
relied on exclusively in the ascertainment of MS.  Therefore, the diagnosis of clinically 
definite MS must adhere to the following criteria set forth by Poser (1983) and modified 
by McDonald (2001).  The symptoms must show dissemination of lesions typical of MS 
between “time and space”, and all other potential diseases must be excluded (Poser et al., 
1983; McDonald et al., 2001).  For example, a patient must demonstrate a least two 
relapses lasting no lessthan 24 hours in duration (time), that occur at least 30 days apart, 
each of which demonstrate different affected areas (space).  If two separate relapses 
occur that cannot be designated to a different anatomical location by the presentation of 
clinical symptoms, visual evoked potentials (VEP) can be used to determine lesion 
within the visual pathway or MRI findings can substitute (McDonald et al., 2001).   In 
fact, MRI analysis alone can provide evidence of clinically definite MS given that three 
out of four of the following are ascertained over time: one hyperintensive Gd-enhancing 
T1 or nine hyperintensive T2 lesions, at least one infratentorial lesions, at least one 
juxtacortical lesion, or at least three periventricular lesions (McDonald et al., 2001).  
Additionally, one spinal cord lesion that is typical of MS as seen on MRI can substitute 
for one brain lesion (McDonald et al., 2001).  Oligoclonal banding in CSF can also 
provide evidence typical of MS, even though it has no bearing on the dissemination of 
lesions (McDonald et al., 2001).  The diagnosis is reached when the above-mentioned 
criteria are met.  Therefore, if a patient at presentation has had two or more attacks with 
clinical evidence of two or more lesions, no additional evidence is needed for a 
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diagnosis.  However, if a patient at presentation has had one attack with MRI 
demonstrating two or more lesions, the patient still needs to demonstrate dissemination 
in time, which can be obtained by future MRI analysis or by a second clinical attack 
(McDonald et al., 2001).  Alternatively, if the patient has had two or more attacks, but 
only one clinically apparent lesion, then the patient needs to still show dissemination in 
space, by MRI or two or more MRI lesions with a CSF that is positive for oligoclonal 
bands or by future clinical symptoms indicative of a different affected area (McDonald 
et al., 2001). 
 
1.4  Biological markers of multiple sclerosis 
The difficulty in achieving a diagnosis of clinically definite MS can be 
frustrating both to the patient as they face the uncertainty of the future of their disorder 
and to the clinician as they are forced to withhold potentially beneficial treatment until a 
diagnosis can be reached.  Because the requirement of dissemination between time and 
space must be met before a diagnosis, and given that most patients only experience 1-2 
relapses per year during RRMS, this process could take a substantial amount of time.  
Additional markers of MS are needed to be discovered that will expediate the process of 
obtaining a valid diagnosis as well as a prognosis.  
 On this note, the presence of serum IgM antibodies directed against either 
myelin oligodendrocyte glycoprotein (MOG), a component of myelin that has an Ig 
domain exposed to exogenous space, or myelin basic protein (MBP), a major constituent 
of myelin, have been reported to be of prognostic value and, in fact, correlated with Gd-
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enhancing MRI findings (Berger et al., 2003).  These results are still preliminary as later 
studies conducted by the same group and others have both supported and negated these 
initial observations (Reindl et al., 2006).  
Other markers that may hold some promise in aiding diagnosis are the acute 
phase proteins: C-reactive protein (CRP) and serum amyloid A (SAA).  CRP is the 
major human acute phase protein that can increase up to 10,000 fold within 24 hours 
following an inflammatory event and has a half-life of 19 hours (Pepys and Hirschfield, 
2003).  SAA, also found in humans, is the only molecule with the capability to fluctuate 
between such dynamic ranges as CRP (Pepys and Hirchfield, 2003).  Both CRP and 
SAA have been reported to be increased in the serum of RRMS patients during relapse 
(Wei and Lightman, 1997; Ristori et al., 1998; Boylan et al., 2001), a finding that has 
recently been confirmed for serum CRP by Soilu-Hannieen et al., (2005).  Also, it has 
been shown that over time CRP levels significantly correlate with change in brain 
volume (Giovannoni et al., 2001a) as well as correlate with fatigue in MS patients 
(Giovannoni et al., 2001b).  However, it is important to mention here that acute phase 
proteins, as well as cytokines, reactive oxygen species (such as nitric oxide) and cell 
activation markers would never be specific as they are increased by nearly all 
inflammatory events – including atherosclerosis (Pepys and Hirschfield, 2003; Du Clos, 
2003). 
Another marker with potential in both diagnosis and prognosis is the NOGO-A 
isoform.  NOGO-A is a recently discovered neuronal growth inhibitor that is present in 
abundance in myelin and oligodendrocytes (Chen et al., 2000; Kuhlmann et al., 2007).  
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Interestingly, Jurewicz et al. have demonstrated that the N-terminal region of the soluble 
form of the NOGO-A protein is detectable in the CSF of as many as 96% (110 of 114) of 
patients with MS (both RRMS and SPMS), 100% of patients with clinically isolated 
syndromes (11 of 11), and no patients with other neurological diseases (including 
meningo-encephalomyelitis, Creutzfeldt-Jakob disease, epilepsy, vascular event, cranial 
nerve palsies, and chronic inflammatory demyelinating polyneuropathy) or autoimmune 
diseases (systemic lupus erythematosus, and neuromyelitis optica) (Jurewicz et al., 
2007).   Moreover, this protein was detectable in the early and later stages of disease 
(Jurewicz et al., 2007).  However, this finding awaits conformation.   
 
1.5  Autoimmunity in multiple sclerosis 
The major problem in the ascertainment of biological markers specific to MS is 
the fact that it is an idiopathic disease.  Even though much is known about the 
immunology of MS (reviewed by Sospedra and Martin, 2005), it remains to be proven 
that MS is actually an autoimmune disease, since it is unethical to fulfill Witebsky’s 
postulates.  Witebsky’s postulates for autoimmunity were proposed in 1957 following 
his observations on the role of auto-reactive antibodies in chronic thyroiditis, and are 
modeled after Koch’s postulates (Witebsky et al., 1957).  According to Witebsky, for 
autoimmunity to exist; an “active” autoantibody must be isolated from the circulation; 
the corresponding antigen must then be identified, and produce autoantibodies following 
injection into experimental animals; and must result in disease which resembles the 
human disorder (1957).  Rose and Bona have since revised Witebsky’s postulates to 
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include direct, indirect and circumstantial evidence of autoimmunity based on the 
current knowledge of molecular immunology (Rose and Bona, 1993).  Here, for 100% 
confirmation (direct proof) of autoimmune-induced disease, the transfer of autoantibody 
or autoreactive T-cells into a recipient must produce disease – hence the above 
mentioned ethical problems (Rose and Bona, 1993).  However, indirect proof of 
autoimmunity can be provided by: the pathogenic transfer of reactive T-cells to naive or 
severely combined immunodeficient (SCID) mice, the induction of disease in animals by 
autoantigen, the identification of inflammatory cells at the site of lesions, through 
genetic models, and by the presence of autoantibodies in serum (Rose and Bona, 1993).  
Finally, circumstantial evidence of autoimmunity is demonstrated by familial 
aggregation, lymphocyte infiltration of the target organ, statistical associations with 
MHC alleles, and responsiveness of patients to immunosuppressive treatments (Rose and 
Bona, 1993). 
Even though there is no way to prove that MS is an autoimmune-mediated 
disease, there is substantial indirect as well as circumstantial evidence suggesting that 
the myelin damage within the MS lesion is brought about by autoinflammatory events.  
For example, some of the evidence for an autoimmune pathogenesis of MS includes the 
presence of autoreactive CD4+ and CD8+ T-cells in the CSF and plaques of MS patients, 
the presence of antibody in plaques and oligoclonal bands in CSF of MS patients, the 
association of inflammatory events around lesions, and lesions occurring in perivascular 
locations as well as periventricularly, indicating trafficking of cells into the CNS 
(Pugliatti et al., 2006).  Lipid and myelin-laden macrophages at the site of the lesion as 
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well as the responsiveness of RRMS patients to immunosuppressive therapy (i.e. 
cyclophosphamide and glucocorticoids) during relapse also indicates autoimmunity 
(Frohman et al., 2006).  Additionally, treatment with MBP in an attempt to induce 
tolerance in RRMS patients resulted in increased incidence of relapse (Bielekova et al., 
2000).  Another indication of autoimmune pathogenesis can be illustrated by the recent 
clinical trials with natalizumab, a humanized monoclonal antibody that recognizes the 
α4β1 integrin on T-cells and prevents their entry into the CNS by impeding diapedesis 
across the BBB.  This study found that in RRMS patients receiving treatment over the 
course of two years, 68% had reduced relapse rate and the hyperintensive T2-weighted 
lesion load was reduced by 83% (Polman et al., 2006). 
 Knowing about the pathogenesis of a disease may result in some effective 
treatments, but in order to develop an effective cure one must know the causation.  As 
stated previously, the cause of MS is not yet known.  However, multiple factors are 
thought to play a role in onset and exacerbation of the disease.  These include gender, 
genetic and environmental factors. 
  
1.6  Genetic influence on multiple sclerosis 
The familial association with MS onset was first postulated by Eichhorst in 1896 
(Dyment et al., 2004).  Today there is little question pertaining to a genetic involvement 
with MS.  For instance the λs, a measure used to estimate the degree of inheritability of a 
particular disease based on familial aggregation and population prevalence, is between 
20 and 40 (Hauser and Oksenburg, 2006).  Additionally, twin studies from both 
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Canadian (Ebers et al., 1986; Sadovnick et al., 1993; Willer et al., 2003) and Danish 
(Hansen et al., 2005a; Hansen et al., 2005b) groups indicate that the concordant risk 
among female monozygotic twins is between 25-30%, but only 3-5% among dizygotic 
twins.  However, it is interesting to note that gender may still have an influential role 
even among monozygotic twins as Willer et al., reported the risk among females to be 
34% ± 5.7% whereas in males the risk was 11.4% ± 7.4% (Willer et al., 2003).  While 
the risk of occurrence is high among twins it quickly begins to approach that of the 
general population in half-siblings (Sadovnick et al., 1996), adoptees (Ebers et al., 
1995), and spouses (Ebers et al., 2000), providing further evidence in support of a 
genetic association with MS. 
 While studies which focus on the familial aggregation of MS associate onset to 
an inheritable trait, linkage mapping studies have demonstrated that the genetic 
association with MS is extremely multigenic.  This is best illustrated by Table 1-1 which 
shows statistically significant regions of the genome that have been associated with MS 
(Dyment et al., 2004).  Indeed, all human chromosomes, with the exception of 
chromosome 21, display at least one locus that is associated with the disease (Dyment et 
al., 2004).  Most recently, genome wide scans for single nucleotide polymorphisms 
(SNPs) of 931 family trios in which both parents and one child had MS versus. 2431 
controls demonstrated multiple SNPs located within the IL-2Rα (p = 2.96 x 10-8),  IL-
7Rα, (p = 2.94 x 10-7)  and HLA-DRA locus (p = 8.94 x 10-81) (Hafler et al., 2007).  As 
these genes are strongly associated with CD4+ T-cell responses, these findings provide 
circumstantial evidence for autoimmunity in MS. 
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 Among the associated alleles for multiple sclerosis are several HLA class I 
alleles.  In fact, the first genetic association with MS was determined to be the HLA-A3 
allele (Jersild et al., 1972; Naito et al., 1972).  These initial findings have been 
substantiated by Fogdell-Hahn et al. (2000), who demonstrated that 41% of MS patients 
(n = 200) were positive for HLA-A*0301 compared to 25% of controls (n = 210).  
Additionally, this group also noted a statistically positive association with the HLA-
B*0702 allele, which was subsequently found to be in linkage disequilibrium with HLA-
DRB1*1501 (see below) (Fogdell-Hahn et al., 2000).  The most interesting finding by 
this group was their ability to demonstrate a negative association with the HLA*A0201 
class I allele, such that 45% of MS patients are positive for HLA*A0201 compared to 
61% of controls (odds ratio = 0.52; p = 0.005).  Surprisingly, further analysis by this 
group indicated a protective effect of HLA*A0201, as the presence of this allele and 
HLA-DRB1*1501 actually lowered the risk for developing MS from 3.6 to 1.5 in a 
Swedish population (Fogdell-Hahn et al., 2000).  Even though these associations are not 
the strongest, they may prove to have merit, especially when considering the fact that all 
cells of the CNS are capable of expressing MHC class I (Hoftberger et al., 2004; Friese 
and Fugger, 2005), MHC class I expression is upregulated in MS lesions (Friese and 
Fugger, 2005), and that the majority of infiltrating T-lymphocytes occurring in the 
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Table 1-1  Positive linkage regions associated with MS
Chromosome
Chr1 p35, p21, q11-24, q31, q42-44
Chr2 p23, p21, p13, q24-33, 2q36
Chr3 p26, p25, p14, q21-24, 3q26
Chr4 p16, q12, q24, q26-28, q31-35
Chr5 p14-tel, p14-12, q11-13, q13-23, q33
Chr6 p25, p21, q14, q21, q22, q26, q27
Chr7 p21, p15, p14, q11, q21-22, p32-35
Chr8 8p23-21
Chr9 q21, p24-22, q34
Chr10 p15, p12-13, cen, q21-22, q24, q26
Chr11 p15, q25, q22
Chr12 12p13, q21, q23, q24
Chr13 q31-32, q33-34
Chr14 q32
Chr15 q21, p24-22, q34
Chr16 p13, p11, q23-24, q12






ChrX p21, p11, p22, q23-28, q26
Taken from Dyment et al., 2004 with slight modification
Highlighted regions (Chr5p13, 6p21and 10p15) represent strongest 
known associations with MS as discerned by Hafler et al., 2007





lesions of MS patients are CD8+ T-cells outnumbering CD4+ T-cells by approximately 
3:1 (Babbe et al., 2000).  Additionally, there is evidence that the CD8+ T-cells within 
MS lesions have been oligoclonally expanded (Bebbe et al., 2000).  Furthermore, the 
number of CD8+ T-cells in the CNS of MS patients has been shown to be correlative 
with neuronal damage (Friese and Fugger, 2005).  Moreover, the negative association 
and protective effects of HLA*A0201 could indicate the involvement of suppressor T-
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cells in curbing autoimmune CD4+ T-cell responses to myelin antigens.  Alternatively, 
this protective effect may be illustrating the benefit of this allele in clearing the CNS of 
an infectious agent as indicated by its ability to specifically bind epitopes from both 
measles and vaccinia viruses (van Els et al., 2000; Johnson et al., 2005).  However, it is 
important to mention, that in patients with MS, HLA-A*A0201 it has been shown to 
recognize epitopes originating from transaldolase as well as MOG resulting in lysis pf  
oligodendrocytes in vitro (Niland et al., 2005; Mars et al., 2007). 
 Not long after the discovery of associations with HLA class I alleles was made, 
the discovery of a stronger association on the HLA class II allele was found, which may 
confirm the relationship with CD4+-mediated responses and disease susceptibility 
(Jersild et al., 1973).  As mentioned above, HLA-DR is highly associated with 
susceptibility to MS (Hafler et al., 2007).  HLA-DRB1 is also strongly associated with 
the onset of the disease as determined through the genotyping of over 4000 individuals 
from Canadian and Finnish families using a high-density SNP panel, which covered the 
genes encoding MHC and flanking genomic regions (Lincoln et al., 2005).  Within the 
HLA-DRB1 locus, HLA-DRB1*1501 is the most consistently associated allele (Hauser 
and Okenberg, 2006).  However, the issue becomes more confused when other HLA 
alleles are taken into consideration.  For instance, Okenberg recently found that HLA-
DRB1*15 in the absence of DQB1*0602 is associated with the onset of MS in African 
American MS patients (Oksenberg et al., 2004).  In contrast, Caballero et al. (1999) 
found the opposite, that in Brazilians of African origin DQD1*0602 and DQA1*0102 in 
the absence of DRB1*1501 are associated with MS onset.  Even still, a dose effect for 
 16
the HLA-DR15 loci seems to exist (Barcellos et al., 2003; Modin et al., 2004).   Most 
interesting is the relationship between HLA-DRB1*1501 (DR2b) and HLA-DRB5*0101 
(DR2a), which are located 85 kb apart and are in almost complete linkage disequilibrium 
(always inherited together).  These alleles code for MHC class II molecules that are 
capable of binding the immunodominant peptide MBP85-99 (Madsen et al., 1999).  
Moreover, when transgenic mice possessing these humanized alleles are crossed with 
RAG-/- transgenic mice that possess T-cells receptors (TCR) extracted from cloned T-
cells from MS patients, they develop spontaneous experimental autoimmune 
encephalomyelitis (EAE), providing strong indirect evidence that MS is autoimmune 
mediated (Madsen et al., 1999).  Using this “humanized mouse model” of MS, 
Gregersen et al. demonstrated that 88% of mice expressing human T-cell receptors from 
MS patients as well as DR2b, developed spontaneous EAE, while mice expressing DR2a 
do not develop disease (2006).  Moreover, when these alleles are coexpressed, the 
disease incidence is decreased and the onset of EAE is delayed (Gregersen et al., 2006).  
Finally, using Annexin-V as a marker for apoptosis, the authors were able to conclude 
that DR2a functions to regulate DR2b by promoting peripheral tolerance (Gregersen et 
al., 2006).  Taken together these results strongly demonstrate the linkage between HLA, 
T-cells, the immune response and MS, as well as the fact that MS can be modulated by 
the alleles. 
 Despite the strong link between HLA and MS, this region is only thought to 
account for 17-60% of the genetic association of the disease (Hauser and Oksenberg, 
2006; Hillert, 1993; Haines et al., 1998), while the remaining 40-83% is located outside 
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the HLA.  As the HLA is located at chromosome 6p21, this means that any of the other 
currently identified 76 loci on 22 chromosomes (Table 1-1) could potentially play a role 
in MS onset and/or exacerbation.  Other than the recently observed associations with IL-
2Rα and IL-7Rα (Hafler et al., 2007), some of the other candidate genes that may be 
involved are TCRβ chain, the inhibitory ligand cytotoxic T lymphocyte antigen-4 
(CTLA-4), TNF-α, TNF-β, and the intracellular adhesion molecule (ICAM)-1 (Sospedra 
and Martin, 2005).  Additionally, specific myelin proteins (i.e. MBP) as well as other 
CNS specific proteins have also been implicated of which apolipoprotein 5 (APOE4) has 
shown some promising, but controversial results (Sospedra and Martin, 2005). 
  
1.7  Infectious etiology of multiple sclerosis  
The possibility that multiple sclerosis could be brought on by an infectious agent 
was first proposed in 1884 by Charcot’s former student Pierre Marie (Marie, 1884).  
While no infectious agent, neither viral, bacterial nor parasite, has been exclusively 
associated with MS onset, there is some substantial evidence that supports the role of 
environmental pathogens in both the onset and exacerbation of the disease.  As 
mentioned previously, the concordance risk for monozygotic twins is approximately 
30%, which means that 70% of the time the non-affected twin, sharing 100% genetic 
material will not develop signs or symptoms of MS, even on a subclinical level as 
determined by MRI (Sadovnick et al., 1993).  Moreover, while 30% concurrent twin rate 
among monozygotic twins may support a genetic contribution to onset, it is far from 
causative as Cook reminds us that there was reported in 1951 a very similar concordance 
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rate from poliomyelitis among twins (Cook, 2006, Herndon and Jennings 1951; 
Eldridge, 1987). 
 Additionally, evidence suggestive of a pathogenic etiology consists of the 
previously mentioned gradient of MS prevalence.  On this topic it is important to 
mention that migration studies have demonstrated that the risk for developing MS 
increases in people who migrate to a higher risk area prior to ages 15-16, whereas the 
risk decreases when people migrate to a lower risk area prior to ages 15-16 (Kurtzke, et 
al., 1985).  The incidence rate does not change following onset of puberty and migration 
(Kurtzke, et al., 1985) which must be taken into consideration when examining the 
incidence among adoptees, spouses and half siblings. 
 Moreover, “outbreaks” of MS have been reported, with the most famous being 
that which occurred on the Faroe Islands (Kurtzke et al., 2001).  Prior to 1943, not a 
single diagnosis of MS had been made on the Islands, but soon after, 76 cases were 
diagnosed in areas that were occupied by British troops during World War II (Kurtzke et 
al., 2001).  As a result of these epidemiological and migrational studies, Kurtzke 
believes the causative agent for MS to be infectious, widespread and persistent, but 
asymptomatic in most cases (Kurtzke et al., 2001).  He refers to this agent as “primary 
multiple sclerosis affection” (PMSA). 
 The possibility for the existence of PMSA is demonstrated by the occurrence, in 
animal and man, of known viruses that cause similar symptomatology to MS.  For 
instance, canine distemper virus in dogs (Wisniewski et al., 1972), Visna virus infection 
in Icelandic sheep (Sigurdsson et al., 1957), Semliki Forest virus infection, the JHM 
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strain of mouse hepatitis virus, and Theiler’s murine encephalomyelitis virus (TMEV) in 
mice all result in demyelination (Weiner, 1973; Daniels et al., 1952; Lipton, 1975).  In 
man, several viral infections of the CNS are known to cause demyelination.  For 
instance, acute disseminated encephalomyelitis, a monophasic immune-mediated 
demyelinating disease, is readily associated with viral infections as well as vaccinations 
(Tenembaum et al., 2007).  Moreover, subacute sclerosing panencephalitis, another 
demyelinating disease, can occur within months to years following morbillivirus 
infection, in particular measles virus.  JC virus, an endemic virus in man, can infect 
oligodendrocytes in severely immunosuppressed people resulting in of progressive 
multifocal leukoencephalopathy, a rapidly occurring demyelinating disease of which 
there are no known survivors (Berger, and Koralnik, 2005). Moreover, there exist 
widespread, generally asymptomatic latent infections with neurotropic viruses such as 
herpes viruses in the normal population (Challoner et al., 1995).  Indeed, a great number 
of viruses and several bacteria have been isolated from the brains of MS patients.  A list 
of the viruses that have been isolated from the CNS of MS patients can be viewed in 



















































































































































































































































































































































































































































































































































































































































































































MS.  Additionally, oligoclonal bands in the CSF are known to react to viruses, and MS 
patients generally have increased humoral responses to viruses in their serum.  MS 
exacerbations are also associated with viral infections (Buljevac et al., 2002).  Taken 
together, these data may exclude the possibility that PMSA is in fact one infectious 
agent; rather it could be one of several agents acting within the CNS to elicit an 
autoimmune response.  Mechanisms by which viruses could induce autoimmunity 
toward myelin are through molecular mimicry, bystander activation, and superantigenic 
activation of T-cells (myelin specific T-cell clones).  The response could later be 
propagated to other parts of myelin by epitope spreading (Croxford et al., 2002).   
 Molecular mimicry occurs when a foreign antigen has a structural or molecular 
composition that is almost identical to that of a self-antigen resulting in autoimmunity.  
Currently, several autoimmune diseases are thought to have initiated from infection for 
which the responsible microbe contains a molecular mimic of a self antigen.  Some of 
the most popular examples are streptococci induced Rheumatic fever, Coxsackievirus B3 
infection and autoimmune myocarditis, Borrelia burgdorfi and Lyme arthritis, and HSV-
1 and herpetic stromal keratitis (Benoist and Mathis, 2001).  One of the strongest cases 
of molecular mimicry comes from the association of Borrelia burgdorfi and Lyme 
arthritis.  Borrelia burgdorfi, the spirochete that causes Lyme disease, contains an 
epitope that closely resembles human leukocyte function-associated antigen 1α (LFA-
1α; L332-340), a protein that can be isolated from synovial fluid.  Interestingly, the 
MHC class II antigen HLA-DRB1*0401, typically associated with Lyme arthritis, is 
capable of binding L332-340 in Lyme arthritis patients.  In conjunction, these patients 
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possess T-cells that respond to L332-340 (Benoist and Mathis, 2001).  Taken together, 
these results strongly implicate molecular mimicry in the pathogenesis of Lyme arthritis. 
 Fairly recently, Wucherpfenning and Strominger have demonstrated how 
molecular mimicry could be implicated in the pathogenesis of MS patients (1995).  
Using L cell transfectants of DRB1*1501 (a susceptibility allele of human MS) which, 
as mentioned previously, is known to present a peptide sequence from myelin basic 
protein (MBP85-99) the authors screened over 600 sequences from viral and bacterial 
genomes for similarity.  They then tested all of the 129 potentially positive sequences for 
their ability to induce proliferation by co-inbubation of the L cell transfectants with 
human T-cell clones possessing T-cell receptors to MBP85-99.  Their screen demonstrated 
molecular mimicry to several viral sequences including herpes simplex virus, Epstein-
Barr virus, adenovirus, Influenza A virus and human papillomavirus (Wucherpfennig 
and Strominger, 1995).  More recently, Lang et al., demonstrated that the class II 
DRB1*1501 allele was specific for MBP85-99 peptide presentation, while the 
DRB5*0101 allele is specific for the EBV DNA polymerase sequence (molecular 
mimic) (Lang et al., 2002).  However, a T-cell receptor isolated from an MS patient 
(Hy.2E11) recognized both MHC molecules (Lang et al., 2002).  It is important to note 
that 99% of MS patients have antibodies to EBV compared to 90% of the general 
population; that 83-99% of children with MS are seropositive for EBV compared to 42-
72% of age-matched controls, and that EBV reactivation is correlated with relapse in MS 
patients (Sumaya et al., 1985; Alotaibi et al., 2004; and Pohl et al., 2006; Wandinger et 
al., 2000).  Interestingly, it has also been demonstrated that CD4+ T-cell clones taken 
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from the CSF of patients during relapse reacted to Torque teno virus, a relatively newly 
discovered orphan virus (Sospedra et al., 2005). Taken together, these data demonstrate 
a strong potential for molecular mimicry in the pathogenesis of MS, as well as point to 
infectious agents as triggers for autoimmunity. 
 Another way in which viruses and bacteria could lead to autoimmune responses 
is through the expansion of autoreactive T-cell clones by superantigenic activation.  
While central tolerance occurring in the thymus is effective at eliminating the body of 
most autoreactive cells through positive and negative selection processes, some 
autoreactive cells escape, and are present in the circulation.  This is clearly indicated by 
the fact that both MS patients, and healthy controls, possess T-cell clones that are myelin 
specific in their circulation (Frohman et al., 2006).  In this regard, Sutkowski et al. have 
recently demonstrated that the latent membrane protein LMP-2A of EBV can 
transactivate the human endogenous retrovirus HERV-K18 resulting in the transcription 
of a superantigen (Sutkowski et al., 2001; 2004).  Thus, EBV infection could 
theoretically bring about expansion of autoreactive T-cell clones by induction of 
superantigenic stimulation.  Bystander activation of these clones within the CNS could 
also result in autoimmunity (Sospedra and Martin, 2005).  Alternatively, a persistent 
infection may lead to the generation of new autoreactive T-cell clones by this method.  
In this scenario, a persistently infected tissue (especially one infected with a lytic virus) 
causes the constant release of self-antigens in the presence of an adjuvant (i.e. the virus).  
This constant inflammation may then result in the loss of tolerance (Sospedra and 
Martin, 2005).  This concept becomes a legitimate possibility when considering that 
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autoimmune-mediated myocarditis is probably brought on by Coxsackievirus B3 
infection (Whitton and Feuer, 2004).  Moreover, Furtado et al., (2006) have shown that 
the conditional expression of Flt3 (an hematopoeitic factor for DCs and macrophages) in 
transgenic mice expressing the chemokine CCL2 in parenchymal cells resulted in 
spontaneous ascending paralysis that was T-cell independent (Furtado et al., 2006). 
 
1.8  Stress and multiple sclerosis  
A relatively underappreciated, but certainly prevalent, environmental stimulus 
that may help facilitate the onset of MS is psychological stress.  Stress was first 
associated with MS onset by Charcot in one of his initial descriptions of the disease 
(Charcot, 1877).  To date it has been demonstrated that nearly all MS patients report the 
occurrence of a major stressful life event within the two years prior to onset of their 
disease (Warren et al., 1982; Grant et al., 1989).  Li et al. demonstrated that parents who 
had lost a child were at elevated risk of developing MS, and that those who lost a child 
unexpectedly were at even higher risk for developing MS (Li et al., 2004).  Stress has 
also been shown to play a role in the exacerbation of RRMS, as illustrated by a meta-
analysis of 14 studies conducted by Mohr et al. (2004), which showed that stress resulted 
in increased risk of exacerbation (Mohr et al., 2004).  Most recent studies by Brown et 
al. indicate that it is, in fact, the number of acute stressful life events rather than chronic 
stressors that can predict relapse in disease (Brown et al., 2006a; Brown et al., 2006b).  
Mechanistically, stress could influence the pathogenesis and subsequent progression of 
MS in several fashions. According to Mohr and Pelletier, stress-induced dysregulation of 
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the hypothalamic-pituitary-adrenal (HPA) axis responses can influence MS in 3 ways:  
through the resolution of the stressor, by glucocorticoid resistance brought on by over 
stimulation of HPA axis, or by glucocorticoid induced-mast cell degranulation resulting 
in BBB permeability (Mohr and Pellelier, 2006). 
 
2.  Stress 
2.1  Overview of stress 
The effects of stress on the immune system are pronounced and are brought 
about directly from responses generated in the brain as a result of perceived challenges 
(real or not) that threaten homeostasis.  The effector molecules that facilitate these 
responses are the hormone cortisol (corticosterone in mice) from the hypothalamic-
pituitary-adrenal axis and catecholamines (epinephrine and norepinephrine) released by 
direct sympathetic nerve innervation of immune organs or the medulla of the adrenal 
gland.  Interestingly, stress seems to have a bi-directional response on immunity such 
that acute stress can be immunostimulatory, but chronic stress is immunosuppressive 
(Dhabhar and McEwen, 1997), suggesting that stress (in all forms) may affect immunity 
to all infectious diseases.   
The term “stress” is difficult to define, and as McEwen often states is ambiguous 
in meaning (McEwen 2005; Korte et al., 2005).  However, one of the best and most 
precise definitions of stress is credited to Ramsey who states that stress can be defined as 
a state of altered (or threatened) homeostasis resulting from either an external or internal 
stimulus (Ramsey, 1982).  Here it is important to note that this state induced by a 
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stressor (or stimulus) can actually be threatening, but it can also be only perceived as 
such by the individual.  For instance, an exam (stimulus) can be perceived as threatening 
and become a stressor even though the exam itself does not pose much of a threat to the 
individual.  Once the stimulus is perceived as a stressor within the brain, a physiological 
response will be set into motion that will attempt to deal with the altered homeostasis.  
Adaption to stress requires the organism to make adjustments to its allostatic properties 
(see below), which may include; down-regulation of glucocorticoid receptor or 
catacholamine receptors within the cell or changing lifestyles to address the stressor (i.e. 
coping mechanisms).  Not all stressors or inducers of allostasis are bad, but the response 
to them depends on timing, duration, and type.  For instance acute stressors can be 
healthy, but chronic stressors (ones that significantly increase allostatic load) are 
generally unhealthy. 
Hans Selye is credited with making popular the concept of stress (McEwen, 
2005).  While trying to discover a new hormone, Selye noticed that his animals 
developed a specific response, which he termed as a syndrome, to many noxious stimuli, 
including cold exposure, surgical injury, morphine, formaldehyde and exercise (Selye, 
1936).  This response, which he coined the general alarm syndrome, consisted of three 
phases (Selye, 1936).  The first phase, occurring 6-48 hours after an alarm response 
ensued, was characterized by thymic, splenic, and hepatic atrophy, decreased fat tissue, 
loss of muscle tone, a decrease in body temperature, and hepatic necrosis.  The next 
response began after 48 hours and was characterized by a period of resistance.  In the 
beginning phases of resistance, the adrenal glands were enlarged, numerous basophils 
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accumulated at the pituitary, general body growth stopped, and the reproductive organs 
ceased to function.  With continued exposure to the noxious stimulus, the body’s 
functions begin to return to normal (Selye, 1936).  However, after about 30 days of 
exposure, the animal succumbed to the response and displayed symptoms similar to 
those initially seen in the first phase.  Therefore, the final phase was termed 
“exhaustion”.  Together this represents Selye’s general adoption syndrome (GAS) as it 
characterized the organisms attempt to adapt to an external challenge.  Key features 
within this description can illustrate the stress response.  First, the animal perceives a 
stressor and homeostasis is altered.  In the second phase, responses possibly originating 
in the adrenal gland (as it displays hypertrophy) return the animal to a state of 
homeostasis.  However, these responses seem to be only temporary as seen in the third 
phase by their failure to maintain homeostasis resulting in illness or death (McEwen, 
2005). 
Even though Selye’s GAS model remains in many ways applicable today, several 
flaws in his initial concept have recently been illustrated by work from Bruce McEwen’s 
laboratory and others.  Specifically, it has been illustrated that i) the HPA and SNS work 
differently to control the stress response, ii) the “fight or flight” response (which is 
essentially the basis for Selye’s model) does not equally apply to male and female 
responses, and iii) the exhaustion stage of Selye’s model implies an overall negative 
connotation for stress, whereas that may not be true depending on the context in which 
stress occurs (i.e. immunosuppression during autoimmunity) (McEwen, 2005).  Because 
of these reasons and the feeling that the word “homeostasis” has an overly strong 
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connotation in describing the influence of stress on physiological processes, McEwen 
and Stellar recently coined the concept of allostasis and allostatic load (McEwen and 
Stellar, 1993).  In this concept, homeostasis is concerned with the maintenance of 
physiological set points that are essential for life, such as blood pH, body temperature, 
glucose levels and oxygen tension, and allostasis refers to the maintence of homeostatsis 
through the regulation of cytokines, catecholamines, and hormones of the HPA axis – 
those responses that are not as essential for maintaining life (McEwen, 2005).  
Therefore, according to McEwen (2005), one can cope with changes in allostasis 
inflicted by stress, and in some cases, these changes can be beneficial.  For example, 
glucocorticoids produced from acute stress will facilitate lymphocyte trafficking from 
the secondary immune organs, such as the lymph nodes and spleen, to areas such as the 
skin in preparation for a perceived attack from a predator (Dhabhar and McEwen, 1997).  
However, with repeated stressor stimuli, the allostatic load increases and eventually 
crosses a threshold where it becomes detrimental to the animal resulting in 
immunosuppression (Korte et al., 2005).  Factors that influence allostatic load include i) 
repeated challenge, ii) failure to habituate, iii) failure to shut off in the absence of 
stimulus and iv) failure to mount an adequate response (Korte et al., 2005).   
While both Selye and McEwen illustrate models of the stress response, these 
models tend to differ in terms of their outcome on immunity.  For example, in Selye’s 
model, the outcome of continual stress is immunosuppression.  Strict adherence to this 
paradigm would indicate that stress always increases the susceptibility to infectious 
disease and decreases in autoimmune responses.  In contrast, the idea of allostasis and 
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allostatic load allows for differences in the outcome of infection depending on the type, 
duration and timing of the stressor.  In this model, moderate changes in allostasis leading 
to increases in certain cytokines or lymphocyte trafficking may prove to be beneficial in 
combating infectious agents, but at the same time detrimental to patients with 
autoimmune diseases such as multiple sclerosis (MS).  Alternatively, increases in 
allostatic load caused by constant stress could lead to immunosuppression, resulting in 
increased dissemination of a pathogen or reduction in exacerbation due to autoimmune 
responses.  
 
2.2  Stress and immunity  
As mentioned previously, the hypothalamic-pituitary-adrenal (HPA) axis, the 
sympathetic-adrenomedullary (SAM), and the sympathetic nerve innervation of the 
secondary lymphoid organs are directly implicated in the response to stress.  In terms of 
the HPA axis, stress can cause increases in corticotropin releasing hormone (CRH) from 
the periventricular nucleus of the hypothalamus that acts on the anterior pituitary gland 
to release adrenocorticotropin-releasing hormone (ACTH).  ACTH stimulates the 
adrenal cortex to secrete glucocorticoids (Webster et al., 2002).  The effects of 
glucocorticoids are numerous and biphasic.  For instance, glucocorticoids (GC) act on 
the liver to facilitate the release of glucose into the blood, thus regulating metabolism.  
However, GC elicits biphasic responses with regard to the immune system.  Here, a 
small amount of the hormone may be beneficial (facilitating lymphocyte trafficking) 
whereas larger amounts are immunosuppressive.  The actions of GC are facilitated in 
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two fashions.   First, GC binds to the glucocorticoid receptor (GCR) causing 
dimerization, activation and its translocation to the nucleus, where it binds the 
glucocoroticoid response element (GRE).  Binding of the GCR to the GRE will cause 
either the activation or repression of transcription.  Alternatively the activated GCR can 
influence transcription by molecular “crosstalk” which involves transactivation or 
transrepression, mediated by direct protein to protein interactions which occur between 
the GCR and other transcription factors.  In terms of immunosuppression, it has been 
shown that GCs can inflict their immunomodulatory responses at multiple levels.  For 
instance, GCs bound to their receptor can cause the inhibition of transcription factors 
(including NF-kB as well as AP-1), signal transducers and activators of transcription 
(STATs), as well as induce the expression of genes that will also facilitate 
immunosuppression, and may cause an overall shift in the immune response from Th1 
toward Th2 (discussed below).  Thus, in high quantities GCs are highly 
immunosuppressive (Webster et al., 2002). 
The effects of allostasis and allostatic load are also illustrated within the context 
of the effects of stress on the sympathetic nervous system.  Here, the perception of stress 
will activate the SNS to release epinephrine and norepinepherine in both the adrenal 
medulla and the secondary lymphoid organs.  The sympathetic nervous system regulates 
the “flight or fight” response within seconds.  Following the activation of the SNS, the 
stomach is inhibited, the heart is stimulated, arteries constrict, and lung airways relax 
shifting all responses toward an alerted state (as Selye would describe it).  However, 
unresolved stress results in arterial wall thickening due to hypertension, and adenergic 
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receptor desensitization (Fleshner, 2006).  Like GC, the SNS can modulate the immune 
system.  For instance, acute stress has been shown to be immunostimulatory, resulting in 
norepinepherine (NE) mediated enhancement of the innate immune system by releasing 
exogenous heat-shock protein (eHSP)72 from immune cells in an α1ADR dependent 
fashion (Fleshner, 2006) leading to a increased production of inflammatory cytokines, 
and inducible nitric oxide synthase (reviewed in Fleshner, 2006).  Because these actions 
are independent of antigenic challenge they may indicate that acute stress has a role as 
an adjuvant thereby functioning as the “danger-signal” to facilitate the start of an 
immune response (Fleshner, 2006).  These properties would be advantageous if they 
immediately preceded an infection, but would be disadvantageous if they occurred in 
patients with autoimmune diseases.  Like glucocorticoids, chronic activation of the SNS 
results in immunosuppression.  However, the mode by which this occurs is not yet 
clearly defined.  For instance, chronic stress results in the systemic increase in 
catecolamines.  Interestingly, Th1 and B-cells, but not Th2 cells, have receptors for 
catecolamines, indicating that direct exposure will modulate and perhaps shift these 
immune responses (reviewed in Sanders, 2006).  Indeed research in this area supports 
the idea that increases in NE, suppress adaptive Th1 immunity.  However, Fleshner has 
generated convincing data that suggest that a lack of NE rather than an increase in NE to 
the spleen is responsible for chronic stress-induced immunosuppresion of humoral 
responses (Fleshner, 2006).  The resolution of these seemingly conflicting ideas may be 
attributable to the effects of NE on B-cells and Th1 cells but not on Th2 cells.  
Alternatively, chronic stress may result in decreased expression of enzymes from the 
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neuron that is responsible for the uptake of NE after secretion, thus, extending the effects 
of the amine.  In any case, chronic activation of the SNS by stress results in the 
suppression of adaptive immune responses and might impede pathogenic clearance from 
the body but decrease exacerbation of autoimmune phenomenon. 
Following viral infection, the generation of an effective immune response is 
summarized as follows: resident dendritic cells (DC) phagocytose the pathogen, become 
activated and then transport it to the nearest lymph node.  Here, the antigen is presented 
to a helper T-cells (CD4+).  Upon the recognition of non-self by the T-cell and in the 
presence of co-activators, the T-cell will become activated, secrete cytokines which 
result (after recognition of the pathogen) in the activation of B-cells to secrete antibody 
and CD8+ T-cells to kill cells infected with the pathogen.  Importantly, the immune 
response generated by the CD4+ T-cell depends on the context in which it was stimulated 
by the DC.  For instance, T-cells stimulated with IL-12 will result in the activation and 
phophorylation of STAT4 resulting in activation of the transcription factor T-box-
expressed in T-cells (T-bet) which is both necessary and sufficient for Th1 polarization 
(Szabo et al., 2000).  Th1 cells are considered proinflammatory and are characterized 
primarily by their secretion of IFN-γ.  IFN-γ can activate macrophages and DCs to 
upregulate MHC class II expression, as well as costimulatory molecules (CD80/CD86), 
increase IL-12 production, and can stimulate STAT1 in T-cells influencing T-bet 
expression (moreso than STAT4) providing a positive feedback loop.  Th1 cells also 
produce Th1 type chemokine receptors (i.e. RANTES).  On the other hand, IL-4 
stimulation will result in the activation of STAT6 resulting in the activation of the 
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transcription factor GATA-3, which is necessary and sufficient for the generation of a 
Th2 response resulting in the secretion of IL-4, IL-5, IL-6, IL-10, and IL-13 from T-cells 
(Zheng and Flavell, 1997).  The Th2 cell functions in humoral immunity against 
helminths, and is considered to be anti-inflammatory.  Moreover, the chemokine CCL2 
or MCP-1 and granulocyte/monocyte colony stimulating factor (GM-CSF) are 
considered Th2 chemokines. 
Stress and glucocorticoids have profound effects on these cell signaling 
processes, and influence the generation of a Th1 or Th2 response.  Indeed, chronic stress 
or GC (including the synthetic GC dexamethasone) are thought to result in a shift from 
Th1 immunity toward Th2 immunity (Th1/Th2 shift).  However, like all other effects of 
stress, the timing, duration, and amount of GCs seem to play a role in these responses.  
For instance GC have been shown to decrease both STAT1 and STAT4 (Franchimont et 
al., 2000; Hu et al., 2003).  Additionally, they can induce the expression of a protein 
called glucocorticoid-induced leucine zipper (GILZ) which can upregulate GATA-3 
expression as well as STAT6 (Cannarile et al., 2006) in T-cells and is 
immunosuppressive in macrophages (Th2 type shift) (Berrebi et al., 2003).  These results 
strongly suggest a GC induced Th1 to Th2 shift as one mechanism of 
immunosuppression toward a viral pathogen.  However, it has also been shown that 
dexamethasone can directly inhibit the activities of GATA-3 on the IL-5 promotor (Jee 
et al., 2005; Quan et al., 2001).  Because GATA-3 is absolutely required for Th2 
polarization, these results suggest that no Th1 to Th2 shift occurs.  In support of an 
immunosuppressive effect of stress, Dobbs et al., (1993) have demonstrated that during 
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experimental influenza infection in mice both virus specific Th1 and Th2 cytokines are 
suppressed. 
Regardless of whether a Th1 to Th2 shift occurs or not, chronic stress drastically 
affects immune responses.  In the case of immunosuppression, the host will be rendered 
more susceptible to pathogens, and disease will be exacerbated.  In the case of 
autoimmunity, immunosuppression may result in alleviation of symptoms.  
 
3. Theiler’s virus 
3.1  Brief history of Theiler’s virus 
 In 1933, Max Theiler noticed that a mouse in his stock had developed 
spontaneous encephalitis and flaccid paralysis (Theiler, 1934).  Further analysis 
indicated that the agent that caused this disease in mice was non-filterable and 
approximately the same size as that of the virus of human poliomyelitis, but shared no 
serological identity to human poliovirus and was not able to infect non-human primates 
(Theiler 1934; 1937).  It was also determined early on that the natural incidence of this 
disease was approximately 1-2/1000 (Theiler, 1937; Sabin and Olitsky, 1938), that in 
mice that developed flaccid paralysis the spinal cord, but not the brain, were infectious 
for up to one year, and the feces infectious for up to 53 days (Theiler, 1937; Thieler and 
Gard, 1940).  Moreover, in normal, unaffected mice the virus was present in 65% of 
fecal content, and when the digestive system was meticulously examined it was found 
that the virus was most often isolated from the wall of the small intestine (Theiler and 
Gard, 1940; Olitsky, 1939).  These early studies indicated that the virus was endemic in 
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mice, was probably transmitted by a fecal-oral route, but only rarely caused disease of 
the CNS.  Interestingly, in the early studies by Theiler, Gard, Olitsky and Sabin it was 
noted that the age of infection greatly influenced the subsequent pathogenesis of flaccid 
paralysis (Theiler, 1934; Theiler and Gard, 1940; Olitsky, 1939).  In particular, mice 
aged 0-4 weeks often died of encephalitis, mice aged 5-7 weeks were most readily 
affected, but mice infected at a later age were completely resistant to the paralysis and 
disease (Theiler, 1934; Theiler and Gard, 1940; Olitsky, 1939).   
 Because of the size of the virus, and the appearance of polioencephalitic disease 
following intracerebral inoculation, the “virus of spontaneous encephalitis of mice” or 
Theiler’s virus, as it became known, was used as a mouse model of human poliomyelitis.  
However, subsequent histological and immunological characterization of the disease 
caused by Theiler’s virus would eventually change the use of TMEV from a model of 
human poliomyelitis to a model for human multiple sclerosis. The first findings that 
began this process occurred in 1948 when Joan Daniels recovered a strain of virus from 
her mouse colony at Harvard.  After extensive characterization of this virus, which was 
determined to be a strain of Theiler’s virus, the results were published in 1952.  It was in 
this paper that Joan Daniels first described a chronic form of disease which was 
characterized by demyelination (Daniels et al., 1952).  According to Daniels multiple 
lesions occurred in the meninges, the brain (medulla, midbrain, cortex, hippocampus and 
cerebellum), spinal cord, anterior nerve roots and sometimes in the peripheral nerves 
following intracerebral inoculation, but less frequently following intraperitoneal 
inoculation (Daniels et al., 1952).  As these lesions were similar to those induced with 
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spinal cord homogenate in complete freunds adjuvant in mice as described by Rain et al., 
(Experimental allergic encephalomyelitis) the authors could not rule out the possibility 
of post vaccination encephalomyelitis as their inoculate was generated from dilutions of 
spinal cord homogenate (Rivers et al., 1933).   
In 1975 the issue of pathogenesis was resolved.  By using Daniel’s (DA) strain of 
Theiler’s virus adapted to grow in baby hamster kidney (BHK) cells, Howard Lipton 
described a biphasic disease consisting of an early encephalitic phase followed by a 
chronic progressive phase in which 84% (n=177) of infected Swiss mice demonstrated 
demyelination (Lipton, 1975).  Like Daniel et al. (1952), Lipton also described an 
inflammatory infiltrate at the lesion site, an occurrence that has similarities to human MS 
(Lipton, 1975).  Subsequent studies indicated that the demyelination process occurring in 
the chronic disease state was immune-mediated as it could be inhibited by various 
immunosuppressive agents including administration of cyclophosphamide or anti-
thymocyte antibody (Lipton and Dal Canto, 1976) as well as by the administration of 
anti-CD4 or anti-CD8 antibodies (Welsh et al., 1987). Importantly, because a tissue 
adaptive strain of TMEV was used, the inoculate contained no residual CNS tissue and 
Lipton was able to dispel the possibility that demyelination was attributable to a post-
vaccination encephalomyelitis (Lipton, 1975).  Figure 1-1 demonstrates the differences 
between acute encephalomyelitis, which occurs during early disease (Fig. 1-1A-D), and 
the immune-mediated chronic demyelination phase which occurs in late disease (Fig. 1-
1E-H), confirming Lipton’s initial findings. 
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Figure 1-1.  Biphasic nature of Theiler’s virus infection.  A-D. Male SJL mouse experimentally 
infected with the BeAn 8386 strain of TMEV spontaneously presented with complete paralysis 
of the left leg accompanied by paresis of the contralateral limb as well as encephalitis at day 31 
p.i.  A.  H&E staining shows focal inflammation of the gray matter lateral to the central canal 
(arrows).  B.  Serial sections moving caudally, indicated focal inflammation of the lower motor 
horn of the gray (G) matter (arrows).  C. Lumber sections showed diffuse inflammation with 
tissue destruction (arrows) corresponding to the ipsilateral side of paralysis .  D.  Luxol fast blue 
staining demonstrated complete sparing of the white mater (W).  E-H.  Male SJL mouse showing 
typical signs of chronic demyelination sacrificed at day 195 p.i.  E.  Diffuse inflammation of the 
white (W) matter in the thoracic section of the spinal cord is illustrated by H&E staining, while 
serial sections stained for myelin with luxol fast blue (F) demonstrated two separate 
demyelinating lesions (arrows).   G.  Perivascular cuffs confined to the white matter (W) are 
easily distinguishable (arrows) by H&E staining which typically surround active sites of 
demyelination (H) illustrated by luxol fast blue staining.  
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Figure 1-1, continued. 
 
Because infection with TMEV causes immune-mediated demyelination, the 
production of anti-myelin antibodies in the serum (Rauch et al., 1987), including 
antibodies to MBP, MOG35-55, and PLP139-151 (Sieve et al., 2004), intrathecally produced 
antibodies (Pachner et al., 2007a), is pathologically influenced by gender (males affected 
more severely than females) (Fuller et al., 2005), the H-2 and non-H-2 associated alleles 
(Brahic et al., 2005), and the prevalence of virus among mice made this an excellent 
model in the study of human  MS (Olesack et al., 2004). 
 
3.2  Theiler’s virus infection and replication 
Theiler’s viruses belong to the Picornaviridae family of viruses and the genus 
cardiovirus (Ozden et al., 1986; Pevear et al., 1987).  Like other members of the family, 
including poliovirus, coxsackievirus, rhinovirus, foot and mouth disease virus, 
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encephalomyocarditis, and mengo virus, the Theiler’s viruses are small in size (28-30nm 
in diameter), contain a pseudo T=3 icosohedron shape, and consist of a positive sense 
single stranded RNA genome which is approximately 8100 neucleotides in length and 
contains one open reading frame.  Upon entry into the cell, (i.e. macrophages, 
monocytes, microglia, cerebrovascular endothelial cells, astrocytes, neurons, intestinal 
epithelial cells ect.) for which the receptor is not yet known, Theiler’s replication is 
thought to proceed in a fashion that is not dissimilar to other picornaviruses.  Here, the 
RNA genome, stabilized by the binding of the VPg to the poly-A tail template, contains 
an intraribosomal entry sequence (IRES) within the leader sequence.  This secondary 
RNA structure is able to bind to the ribosomes and is translated into a single long 
polyprotein.  This protein is subsequently cleaved into three progenitor proteins termed 
P1, P2, and P3.  The progenitor proteins undergo further cleavage processes which result 
in capsid proteins (VP1, VP2, VP3, VP4) from P1 and proteins involved in replication or 
cleavage from P2 (2A, 2B, 2C) and P3 (3A, 3B, 3C, 3D) for a total of 12 proteins.  The 
exception is the generation of L* which is translated from a sub-genomic reading frame 
located within the leader strand of both DA and BeAn 8386 strains (Oleszack et al., 
2004; Brahic et al., 2005).  As members of the family Picornaviridae do not contain an 
intravirion RNA dependent-RNA polymerase, replication of the genome follows protein 
synthesis, which both occur in the cytoplasm.  Indeed, protein 3D is the RNA-
dependent-RNA polymerase for TMEV (Johnston et al., 1995) as well as other 
picornaviruses.  Following the generation of 3D, replication of the genome occurs from a 
5’ to 3’ fashion within the cytoplasm producing a negative sense genomic strand, and 
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potentially a double stranded RNA intermediate.  The negative strand is used again as a 
template by the RNA-dependent-RNA polymerase and transcribed back into a positive 
sense strand.  The genome is packaged into the virion and the marture virions are 
released from the cell by lysis.   
Interestingly, while sequences across strains of Theiler’s viruses share 90.4% 
homology (Pevear et al., 1988) these strains can be further classified by pathology.  For 
instance, GDVII and FA are extremely neurovirulent and result in rapid onset of 
paralysis and fatality following nearly all routes of inoculation due, at least in part, to 
encephalitis (Kohanawa et al., 1995; Villarreal et al., 2006).  On the other hand, the 
Theiler’s Original (TO) subtypes which consists of the DA, BeAn 8386, Yale, and WW 
strains, are less neurovirulent, typically resulting in a sub-clinical acute infection which 
is easily cleared in resistant strains of mice.  However, in susceptible strains of mice, the 
TO viral strains will persist in glia (microglia, astrocytes, oligodendrocytes), and 
macrophages and monocytes for the duration of the animal’s life-span, and contribute to 
the onset and progression of the previously mentioned immune-mediated demyelination 
process. 
 
3.3  Innate immune responses to TMEV infection  
Clearance of viral infection is dependent on the generation of adaptive immune 
responses.  Innate immunity, acting through natural killer (NK) cells, activated antigen 
presenting cells (APC), and various cytokines and chemokines plays an imperative role 
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in both the limitation of viral dissemination and replication, as well as the generation of 
virus-specific adaptive immune responses during acute infection (Kim et al., 2005).  
The function of the innate immune response to TMEV infection has been the 
subject of considerable study and has recently been reviewed (Kim et al., 2005).  For 
instance Paya et al., (1989), as well as others, have demonstrated ablation of the NK cell 
response, through antibody-mediated depletion or through the use of NK cell deficient 
mice, resulted in increased gray matter disease of the central nervous system (Paya et al., 
1989; Kim et al., 2005). Furthermore, because NK cells are an important source of IFN-
γ, which can act to facilitate the signal transducer and activator of transcription (STAT)1 
dependent activation of the transcription factor T-box expressed in T cell (T-bet), early 
decreases in NK cell activity would be expected to influence Th1 polarization (Szabo et 
al., 2000).  Another role for NK cells in aiding in resistance is supported by studies that 
demonstrated that IFN-γ was required for resistance to TMEV-induced demyelination 
(Rodriguez et al., 1995).  It is important to note that while it has been shown that both 
CD4+ and CD8+ T-cells are important sources of this cytokine, the role of NK cells as a 
source of IFN-γ has not completely been elucidated (Murray et al., 2002).  
 Other cytokines have also been shown to be induced by infection with TMEV 
(Kim et al., 2005).  Of particular interest is the association of IL-12 with TMEV 
pathogenesis.   IL-12 is a heterodimer composed of IL-12(p35) and IL-12(p40) subunits 
forming active IL-12(p70).  Active IL-12, signaling through STAT4, strongly induces 
Th1-mediated responses in T-cells.  Interestingly, the depletion of IL-12 by antibody 
administration during the acute phase of TMEV infection delays the onset of 
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demyelination in susceptible mice (Inoue et al., 1998), whereas STAT4-/- mice on a 
normally resistant background are made susceptible to demyelination (Rodriguez et al., 
2006).  Moreover, it has recently been suggested that IL-12(p70) may limit infectivity of 
macrophages, the cell lineage in which the virus is thought to persist, resulting in the 
differences that are observed in susceptibility between SJL and B.10S strains of mice 
(Petro, 2005a). 
 Chemokines are small proteins that function in the chemoattraction of immune 
cells, including T cells, to the site of infection thus aiding in viral clearance.  Theiler’s 
virus infection causes a marked increase in chemokine mRNA expression in the CNS of 
both susceptible and resistant strains of mice (Ransohoff et al., 2002; Mi et al., 2004; 
Kim et al., 2005), and this increase has been shown to correspond with decreases in viral 
titers.  However, in the susceptible SJL strain, the chemokines RANTES and MCP-1 
remain elevated during later disease, and likely contribute to Theiler’s virus induced 
demyelinating disease (TMEV-IDD) pathogenesis (Ransohoff et al., 2002).  
Additionally, the chemokine MIP-2 has also been associated with TMEV-IDD (Rubio et 
al., 2006).  Nevertheless, chemokine expression during acute infection is viewed as 
immunoprotective, as it aids in viral clearance through the recruitment of immune cells 
to the site of infection.  
 
3.4  Adaptive immune responses to TMEV infection 
While the degree of susceptibility to TMEV-IDD may be multigenic, resistance 
to this disease has been mapped to the H-2D locus (Brahic et al., 2005) such that mice of 
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the haplotypes H-2Dd,b,k haplotypes are resistant, whereas mice of the H-2Ds,v,q,r,f 
haplotypes are susceptible (Azoulay-Cayla et al., 2000; Rodriguez and David 1985).  
This association of resistance with class 1 antigen haplotypes implies the association of 
CD8+ T-cells in viral clearance.  Findings in support of this hypothesis are (i) deletion of 
CD8+ cells by antibody administration exacerbates disease (Borrow et al., 1992), (ii) β-2 
microglobulin deficient (Begolka et al., 2001; Fiette et al., 1993; Miller et al., 1995; 
Pullen et al., 1993; Rodriguez et al., 1993),  (iii) perforin deficient (Palma et al., 2001; 
Rossi et al., 1998; Murray et al., 1998) and (iv), CD8-/- (Ransohoff et al., 2002) mice 
generated on a Theiler’s virus-induced demyelination resistant background are rendered 
susceptible.  Additionally, it has been shown that an early and robust cytotoxic response 
(Dethlefs et al., 1997a) to a single immunodominant epitope (VP2121-159) is sufficient for 
viral clearance and resistance (Dethlefs et al., 1997b; Mendez-Fernandez et al., 2003).  
Recently, Kang et al. (2002a) have demonstrated that susceptible SJL mice are capable 
of mounting a robust response to the BeAn epitopes VP3159-166, VP3171-190 and VP111-30 
with the response to VP3159-166 predominating (Kang et al., 2002a), but quantitatively 
this response occurring within the CNS is not sufficient to prevent viral persistence 
(Lyman et al., 2004).  Interestingly, another study conducted by the same group 
involving susceptible SJL mice and the comparison of the CD8+ T-cell response directed 
against the BeAn and more virulent DA strain of TMEV, suggested that the more severe 
outcome following DA infection maybe due to the fact that DA has only one 
immunoreactive epitope compared to the three that occur within the BeAn strain (Kang 
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et al., 2002b).  The known immunodominant CD8+ T-cell restricted epitopes are shown 
in Table 1-3.  
The generation of a strong antiviral CD8+ T-cell response is subsequent to the 
formation of a Th1 type CD4 T-cell-mediated response.   The protective role of CD4+ T-
cells in the acute phase of TMEV infection is undisputedly illustrated by the survival 
curves that can be generated in both susceptible and resistant mice in their absence 
(Welsh et al., 1987; Ransohoff et al., 2002).  Indeed, the depletion of CD4+ T-cells by 
either genetic manipulation (Ransohoff et al., 2002) or thymectomy coupled with 
intravenous administration of anti-CD4 antibodies has been shown to result in high 
mortality rates for C57BL/6, PL/J (40 and 60% respectively by day 6 post infection), and 
CBA (40% by day 20 post infection) mice (Welsh et al., 1987; Ransohoff et al., 2002).    
Alternatively, prior immunization with the TMEV-specific immunodominant CD4+ 
peptides in complete Freund’s adjuvant delays the onset of TMEV-induced 
demyelinating disease (Mohindru et al., 2006).  The immunodominant CD4+ T-cell 
restricted epitopes are shown in Table 1-4.  Interestingly, while prior immunization with 
these epitopes is protective, continued immune responsiveness to some of these, 
particularly VP274-86, correlates with demyelination during chronic infection (Gerety et 

























































































































































































































































































































































































































































































































































































Antiviral antibodies become detectable in the serum of infected mice beginning 
as early as day 8 p.i., and increase during the course of infection.  Moreover, Pachner et 
al. (2007a; 2007b) have recently demonstrated intrathecal antibody production, as well 
as antibody in the CSF during the course of TMEV infection, with both the BeAn 8386  
and DA strains.  Using ELISPOT, RT-PCR and ELISA techniques, the authors were 
able to demonstrate a logarithmic humoral response occurring within the CNS which 
begins as early as 30 days p.i. and correlates highly with viral load (Pachner et al., 
2007a).  It is believed that antiviral antibody responses to TMEV aid in viral clearance 
through neutralization.   For example, Kang et al., (2005) showed that antibody-
mediated neutralization of virus contributed to resistance even in the absence of a CD8+ 
T-cell response (Kang et al., 2005).  Additional evidence supporting a role for anti-viral 
antibody-mediated decreases in pathology is that rising antibody titers correlated with 
decreases in viral titers (Welsh et al., 1989), and that gender differences in susceptibility 
are accounted for by anti-viral antibody responses (Fuller et al., 2005).  Furthermore, as 
illustrated with the CD4+ response, immunization with the B-cell immunodominant 
epitope prior to infection conveys slight protection in susceptible mice (Oleszak et al., 
2004).  
 
3.5  Stress and TMEV infection  
To date we have shown that chronic stress, brought on by physical restraint, 
activates the HPA axis of CBA and SJL mice as demonstrated by increased adrenal mass 
coupled with increased serum corticosterone levels (Campbell et al., 2001; Sieve et al., 
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2004).  In turn, HPA activation causes a decrease in body, splenic and thymic mass as 
well as a reduction in total blood lymphocytes (Campbell et al., 2001; Welsh et al., 
2004). As early as day 2 p.i. with TMEV, RS has been shown to decrease mRNA 
expression of the chemokines IP-10, Ltn, MCP-1, RANTES, and TCA-3 in the spleens 
of CBA mice as determined by RNA protection assay (RPA; Mi et al., 2004).  By day 7 
p.i. the virus-induced mRNA expression of the chemokines IP-10, RANTES, and Ltn in 
the brain are reduced by stress (RPA; Mi et al., 2004).  Decreases in these chemokine 
mRNA expression levels, particularly in the brain, seem to correspond to decreased 
inflammatory infiltrates in the brain, implying that restraint stress alters cell trafficking 
to this organ (Mi et al., 2004).   In male CBA mice, two or three sessions of RS was 
found to increase TNF-α levels while two sessions of RS were found to decrease the 
TMEV-specific NK cell response (Welsh et al., 2004).  Taken together, these findings 
indicate an overall negative effect of stress on the immune function which is most 
clearly demonstrated by the finding that stressed mice have increased viral titers in most 
all organs (Mi et al., 2006b) compared to non-stressed mice including in the central 
nervous system (Campbell et al., 2001).  
While a plethora of information has been generated on the effects of restraint 
stress in the acute phases of Theiler’s virus infection (Campbell et al., 2001; Mi et al., 
2004; Welsh et al., 2004; Mi et al., 2006a; 2006b) not many studies have addressed the 
effects of chronic stress in the acute phase of Theiler’s virus on the outcome of the 
demyelinating phase of Theiler’s virus.  However, Sieve et al, have shown that as a 
result of RS, immune impairment in the early phase of TMEV infection coupled with 
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unchecked viral replication seems to lead to an earlier and exacerbated demyelinating 




















II  RESTRAINT STRESS-INDUCED DECREASES IN NK CELL ACTIVITY 
CORRELATE WITH INCREASED VIRAL TITERS DURING ACUTE 
THEILER’S VIRUS INFECTION 
 
  1.  Introduction 
Theiler’s murine encephalomyelitis virus (TMEV) infection with either DA or 
the BeAn strain provides a unique model for the study of virally-induced demyelination.  
Additionally, its clinical, histological and immunological similarities to secondary 
progressive multiple sclerosis (MS), makes TMEV infection a good model for the study 
of human MS (Lipton, 1975).  Following intracranial (i.c.) injection with either DA or 
BeAn strains of TMEV, susceptible strains of mice (e.g. SJL and CBA) develop acute 
gray matter disease followed by chronic inflammation of the central nervous system 
(CNS) white matter, leading to immune-mediated demyelination (Oleszak et al., 2004).   
The ensuing chronic demyelinating disease is dependent on viral persistence within the 
CNS (Brahic et al., 1981).  In contrast, resistant mice, through a well-orchestrated 
immune response, are able to clear the virus early and, as a result, do not develop the 
chronic demyelinating form of the disease (Brahic et al., 2005).  
Interestingly, it has been reported that as many as 77% of MS patients 
experienced a major stressful life event prior to disease onset (Grant et al., 1989).  
Psychological stress has been shown to modulate the immune system through the 
hypothalamic-pituitary-adrenal (HPA) axis, as well as through the autonomic nervous 
system (reviewed by Webster et al., 2002).  Generally, the effects of stress are 
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determined by both the duration and type of stressor (Dhabhar and McEwen, 1997).  In 
terms of chronic stress, immunosuppression is achieved by glucocorticoid-induced 
apoptosis, decreased cell trafficking, and an overall Th1 to Th2 shift (Webster et al., 
2002).  
We have demonstrated that stress, during acute TMEV infection, results in a 
decrease in mRNA expression of chemokines and cytokines (Mi et al., 2004 and 2006a), 
a decrease in NK cell cytotoxicity (Welsh et al., 2004), and splenic and thymic atrophy 
(Campbell et al., 2001) in CBA mice.  In our model, immunosuppression in the acute 
phase of TMEV infection by RS, results in higher CNS viral titers (Campbell et al., 
2001; Mi et al., 2006b) which in turn causes an earlier onset of the demyelinating phase, 
as well as increased disease severity in SJL mice (Borrow et al., 1992; Sieve et al., 
2004).  
While the adaptive immune response to TMEV is ultimately responsible for the 
clearance of the virus from the CNS, the innate immune response may play an important 
role in limiting early viral replication. Even though natural killer (NK) cells are not 
directly responsible for conferring resistance to TMEV (Paya et al., 1989; Lin et al., 
2003), their depletion via monoclonal antibody administration has resulted in increased 
gray matter inflammation following DA infection of C57BL/6 mice (Paya et al., 1989).   
In TMEV infection, susceptible SJL mice were found to have a 50% lower NK cell 
activity compared to resistant C57BL/6 mice (Paya et al., 1989).  The low activity of NK 
cells in the SJL mice is due to a differentiation defect in the thymus that impairs the 
responsiveness of NK cells to stimulation by IFN-β (Kaminsky et al., 1987).   In 
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addition to lysing virally-infected cells, NK cells have the ability to secrete IFN-γ, a 
potent Th1 cytokine that plays a major role in TMEV clearance (Pullen et al., 1994; 
Rodriguez et al., 1995; Murray et al., 2002; Rodriguez et al., 2003).  We and others have 
shown that RS can decrease virally-induced NK cell activity (Welsh et al., 2004; Tseng 
et al., 2005).   
Here, we were interested in the effects of RS on NK cell activity at day one post 
infection in three strains of mice of varying susceptibility to Theiler’s virus.  Using 
BALB/c, CBA and SJL mice we investigated NK cell activity using cytotoxicity, 
cytokine production and viral titers in the blood, and brain. We hypothesized that NK 
cell responses would correlate with the degree of susceptibility in these strains, and that 
stress would lead to increased viral titers in all strains. 
 
2.  Methods and materials 
2.1  Mice 
Three to four-week old female SJL, CBA and BALB/c mice were purchased 
from Harlan (Indianapolis, IL).  Upon arrival, the mice were counterbalanced according 
to strain by weight and assigned to either the infected restrained (I/R), infected non-
restrained (I/NR), non-infected restrained (NI/R) or non-infected non-restrained (NI/NR) 
groups.  Each mouse was identifiable by unique cage number and markings on made on 
the tale.  Mice were housed five per cage.  All mice were given one week to acclimate to 
their housing environment (light dark cycle 500 to 1700) prior to the onset of the 
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experiment.  Throughout the duration of the experiment food and water, provided by the 
animal care facility at Texas A&M University were provided ad libitum. 
 
2.2  Virus 
The BeAn strain of Theiler’s virus (kindly provided by Dr. H. L. Lipton, 
Department of Microbiology-Immunology, University of Illinois at Chicago, IL) was 
initially propagated in lung tumor (L2) cells (Welsh et al., 1987).  
 
2.3  Infection and restraint 
All mice in the infection groups were anesthetized with isoflurane (Vedco, MO, 
USA) and immediately inoculated in the right cerebral hemisphere with 5.0 x 105 pfu 
BeAn in 20μl of media.  Non-infected groups were inoculated in the right cerebral 
hemisphere with 20μl sterile PBS (pH 7.2).  Mice in the restraint groups (I/R and NI/R) 
were subjected to eight hours of restraint stress (from 1200 to 800) one night prior to 
infection and one night following infection for a total of two nights.  During each 
restraint session, mice were placed in well-ventilated 60 ml syringes as described 
previously (Sieve et al., 2004).  
 
2.4  Body mass 
Total body mass was recorded for each mouse following the first session of 
restraint (day 0 pi) and at the conclusion of the experiment (day 1 pi).  
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2.5  Tissue isolation 
At day 1pi, mice were sacrificed with 150mg/kg  beuthanasia-D special 
(Schering-Plough Animal Health).  Blood was collected from all mice via transection of 
the subclavian artery.  The brains were extracted and placed in 2.0ml cryogenic vials 
(Corning Inc. New York, USA), flash frozen in liquid nitrogen and stored at -80°C until 
used for plaque assays. Serum was obtained by centrifugation of clotted blood at 3000 x 
g for 10 minutes and was stored at -80°C until used to assay for cytokine profiles.  In 
addition, the cellular fraction of whole blood including red blood cells was retained, and 
kept at -80°C until it was used for plaque assays.  Single cells suspensions were made 
from the spleens as described previously (Welsh et al., 2004). 
 
2.6  NK cell activity 
NK cell activity was assessed using a standard 51Cr release assay as previously 
described using splenocytes as effectors and YAC cells as targets (Welsh et al., 2004). 
Total 51Cr release was determined by incubating targets with 10% Triton-X 100.  
Spontaneous release was determined by counting the amount of 51Cr released after 
incubation of targets in complete RPMI media.  Total lysis of experimental samples was 
calculated using the following equation:  [(experimental release – spontaneous 





2.7  Plaque assays 
Plaque assays were used to determine the amount of virus present in brains, and 
in the cellular fraction of blood as described previously (Welsh et al., 1987).  
 
2.8  Cytokine profiling 
Serum IFN-γ and TNF-α levels were determined using bioplex kits according to 
the manufacturer’s instructions (Bio-rad Laboratories Hercules, CA).  Positive control 
serum for this assay was generated by the intraperitoneal injection of an SJL mouse with 
a sub-lethal dose (100μg/mouse) of lipopolysaccharide (LPS) (Sigma).   After 24 hours, 
the mouse was sacrificed, blood collected, and the serum stored at –80° C until cytokine 
levels were determined. 
 
2.9  Statistical analysis 
Data are presented as mean ± SEM.  Correlations were assessed using simple 
regressions.  All other data were analyzed using analysis of variance (ANOVA).  When 
appropriate, Fisher’s protected least significant difference model was used for post hoc 
comparison of means.  In all cases significance was set at p ≤ 0.05.   
 
3.  Results 
3.1  Both restraint stress and TMEV infection had marked effects on body mass 
We found that restraint decreased body mass in infected and non-infected CBA, 
SJL and BALB/c mice (p < 0.001; Fig. 2-1).  In addition, infection alone was also found 
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to significantly decrease body mass at day 1 p.i. in all strains tested (p < 0.001; Fig. 2-1), 
and there was a strong trend supporting an interaction between restraint stress and 



























Figure 2-1.  The effects of infection and restraint stress on body mass.  Body mass was recorded 
prior to infection with the BeAn strain of TMEV, and at 1 day post infection the percentage 
change in body mass was calculated for all three strains of mice.  In all strains, mice in both the 
restraint (NI/R, I/R) and infected (I/NR, I/R) groups showed marked decreases in body mass.  
Results are expressed as means ± SEMs. *P < 0.05, ** P < 0.01. 
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3.2  Effects of restraint stress and TMEV infection on IFN-γ and TNF-α levels 
Serum IFN-γ and TNF-α levels were measured using luminex technology with 
an IFN-γ and TNF-α kit (Bio-rad Laboratories Hercules, CA).  IFN-γ levels were found 
to be consistently below the detection levels of the assay (< 0.2 pg/ml).   No differences 
were found in serum TNF-α levels between groups within strains, although it appeared 
that BALB/c mice possessed on average higher serum TNF-α levels than the other 
strains (Fig. 2-2A).  Therefore, for each strain of mouse the groups were averaged to 
determine if differences existed between mouse strains.  There was a significant strain 
difference in serum TNF-α levels, (p < 0.05), such that BALB/c mice had higher levels 
than either CBA or SJL (confirmed by Post hoc p < 0.05) (Fig. 2-2B).  Serum TNF-α 
levels were identical between CBA and SJL mice. No significant differences were found 
to be attributable to either restraint stress or infection in TNF-α levels.  To ensure the 
validitiy of our findings, serum from a SJL mouse previously injected 24 hours prior 













































Figure 2-2.  The effect of stress and strain on serum TNF-α levels. Serum cytokine levels were 
measured using a IFN-γ and TNF-α kit. A. Effects of stress on goups within strains.  B.  BALB/c 
mice had higher basal TNF-α levels than SJL or CBA mice. Serum from a single LPS injected 
SJL mouse was included as a positive control and was run in douplicate.  Results are expressed 
as mean ± SEMs. * P < 0.05. 
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3.3  Effects of restraint stress and TMEV infection on splenic NK cell lysis  
Doubling dilutions of effector to target ratios revealed the specificity of the NK 
cell cytotoxcity assay (Fig. 2-3A) and, an effector to target ratio of 100:1 was used for 
all comparisons.  Infection with TMEV resulted in an overall increase in NK cell activity 
(p < 0.01).  Conversely, restraint stress significantly decreased overall NK cell activity 
(p < 0.001).  Interestingly, NK cell percent lysis was found to be significantly different 
between strains (p < 0.001), such that CBA > BALB/c > SJL (confirmed by Post hoc all 
ps ≤.0054) (Fig. 2-3B).   In addition there were significant interactions noted between 
both strain and infection (p < 0.05) as well as strain and stress (p < 0.05).  However, the 
interaction between infection and stress failed to reach significance (Fig. 2-3B).   
Analyses between individual groups reflected the above mentioned interactions.  For 
instance, in CBA mice, the I/NR group had the highest percent lysis, which was reduced 
in I/R mice (p < 0.05).  Additionally, in CBA mice the level of percent lysis was found 
to be reduced in NI/R mice when compared to NI/NR mice (confimed by Post hoc, all ps 
< 0.05; Fig. 2-3B).  Alternatively, in BALB/c mice the I/NR group had significantly 
higher levels of pecent lysis than NI/R mice (p < 0.001), but were not found to differ 
from those of I/R mice (p = 0.063).  In addition, the levels of percent lysis did not differ 
between NI/NR mice and NI/R mice (p = 0.077).  In order to fully understand the 
significant interactions between strain and infection as well as strain and stress, 2-way 
ANOVA’s were conducted on each individual strain.  These subsequent analyses 
confirmed the previous findings for both BALB/c and CBA mice (Fig. 2-3B).  However, 
the splenic NK cell response in SJL mice was neither influenced by stress nor infection 
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(Fig. 2-3B).   This was probably due to the fact that NK cell responses in this strain are 


























Figure 2-3.  Infection and restraint stress influenced NK cell lysis in CBA and BALB/c mice.  
A.  The effects of infection and restraint stress on NK cell lysis at day 1 post infection with 
TMEV were determined by a standard 51Cr release assay using YAC-1 cells as targets and 
doubling dilutions of splenocytes as effectors.  B.  Infection increased NK cell activity in CBA 
but not BALB/c mice while restraint stress decreased NK cell activity in these strains.  Neither 
infection nor restraint influenced the NK cell activity in SJL mice. CBA mice generated the 
strongest splenic NK cell response, BALB/c an intermediary response and SJL the lowest 
response.  C.  Conversely, restraint stress increased the viral load in BALB/c and CBA mice.  
The brains of SJL mice appeared to have higher levels of TMEV than BALB/c or CBA, but this 















































Figure 2-3, continued. 
 
3.4  Effects of restraint stress and TMEV infection on viral load in the blood and brain. 
Plaque assays were used to measure viral titers in the blood and brain.  There was 
no virus detected in the blood of any samples (data not shown).  However, infection 
increased viral titers in the brains of all strains tested (p < 0.0001).  No virus was 
detected in any of the non-infected groups.  SJL mice appeared to have more virus in 
their CNS than either CBA or BALB/c mice (Fig. 2-3C), but this trend failed to reach 
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statistical significance (p = 0.0774).  Even though restraint stress did not influence the 
quantity of virus present in the brains of SJL mice, there was found to be an interaction 
between infection and restraint stress, such that restraint stress significantly increased the 
viral load in the brains of both BALB/c and CBA mice p < 0.05 (Fig. 2-3C).   Because 
restraint stress increased viral load in CBA and BALB/c mice while at the same time 
decreased overall NK cell activity in the spleen, we were interested in whether or not 
there was a correlation between splenic NK cell activity and viral load in the brain.  
Simple regression analysis produced a negatively sloped effect, but this effect was not 
significant (p = .2563). 
 
4.  Discussion 
Experimentally, chronic stress can hinder the generation of an immune response 
to many types of viral infections.  In particular, restraint stress has been shown to reduce 
levels of NK cell cytotoxicity following infection with either herpes simplex virus 
(Bonneau et al., 1991), influenza virus (Hunzeker et al., 2004; Tseng et al., 2005) or 
TMEV (Welsh et al., 2004).  While glucocorticoids are thought to alter the cellularity of 
NK cells in lymphoid organs such as the spleen, the mechanism by which restraint stress 
decreases NK cell cytotoxicity is thought to be directly related to the µ-opioid receptor 
since the administration of β-funaltrexamine, but not nor-binaltorphimine or naltrindole, 
has been shown to restore NK cell cytotoxicity (Tseng et al., 2005).  In the current study, 
we found that RS decreased splenic NK cell cytotoxicity in BALB/c and CBA mouse 
strains, but did not affect SJL NK cell cytotoxicity.  However, the latter mouse strain is 
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known to have an NK cell deficiency (Kaminsky et al., 1987), making detection of 
differences in NK cell cytotoxicity between treatment groups difficult.  Moreover, it 
appeared that decreased splenic NK cell effector function corresponded to increased 
viral titers in the brains of infected mice (Fig. 2-3B-C).  SJL mice had the lowest NK cell 
response, which tended to correspond to the highest viral titer, although this did not 
reach statistical significance.  It is important to remember that these mice had only been 
infected for one day (see methods and materials).  Therefore, it is likely that the large 
standard deviations from the means of viral titers in the CNS of SJL mice is due, in part, 
to viral replication and dissemination and not just sample variation.  
To date, we have shown that chronic restraint stress results in an overall negative 
effect on the immune function (Campbell et al., 2001; Welsh et al., 2004; Mi et al., 
2004) which is most clearly demonstrated by the finding that RS mice have increased 
viral titers in most organs (Mi et al., 2006a) as well as the central nervous system 
(Campbell et al., 2001).  Recently, Sieve et al. have shown that, as a result of RS, 
immune impairment in the early phase of TMEV infection, coupled with increased viral 
replication leads to an earlier onset and exacerbated demyelinating disease as evidenced 
by both clinical and histological findings in both male and female SJL mice (Sieve et al., 
2004).  However, in CBA mice, a sex-dependent effect of stress was observed such that 
previously stressed female mice developed more severe demyelinating disease, whereas 
previously stressed males actually showed improvements during the chronic phase of 
TVID (Sieve et al., 2006).  Since restraint-stress induces approximately 50% reduction 
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in NK cell activity in both male and female CBA mice (Welsh et al., 2004; and current 
study), NK cell activity is unlikely to be the sole factor in determining disease outcomes. 
In this study we found that the non-susceptible BALB/c strain of mice have 
higher basal serum TNF-α levels than either the semi-susceptible CBA or susceptible 
SJL mice (Fig. 2-2B).  This increased TNF-α level may play an important role in 
providing innate resistance to TMEV since TNF-α has been shown to have anti-viral 
properties (Welsh et al., 1995).  In contrast to our previous work, we did not observe 
significant stress-induced elevations in CBA serum TNF-α levels (Welsh et al., 2004).  
Even though RS CBA mice appeared to have higher mean values of serum TNF-α levels 
than did their non-RS counterparts, this effect did not reach statistical significance (Fig. 
2-2A). While, the previous study employed male CBA mice (Welsh et al., 2004), the 
current study employed female CBA mice.  Most recently, in a direct comparison study 
of the effects of chronic stress and gender on TMEV-induced demyelination, we have 
found that RS had a greater effect on male CBA body mass, encephalitis and behavioral 
psychology measurements than female CBA mice in the acute phase of infection with 
TMEV (Sieve et al., 2006).   Therefore, the reason for this TNF-α discrepancy between 
studies, in our opinion, can most likely be contributed to gender. 
The non-specific innate immune response plays an important role in the early 
protection against infections (Tosi, 2005).  Even though the innate immune response is 
able to limit infectious pathogens directly through the actions of epithelial cell barriers, 
neutrophils, macrophages/monocytes, eosinophils, basophils, mast cells, NK cells, 
defensins and complement, the innate response also effects the generation of adaptive 
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immunity through the stimulation of T-cells and B-cells.   For instance, IL-12 secretion 
from macrophages and dendritic cells stimulates NK cells to secrete IFN-γ and enhances 
cytolytic activity.  IFN-γ in turn, can activate macrophages, as well as, directly influence 
antiviral CD4 and CD8 responses (Whitmire et al., 2005a; 2005b).  Alternatively, IL-4 
secretion from mast cells can stimulate T-cells to produce anti-helmenthic properties and 
the generation of humoral responses.  Thus, the impedance of this arm of immunity, by 
stress, in TMEV-infected mice would certainly alter the generation of adaptive immune 
responses leading to increased viral replication.  However, in this study we were unable 
to detect any circulating IFN-γ.  In light of the fact that we were able to detect 
differences in NK cell mediated lysis in vitro, future studies should be designed to 
investigate the effects of RS on the ability of NK cells to produce and secrete IFN-γ 
following in vitro stimulation. 
In summary, this study focused on the effect of chronic restraint stress on the NK 
cell-mediated cytotoxic response in three mice strains of varying susceptibility to TMEV 
infection.  Our results indicated that chronic restraint stress can decrease splenic NK cell 
responses while at the same time lead to increased viral titers in the brains of acutely 
infected CBA and BALB/c mice.  In a model of MS that is dependent on viral 
persistence, increased viral titers in the acute phase of infection result in an earlier onset 
and exacerbated chronic phase of disease.  While NK cells certainly play a role in 
limiting viral infection, they are not completely responsible for clearing TMEV from the 
CNS of resistant mice (Paya et al., 1989; Lin et al., 2003).  As such, it becomes 
increasingly important to determine the effects of restraint stress on the effector 
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functions of adaptive immune responses including T-cell and B-cell, since they play a 
more important role in viral clearance, and resistance to demyelination (Oleszak et al., 




















III  RESTRAINT STRESS MODULATES VIRUS-SPECIFIC ADAPTIVE 
IMMUNITY DURING ACUTE THEILER’S VIRUS INFECTION 
 
1.  Introduction 
It has been estimated that multiple sclerosis (MS) affects about 350,000 people in 
the United States alone (Anderson, et al., 1992), around 2.5 million world wide 
(Compston and Coles, 2002), and that its incidence is increasing (Noseworthy et al., 
2000).  MS, characterized first by Charcot in the mid 1800s, is a demyelinating and 
neurodegenerative disorder that targets the central nervous system (CNS) and is 
autoimmune in nature.  MS is rarely a life threatening condition (Redelings et al., 2006), 
but it is almost always debilitating, and causes a wide variety of symptoms including 
optic neuritis, muscle weakness, gait ataxia, cognitive difficulty, pain, fatigue, 
depression, incontinence and sexual dysfunction (Noseworthy et al., 2000). 
While the cause of MS is not known, it is evident that multiple factors are likely 
to contribute to the pathogenesis of this disease, including, gender, genetic background, 
and environment (Noseworthy et al., 2000).  No single known pathogen has been 
associated exclusively with the development of MS, but many different pathogens have 
been isolated from MS plaques (Fazakerley and Walker, 2003).  Other evidence for the 
involvement of an infectious agent in MS development are epidemiological (Kurtzke et 
al., 2001), migrational (Gale and Martyn, 1995), and the pathological characterization of 
MS plaques (Lucchinetti et al., 2000).      
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Another environmental factor that may contribute to both the onset and 
exacerbation of MS is psychological stress (Ackerman et al., 2003; Mohr et al., 2004).  
Stress, acting through the hypothalamic-pituitary-adrenal (HPA) axis as well as the 
autonomic nervous system, has been shown to modulate immune responses in a bi-
directional fashion with acute stress stimulating leukocyte trafficking and chronic stress 
being immunosuppressive (Dhabar and McEwen, 1997).  Recently, Mohr and Pelletier 
have proposed that HPA-axis dysregulation by the following three processes could 
contribute to the pathogenesis in MS (Mohr and Pelletier, 2006):  First, stress resolution 
could result in uncontrolled inflammation. Secondly, glucocorticoid resistance could 
lead to unregulated activation of autoimmune cells. Thirdly, stress-induced mast cell 
activation may result in increased blood-brain barrier permeability allowing autoimmune 
cell infiltration (Mohr and Pelletier, 2006).     
We have recently been interested in the mechanisms by which restraint stress can 
alter the pathogenesis of Theiler’s murine encephalomyelitis virus (TMEV) infection, a 
commonly used animal model of human MS (Lipton, 1975; Oleszak et al., 2004).  In this 
model, intracranial injection of TMEV into susceptible strains of mice, its natural host, 
can lead to a biphasic disease consisting of a polioencephalitic phase followed by a 
chronic demyelinating phase that is perpetuated by T-cell and B-cell autoimmune 
responses (Oleszak et al., 2004).  Conversely, viral inoculation of genetically-resistant 
strains of mice does not result in demyelination.   
After infection with TMEV, susceptible mice fail to generate a well-orchestrated 
immune response, which allows the virus to persist, primarily in 
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macrophages/monocytes as well as astrocytes, for the duration of the animal’s life time 
(Theiler, 1937; Clatch et al., 1990; Zheng et al., 2001).  Therefore, viral persistence is a 
prerequisite for demyelination (Brahic et al., 1981; Rodriguez et al., 1996).  
Susceptibility to TMEV-induced demyelination is attributed to several factors (reviewed 
by Brahic et al., 2005) including the H-2D locus (Lipton and Melvold, 1984; Rodriguez 
and David, 1985), indicating a role of virus-specific CD8+ T-cells in the clearance of 
TMEV.  Findings in support of this hypothesis are: (i) deletion of CD8+ cells by 
antibody administration exacerbates disease (Borrow et al., 1992), (ii) β-2 microglobulin 
deficient mice (Begolka et al., 2001; Fiette et al., 1993; Miller et al., 1995; Pullen et al., 
1993) as well as (iii), perforin-deficient (Palma et al., 2001; Rossi et al., 1998; Murray et 
al., 1998) mice generated on a Theiler’s virus-induced demyelination resistant 
background, are rendered susceptible.  The generation of TMEV specific antibodies has 
also been shown to contribute to viral clearance (Welsh et al., 1989; Kang et al., 2005). 
The effector function of the Th cell is to facilitate the production of adaptive 
immune responses.  However, while Th1 type immunity is essential for early TMEV 
clearance by the generation of both CD8+ T-cell and B-cell responses; in the later phase 
of TMEV Th1 mediated immunity is damaging to the CNS.  Nevertheless, pro-
inflammatory responses early following infection are beneficial.  In fact, in CBA mice, 
deletion of CD4+ T-cells during the time of infection was shown to cause mortality 
(Welsh et al., 1987).  Similarly, in CD4+ T-cell deficient SJL mice infected with the DA 
strain of TMEV the disease was exacerbated (Lin et al., 2004).  
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Restraint stress (RS) has been shown to be immunosuppressive in several viral 
infections including herpes simplex virus (Bonneau et al., 1991) and influenza virus 
(Feng et al., 1991).  We have demonstrated that RS can dramatically influence the 
disease course of TMEV.  Particularly, SJL mice that received 4 weeks of 8 hour nightly 
RS develop an exacerbated disease course (Sieve et al. 2004) with similarities to that 
generated following depletion of CD8+ T-cells via monoclonal antibody administration 
(Borrow et al., 1992).  Moreover, infected CBA mice that received nightly RS of 12 
hours produced a survival curve (Campbell et al., 2001) that was almost identical of that 
generated by the depletion of CD4+ T-cells (Welsh et al., 1987). Because of these 
similarities, we hypothesized that restraint stress during acute infection with the BeAn 
strain of TMEV alters the generation of specific immune responses.  Therefore, in this 
particular study we set out to determine the effects of restraint stress on the generation of 
virus specific CD4+ T-cell, CD8+ T-cell and B-cell effector functions.  
 
2.  Methods and materials 
2.1  Mice 
Three to four week old female SJL mice were purchased from Harlan 
(Indianapolis, IL).  Mice were assigned to either infected restrained (I/R), infected non-
restrained (I/NR), non-infected restrained (NI/R) or non-infected non-restrained (NI/NR) 
groups (Mi et al., 2004; 2006a).  For some experiments, mice were assigned to infected/ 
PBS treated (I/PBS), infected/dexamethasone treated (I/DEX), 
infected/restrained/PEG400 treated (I/R/PEG) or infected/restrained/RU486 treated 
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(I/R/RU486) groups.  Each mouse was identifiable by unique cage number, and 
markings on made on the tale.  For each individual experiment mice were housed two 
animals per cage per group.  All mice were given one week to acclimate to their housing 
environment (light dark cycle 0500- 1700 hr) prior to the onset of the experiment.  All 
mice were kept on a diet of mouse chow containing 9% fat and 20.5% protein.  Food and 
water was provided ad libitum.  All experiments were approved by the animal use and 
care committee at Texas A&M University. 
 
2.2  Virus, Viral purification and inactivation, and viral peptides 
The BeAn 8683 strain of Theiler’s virus (kindly provided by Dr. H. L. Lipton, 
Department of Microbiology-Immunology, University of Illinois at Chicago, IL) was 
initially propagated in lung tumor (L2) cells (Welsh et al., 1987).   Virus was semi-
purified by ultracentrifugation according to (Rueckert and Pallansch, 1981) by pelletting 
through 30% sucrose cushion at 80,000 x g for 3 hours in a Optima L-80 XP 
ultracentrifuge (Beckman Coulter) using an SW-28 rotor.  Pellets were resuspended in 
1M sodium phosphate buffer (pH 7.4).  UV-inactivated virus was generated by exposing 
previously pelleted virus to UV-light (1330 μW/cm3 at 13 cm distance) for 1.5 hours.  
The virus was determined to be inactivated by plaque assay. 
The immunodominant CD4+ T-cell peptide QEAFSHIRIPLPH corresponding to 
TMEV VP274-86   was used to determine CD4+ T-cell specific responses (Gerety et al., 
1991 and 1994).  Additionally, the immunodominant CD8+ T-cell peptide FNFTAPFI 
corresponding to VP3159-166 was used to determine CD8+ T-cell specific responses to 
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TMEV (Kang et al., 2002). The non-specific peptide sequence RLNRITKDSYPNS was 
used as a control peptide to determine non-specific immune responses.  All peptides 
were purchased from Sigma at ≥ 95% purity. 
 
2.3  Infection and restraint stress  
Following anesthesia with isoflourane (Vedco, MO, USA), mice were either 
injected with 5.0 x 105 plaque forming units (PFU) of BeAn strain of TMEV in 20 μl of 
DMEM media or sham-infected with DMEM into the right mid-parietal cortex at a depth 
of approximately 1.5mm (Welsh et al., 1987; Campbell et al., 2001; Mi et al., 2004; 
Sieve et al., 2004). Restraint stress was carried out as described previously (Sieve et al., 
2004).  Restraint sessions began the night prior to infection and continued each night 
until day 8 p.i.  All mice were allowed two hours to recover prior to injection.  Mice 
were weighed daily. 
 
2.4  Physiological indices of infection and stress 
Mice were monitored and scored daily for signs of sickness.  Starting 2 days 
prior to infection mice received clinical scores based on degree of ruffling, hunching, 
weakness, wobbly gait and righting reflex, where 0 = healthy and 4 = moribund for each 
measure (Sieve et al., 2004).  Also, body mass of all animals was recorded daily, and 
abdominal body temperatures were measured daily using an infraRed + Type K 
thermometer (Waltham, MA) starting one day prior to infection and lasting for the 
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duration of the experiment.  All temperature readings were taken in triplicate and at 1200 
hr each day. 
 
2.5  Activity monitoring 
Mice were monitored for behavioral differences at days –1, 3 and 5 post infection 
(p.i.) as described previously (Johnson et al., 2006).  Briefly, each mouse was placed in 
the open field monitoring area between the hours of 0700 hr and 1000 hr.  All horizontal 
and vertical movements were recorded each minute for a total of 20 minutes per session. 
 
2.6  Dexamethasone and RU486 
For some experiments, mice were treated nightly with dexamethasone (DEX) 
(Sigma Chemical, St. Louis, MO) at a dose of 1.0 mg/kg or with vehicle control (PBS) 
by intraperitoneal (i.p.) injection given 1 hour prior to restraint. RU486 (Sigma 
Chemical, St. Louis, MO) treatment was administered according to Tseng et al., (2005) 
such that mice were given nightly subcutaneous (s.c.) injections of RU486 (25mg/kg) or 
vehicle control (PEG400).  Both DEX and RU486 treatments were administered 1 hour 
prior to restraint, began the night prior to infection, and lasted until day 8 p.i.  All 
injection volumes were administered in a total volume of 100 μl. 
 
2.7  Tissue isolation 
At the termination of each experiment (Day 8 or 16 p.i.) all mice were injected 
with a lethal dose of Beuthanasia special 150mg/kg (Schering-Plough Animal Health) 
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(Welsh et al., 2004).  Blood was collected via cardiac puncture, and then mice were 
perfused through the left ventricle with cold Hanks balanced salts solution containing 
heparin (10U/mL) buffered at pH 7.2.  Serum was collected as described (Welsh et al., 
2004). After perfusion, spleens, brains and spinal cords were aseptically removed. Single 
cell suspensions were prepared as described previously (Welsh et al., 2004).  CNS 
infiltrating lymphocytes (CNS-ILs) were prepared from the CNS tissue using nylon 
mesh and incubating the tissue with RPMI 1640 (supplemented with 2% FBS) 
containing 250μg/ml of Collagenase type IV (Worthington Inc., Lakewood, NJ) for 45 
minutes at 37°C and 5% CO2 (Kang et al., 2002a).  Following incubation, the 
lymphocytes were isolated by percoll gradient centrifugation (Irani and Griffin, 1991), 
then re-suspended in complete RPMI-1640 containing L-glutamine (1.0%), penicillin 
and streptomycin (1.0%),  and 10% FBS.  
 
2.8  Plaque assay   
UV-inactivated virus was determined to be inactivated by plaque assay as 
described previously (Mi et al., 2006b). 
 
2.9  Preparation of feeder cells 
Spleens were aseptically removed from aged-matched NI/NR mice and single 
cell suspensions were prepared. Feeder cells were irradiated with 3000 rads (Co60 
source, College of Veterinary Medicine, Texas A&M University).  
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2.10  ELISPOT assays  
The effects of restraint stress on T-cell effector function to TMEV were assessed, 
in part, by the ability of CNS-ILs to generate IFN-γ in response to either the 
immunodominant CD4+ or CD8+ T-cell specific peptide (VP274-86 or VP3159-166, 
respectively).  In this assay, sterile flat-bottomed 96-well filtration plates (MAIPS4510) 
containing PVDF membranes (Millipore, Corp, Bedford, MA) were coated with 1.0 μg 
(in 100μl sterile PBS) of anti-mouse IFN-γ (AN-18) (eBioscience)  capture antibody 
(eBioscience) overnight at 4°C.  The plates were blocked with 200μl complete RPMI-
1640 (supplemented with 10% FBS) for 2 hours at room temperature.  Then 2.0 x 104 
CNS-ILs were mixed with 1.0 x 106 irradiated feeders, in 150 μl of complete RPMI-
1640 with a final concentration of 2.0 μM peptide (CD4+, CD8+ or Non-specific) and 
then added to the plate.  Following an incubation at 37° C and 5.0% CO2 for 24 hours 
the plates were washed with PBS containing 0.05% Tween-20 (5X) and rinsed once with 
water purified by reverse osmosis (RO) H2O.  100 μl assay diluent (PBS with 10% FBS) 
containing 0.1μg of the biotin labeled anti-IFN-γ detection antibody (R4-6A2) 
(eBioscience) was added to each well, and the plates were incubated at room 
temperature for 2 hours.  After the incubation the plates were washed 6X with PBS 
containing Tween-20 (0.05%).  Then, 100μl of avidin-HRP (horseradish peroxidase) 
(eBioscience) diluted 1/1000 in assay diluent was added to each well and the plates were 
incubated for 30 minutes at room temperature.  After washing 6X as described above, 
spots were developed using 100 μl of 3-amino-9-ethyl-carbazole (AEC) substrate 
solution (1.0mg AEC, 1.0ml dimethylformamide, 14ml 0.1M citrate-phosphate buffer 
 76
pH 5.0, and 10.0 μl and H2O2).  After development, the plates were rinsed 3X with 200μl 
of RO H2O, and read with an ELISPOT plate reader (AID EliSpot Reader System, 
Straberg, Germany). The effects of RS on splenic T-cell effector function were 
determined using the methods described above.  However, for these assays, 1.0 x 106 
isolated spleen cells were used in the absence of feeders.  All samples were run in 
duplicate.  Background was determined as the generation of spots to the non-specific 
peptide and was subtracted from CD8+ and CD4+ T-cell virus-specific peptide responses.   
Virus-specific antibody secreting cells (ASCs) were determined using a 
modification of the above assay.  Briefly, 100 μl of previously pelleted virus (10 ug/ml) 
in sterile PBS was used to coat each well overnight.  After blocking, either 2.0 x 104 
CNS-IL or 1.0 x 106 splenocytes were added to each well, and the plates incubated for 
24 hours as described above.  After washing, biotinylated anti-mouse Ig (Jackson) was 
added as described (Pachner et al., 2007) and incubated for 2 hours at room temperature.  
Plates were washed again, then incubated with avidin-HRP for 30 minutes at room 
temperature.  The plates were then developed with AEC substrate and spots enumerated 
as described above. 
 
2.11  Flow cytometry 
Flow cytometry was used to test the effects of RS on splenic T-cell percentages, 
at days 8 and 16 p.i.  Briefly, 1.0 x 106 splenocytes were blocked with 1.0 μg of anti-
mouse CD16/CD32 (93; eBioscience) for 10 minutes at 4°C then labeled with PE 
conjugated anti-CD3e (145-2C11; eBioscience), and FITC conjugated anti-CD4 (RM4-
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5; eBioscience) or FITC conjugated anti-CD8a (53-6.7; eBioscience) for 20 minutes at 
4°C.  Cells were then washed 3X with staining buffer (eBioscience) then resuspended 
with 300μl EM grade paraformaldehyde (Electron Microscopy Science; Ft Washington, 
PA).  T-cell percentages were then determined using a FACScaliber (Becton Dickson) 
and MoFlow software. 
 
2.12  Cytokine secretion 
At day 8 p.i. 5 x 104 CNS-IL and 1.0 x 106 irradiated splenocytes or 1.0 x 106 
splenocytes were cultured with complete RPMI 1640, and stimulated with either plate 
bound anti-CD3 (10 μg/ml) and anti-CD28 (2.0 μg/ml), purified UV-irradiated BeAn, or 
control media for 72 hours at 5.0% CO2 and 37°C.  The supernatants were then collected 
and concentrations of Th1, Th2 and Th17 cytokines measured using Bio-plex kits 
(Th1/Th2) or ELISA (Th17) according to the manufacturers’ instructions.  
For some experiments, the effects of RS or dexamethasone treatment on virus 
specific IFN-γ secretion was measured by ELISA (eBioscience) after stimulating 1.0 x 
106 splenocytes (isolated at day 8 p.i.) for 24 hours with 2μM of VP274-86, VP3159-166, or 
non-sense (NS) peptide with or without DEX in complete RPMI 1640 at 5.0% CO2 and 
37°C as indicated in the text. 
 
2.13  Effect of dexamethasone on T-cell proliferation  
To determine the effects of DEX on T-cell proliferation, 1.0 x 106 splenocytes 
isolated from I/NR mice at day 8 p.i. were stimulated with media, plate bound anti-CD3 
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(10µg/ml) and anti-CD28 (2.0µg/ml) antibodies or peptides in the presence of DEX.   
After 24 hours of stimulation at 37° C and 5.0% CO2, 20 μl MTT (Sigma) at a 
concentration of 5mg/ml dissolved in PBS was added to each well and the plate was 
incubated for 4 hours at 37° C and 5.0% CO2.  Next, 50 MTT lysis buffer (50% 
dimethylformamide, 20% SDS) was added to each well and the plate was incubated 
overnight at 37° C with 5.0% CO2.  Absorbance was determined at 570 nm in a 
FLUOstar Optima spectrophotometer (BMG Inc., Offenburg, Germany). 
 
2.14  Serum cytokine profile 
At day 8 p.i., the effects of RS on serum cytokine concentrations were 
determined using a Bio-Plex 23 plex profiling kit according to the manufacturer’s 
instructions (Bio-Rad, Inc; Hercules, CA).  This kit gave the concentrations of 23 serum 
cytokines including IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12(p40), 
IL-12(p70), IL-13, IL-17, Eotaxin, G-CSF, GM-CSF, IFN-γ, KC, MCP-1, MIP-1α, 
MIP-1β, RANTES, and TNF-α.  
 
2.15  Quantitative RT-PCR and western blots for T-bet and GATA-3 
Total RNA was isolated from 1.0 x 107 spleen cells by QIAshredders (Qiagen), 
and purified by column and DNase digestion using a Qiagen RNeasy mini kit according 
to the manufacturer’s instructions (Qiagen).  cDNA was generated as described 
previously, albeit using random primers (Promega) (Mi et al., 2006a).  Real-time PCR 
was used to test for IL-4, IL-5, IFN-γ, T-bet, and GATA-3, expression and normalized to 
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β-actin using methods described previously (Mi et al., 2006a).  All primers were 
purchased from Integrated DNA Technologies (Coralville, IA) and sequences can be 
seen in Table 3-1. 
To determine the effects of RS on T-bet and GATA-3 protein levels.  1.0 x 106 
splenocytes were cultured with plate bound anti-CD3 (10 μg/ml) and anti-CD28 (2 
μg/ml) antibodies, or 2 μM peptides VP274-86, VP3159-166, or NS in 150 μl of complete 
RPMI-1640 for 5 or 24 hours at 37°C and 5% CO2.  Nuclear protein was extracted from 
stimulated splenocytes using NU-PER kits (Pierce), quantified by BCA protein assay 
(Pierce), separated on 10% polyacrylamide gels, transferred to nitrocellulose, blocked 
with 5% NFDM, probed with anti-mouse T-bet (4B10; Santa Cruz) or GATA-3 (HG3-
31; Santa Cruz) followed by ImmunoPure anti-mouse IgG-HRP (Pierce) and developed 
with SuperSignal west pico chemiluminescent substrate (Pierce).  Blots were then 
stripped and re-probed with anti-mouse β-actin (a kind gift from Dr. Weston Porter; 
Texas A&M University).  Film (CL-XPosure; Pierce) was developed using an 
autoprocessor, and densitometry analysis was performed with using a Bio-Rad Analyzer 







































































































































































































































































































































































































































2.16  Antibody levels to TMEV 
 Antibody levels to TMEV were determined by ELISA.  Here 96-well flat-
bottomed high-binding polystyrene plates (Corning Inc, Corning, NY) were initially 
coated with purified virus.  Virus was diluted in carbonate buffer (pH 9.6), then added to 
the plates such that the concentration was approximately 5.0 x 106 p.f.u./well in 100μl.  
The plates were then incubated overnight at 4°C, followed by, washing with phosphate 
buffered saline (pH 7.2) containing Tween-20 (0.05%) and rinsing with RO-H2O.  The 
plates were then blocked by adding 300μl of Superblock buffer (Pierce) containing 
Tween-20 (0.05%) 3X, according to the manufacturer’s instructions.  Next, serum was 
diluted in assay buffer as described previously (Sieve et al., 2004).  After incubating at 
37°C for 1.5 hours, the plates were again washed and rinsed.  Either the peroxidase-
conjugated polyvalent goat anti-mouse antibody (A-0412), goat anti-mouse IgG (A-
5278) or goat anti-mouse IgM (A-8786) obtained from Sigma and diluted 1/500 in assay 
buffer was added to each well or the plate was incubated at 37°C for 1 hour.  Finally, 
after washing and rinsing as described, the reaction was developed using 200 μl OPD 
substrate (Sigma) in citrate buffer (pH 5.0) for 30 minutes and stopped with 50 μl of 2.5 
M sulfuric acid.  OD was determined at 490 nm using a FLUOstar Optima 






2.17  Statistical analyses 
Data are presented as mean ± SEM.  Data were analyzed using analysis of 
variance (ANOVA) and students t-tests.  Significance of correlations was determined by 
simple regression analysis.  In all cases significance was set at p ≤ 0.05.   
 
3.  Results 
3.1  Physiological and behavioral measurements of infection and stress 
3.1.1 Theiler’s virus infection and restraint stress produce distinct physiological 
symptoms 
Prior to restraint and infection, all mice were scored, weighed, and had their 
abdominal temperature recorded.  It was determined that both stress and infection 
produced changes in these physiological parameters.  Specifically, mice in the RS 
groups had increased average clinical scores, beginning immediately following the first 
session of RS (Fig. 3-1A). These effects were mostly attributable to increased ruffling 
and grooming scores, and did not reflect sickness-induced by TMEV infection as 
evidenced by the fact that infection had no effect on clinical manifestations (Fig. 3-1A).  
Alternatively, both RS, and infection were found to cause an overall decrease in 
body weight (ps < 0.001; Fig. 3-1B).  Moreover, as illustrated in Figure 3-1B, these 
effects were dependent on time.  Specifically, the effects of infection on change in body 
mass percentage were transient, reaching maximum at day 1 p.i. and resolving thereafter.  
However, RS caused continual weight loss, which was sustained throughout the course 
 83
of the experiment (Fig 3-1B).  RS exacerbated the infection induced weight loss, which 
was illustrated by the significant day x RS x infection interaction, p < 0.01.      
Daily abdominal temperature readings showed that Theiler’s virus infection 
caused hypothermia, p < 0.01 (Fig. 3-1C).  In contrast, RS showed a very strong trend 
towards inducing hyperthermia, but this trend failed to reach statistical significance (p = 







































Day Post Infection  
 
 
Figure 3-1.  The effects of TMEV infection and RS on physiological indices of homeostasis.  
Groups are illustrated as:  infected/non-restrained (I/NR; open circles); infected/restrained (I/R; 
closed circles) non-infected/non-restrained (NI/NR; open squares); non-infected/restrained 
(NI/R; closed squares).  A.  Restraint stress alone significantly increased clinical scores.  B.  
Both TMEV infection and RS altered body mass.  C.  Infection and RS altered abdominal 
temperatures throughout the course of infection.  Results are combined means of 3 independent 





















































































3.1.2 RS alone, but not Theiler’s virus infection alone, alters vertical exploratory 
behavior 
Behavioral data were generated as described previously (Johnson et al., 2006).  
No differences in baseline activity measurements existed between mouse groups (Figs. 
3-2A, B, G and 3-3A, B, G).  However, by day 3 post infection (p.i.), mice in the RS 
groups showed reduced vertical time as well as reduced numbers of vertical movements, 
all ps < 0.05 (Figs. 3-2D and 3D).  Although infection with TMEV alone did not 
influence exploratory behavior, there was a significant interaction between infection and 
RS at day 3 p.i. when mice in the I/R group had decreased vertical activity (Fig. 3-2C), 
vertical time (Fig. 3-2D), number of movements (Fig. 3-3C) and number of vertical 
movements (Fig. 3-3D) when compared to mice in all other groups, (ps < 0.05).  By day 
5 p.i., the effects of RS became more evident, as RS was found to decrease the vertical 
activity (Fig. 3-2E-G), vertical time (Fig. 3-2F-H), the total number of movements (Fig. 
3E-G), and the number of vertical movements (Fig 3-3F-H), all ps < 0.01.  Conversely, 
no effects of infection were seen at this time point. 
Of all measurements taken, change in body weight most adequately reflected 
influences of both stress and infection.  Therefore, this measurement was used to 










































































































Figure 3-2.  The effects of RS and TMEV infection on vertical activity.  Activity was recorded 
for 20 min during the hours of 0700 to 1000 using a digipro machine on days –1, 3, and 5 p.i.  
Groups are:  infected/non-restrained (I/NR; open circles); infected/restrained (I/R; closed circles) 
non-infected/non-restrained (NI/NR; open squares); non-infected/restrained (NI/R; closed 
squares).  There were no differences in the amount of vertical activity or vertical time between 
groups at baseline (day -1p.i.) (A and B).  At day 3 p.i., however, RS reduced the vertical time 
(D), and there were interactions between minute and infection and stress (C and D).  At day 5 p.i. 
stress mice were disinclined to demonstrate vertical activity or vertical time (E and F).  The 
effect of day on both vertical activity and time are represented by graphing the averages of the 




















































































































































































































Figure 3-3:  The effects of RS and TMEV infection on movement. The activity of all mice was 
recorded for twenty minutes during the hours of 0700 to 1000 using a digipro machine on days –
1, 3, and 5 p.i. Groups are illustrated as:  infected/non-restrained (I/NR; open circles); 
infected/restrained (I/R; closed circles) non-infected/non-restrained (NI/NR; open squares); non-
infected/restrained (NI/R; closed squares).  There were no differences in either total movement 
or vertical movement between groups at baseline (day –1p.i.) (A and B).  At day 3p.i. RS 
reduced the total number of movements (C), but had no effect on vertical movements (D).  At 
this time point interactions existed between stress and minute as well as stress, infection and 
minute for the number of movements (C).  By day 5p.i. RS resulted in decreases in both the total 
number of movements (E) as well as the number of vertical movements (F).  Averages of the 20 
sessions for both number of movements (G) and number of vertical movements (H) are 









































































































Figure 3-3, continued. 
 
3.1 Effects of stress on the immunologic responses to infection 
3.2.1 Restraint stress has a profound influence on T-cell responses in the CNS and 
spleens at days 8 p.i. 
Cellular immune responses, particularly CD8+ T-cell responses, are imperative 
for the clearance of TMEV from the CNS and, thus, essential for preventing the 
development of immune-mediated demyelination in this model of human MS.  The 
benefit of IFN-γ in the clearance of TMEV is illustrated by the fact that IFN-γ-/- mice on 
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a normally resistant background succumb to viral persistence and eventually 
demyelination (Rodriguez et al., 2003).  In order to determine the effects of RS on IFN-γ 
producing T-cells in both the CNS and the periphery, we utilized known 
immunodominant CD4+ (VP274-86), and CD8+ (VP3159-166) T-cell epitopes to stimulate 
these cells in the context of an ELISPOT assay.  Within the CNS, very few cells 
responded to the CD4+ immunodominant peptide (VP274-86), confirming the results of 
others that suggest that almost no capsid specific Th1 cells are present in the CNS of 
TMEV infected SJL mice at this time point (Fig. 3-4A; Mohindru et al., 2006).  In sharp 
contrast, infection caused an influx of CNS-IL that were specific for the CD8+ 
immunodominant epitope (VP3159-166) (p < 0.001) at day 8 p.i. (Fig.3-4B).  Within 
infected animals, RS decreased the number of VP3159-166 reactive CD8+ cells by 
approximately 58% (p < 0.05).  Additionally, at this same time point, infection increased 
the number of both VP274-86 (CD4+)  and VP3159-166 (CD8+) specific IFN-γ producing 
cells in the spleens of infected mice (ps < 0.01) (Fig 3-4C-D).  While CD4+ T-cell 
responses were different between the periphery and the CNS, it is worth noting that the 
CD8+ T-cell responses were very similar and in fact significantly correlative (r = 0.6481; 
p < 0.01; see Appendix A for correlation).   Importantly, restraint stress decreased both 
of these responses in the spleens of infected mice by approximately 50 and 60% 
respectively (ps < 0.01) (Fig. 3-4B&D). Taken together these data indicate that RS 
drastically reduces the number of virus-specific IFN-γ producing CD4+ and CD8+ T-cells 

















































































































Figure 3-4.  Restraint stress alters the numbers of virus specific IFN-γ producing cells in the 
CNS and spleens of SJL mice at days 8 and 16 p.i.  Mice were assigned to either infected/non-
restrained (I/NR), infected/restrained (I/R), non-infected/non-restrained (NI/NR) or non-
infected/restrained (NI/R) groups.  At day -1 p.i. mice in the restrained groups were subjected to 
8 h nightly restraint sessions which lasted until day 8 p.i.  At day 8 or 16 p.i. isolated 
lymphocytes were stimulated with either CD4 (VP274-86) or CD8 (VP3159-166) restrictive or non-
specific (NS) peptide in the context of an IFN-γ ELISPOT assay. A. IFN-γ producing cells 
specific for VP274-86 in the CNS at day 8 p.i.  B.  VP3 specific IFN-γ producing cells in the CNS 
at day 8 p.i.  C.  VP274-86 specific IFN-γ producing cells from spleens.  D.  VP3159-166 reactive 
cells from spleens at day 8 p.i.  E.  VP274-86 specific IFN-γ producing cells from the CNS of mice 
at day 16 p.i.  F.  VP3159-166 specific IFN-γ producing cells isolated from the CNS spleens (H) at 
day 16 p.i.  G. VP274-86 specific IFN-γ producing cells in their spleens at day 16 p.i.  All samples 
were run in duplicate.  Background spots were determined for each sample using a NS peptide as 
a stimulus and were subtracted from results obtained from stimulation with viral peptides.   
Results are combined means ± SEM of 2-3 separate experiments, and represent 5-7 mice per 










































































































Figure 3-4, continued. 
 
3.1.2 Recovery from restraint stress is evident by day 16 p.i.  
Because overall activity, as well as body weight are rapidly returned to levels 
comparable to those of non-stressed mice following the secession of RS, we questioned 
if the immune response would be as resilient, or if the observed suppression would be 
sustained.  Therefore, in repeat experiments, we subjected mice to 9 sessions of RS as 
before.  At day 8 p.i. stress sessions ceased and mice were given until day 16 to recover, 
at which time the number of IFN- γ producing cells were measured as indicated above.  
Again, stimulation of CNS-IL with the CD4+ immunodominant peptide, VP274-86, did 
not stimulate the production of IFN-γ indicating a lack of virus specific Th1 response in 
the CNS of these mice at day 16 p.i. (Fig. 3-4E).  As occurred at day 8 p.i., stimulation 
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of CNS-IL with VP3159-166 demonstrated high numbers of IFN-γ producing CD8+ cells 
only in infected mice (Fig. 3-4F) at day 16 (p < 0.001).  However, when compared to 
day 8 p.i. this response was lower in I/NR animals (Fig. 3-4B vs. 3-4F).  Unlike at day 8, 
the effects of RS on VP3159-166 specific cells from the CNS were nearly identical 
between non-stressed (I/NR) and stressed (I/R) groups (Fig. 3-4F).  In the spleen, 
infected mice had increased numbers of VP274-86 specific IFN-γ producing CD4+ cells (p 
< 0.01) at day 16 p.i. (Fig. 3-4G).  Surprisingly however, the effect of stress was now 
reversed to almost the exact opposite of what occurred at day 8 p.i. such that non-
stressed mice (I/NR) had significantly fewer VP274-86 reactive CD4+ cells compared to 
stressed mice (I/R) (p < 0.05; Fig. 3-4C vs. 3-4G).  Similar to the CNS, the numbers of 
VP3159-166 specific IFN-γ producing CD8 cells in the spleens were significantly increased 
by infection (p < 0.0001) and nearly identical between non-stressed and stressed groups 
(Fig. 3-4H).  On day 8 p.i. this response was highly correlative between the spleen and 
the CNS at day 16 p.i. (r = 0.7582; p < 0.001; Appendix A). 
 
3.2.3  Restraint stress alters virus-specific antibody responses at days 8 and 16 p.i. 
The effect of restraint stress on the humoral immune response to TMEV was 
determined using ELISA’s and ELISPOT assays at days 8 and 16 p.i.  Virus-specific 
serum antibody levels were found to be significantly increased in infected mice at day 8 
p.i. when compared to non-infected mice (p < 0.01), and while we found that RS 
appeared to result in a slight increase in the virus-specific antibody response at this time, 
the effect did not reach statistical significance (p = 0.182; Fig. 3-5A).  The effects of 
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both infection and stress on virus-specific antibody levels were much more pronounced 
at day 16 p.i. than at day 8 (Fig. 3-5A; left vs. right).  As expected, infected groups 
(I/NR, I/R) had significantly more antibody than non-infected groups (NI/NR, NI/R) (p 
< 0.0001), and infected mice had higher levels of virus specific antibody in their serum 
than at day 8 (Fig. 3-5A; left).  Moreover, at day 16 p.i. virus specific antibody levels 
were significantly increased in the serum of I/R (n = 10) mice when compared to I/NR (n 
= 10) mice (p < 0.05) indicating that stress increased virus-specific antibody levels in the 
circulation (Fig. 3-5A; right).   The effect of restraint stress on virus-specific antibody 
levels did not appear to be attributable to an alteration in class switching as the same 
trend was observed in virus specific serum IgM and IgG levels at day 8 p.i. (data not 
shown). 
Because serum antibody levels may not be indicative of the humoral response 
that is occurring at the site of infection (CNS), we used ELISPOT assays to determine 
the effects of RS on the number of virus-specific antibody secreting cells (ASCs) in the 
CNS as well as the spleen at days 8 and 16p.i.  No virus-specific ASCs were detected in 
the CNS of either infected or non-infected groups at either time point (data not shown).  
Conversely, small numbers of virus specific ASCs were detected from the spleens of 
mice (Fig. 3-5B).  While the effects of infection and stress on the number of antibody 
secreting cells were not found to be statistically significant at either day 8 or day 16 p.i., 
the results appeared to mirror the findings from the ELISA, insofar as there were 
generally more virus specific APCs in I/R mice than I/NR mice groups at both day 8 and 





























































































Figure 3-5.  Restraint stress facilitates the production of TMEV-specific antibody response.  
Female SJL mice aged 4-5 weeks were grouped according to infection and restraint.  Beginning 
at day -1 post infection (p.i.) mice in the restrained groups were subjected to 8 hours nightly 
restraint sessions which lasted until day 8 p.i.  Serum isolated upon completion of the 
experiments (day 8 or day 16 p.i.) was used to test for virus-specific Ig by ELISA.  A. Infected 
mice had elevated virus specific antibody levels at day 8 p.i. which were further increased by day 
16 p.i.  Stress increased the level of this response at both time points.  B.  ELISPOT assays were 
used to test for virus specific antibody producing cells in the spleens of mice at days 8 and 16 p.i.  
Results are combined means ± SEM of 4 separate experiments, and are representative of 6-10 
mice per group. 
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3.2.4 Restraint stress decreases virus-specific Th1 and Th2 cytokine secretion at day 8 
As our ELISPOT assays were designed to enumerate IFN-γ specific T-cells, it 
could have been possible that stress altered virus-specific T-cell responses by inducing a 
Th1/Th2 shift (Elenkov, 2004).  To ascertain if such a shift occurred, we first measured 
serum cytokines.  As seen in Table 3-2, RS caused a significant decrease in the 
concentrations of circulating type 1 and type 2 cytokines including IFN-γ, IL-12(p40), 
IL-12(p70) (type 1), IL-4, and IL-5 (type 2; ps < 0.05).  However, infection was only 
found to statistically increase circulating concentrations of IL-12(p40) at this time point 
(p < 0.05) (Table 3-2). 
Stress also caused a decrease in the circulating concentrations of the chemokines 
RANTES and MCP-1, but increased serum levels of IL-6, G-CSF and KC (Table 3-3).  
As observed for type 1 and type 2 cytokines these concentrations were not significantly 
altered by infection with TMEV, except in the case of KC, in which case infection 
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Isolation of mRNA from unstimulated splenocytes yielded similar results as 
those obtained with cytokines, insofar as stress appeared to decrease levels of both IFN-γ 


















































































































Figure 3-6.  Neither infection nor stress significantly altered mRNA levels of cytokines from 
unstimulated splenocytes at day 8 p.i.  Mice were assigned to I/NR, I/R, NI/NR and NI/R groups.  
Stress sessions began at day -1 p.i. and lasted until day 8 p.i.  At day 8 p.i. total RNA was 
isolated from splenocytes (1.0 x 107).   A-C. cDNA was generated using random primers and 
RT-PCR was performed using syber green and primers specific for IFN-γ (A), IL-4 (B), and IL-5 
(C).  Samples were first normalized to β-actin, then normalized to NI/NR group. 
 
Therefore, to more specifically address the effects of RS on helper T-cell 
responses, we repeated the above experiments and isolated cells from the CNS and 
spleens of mice at day 8 p.i.  CNS-IL as well as spleen cells were stimulated either with 
plate bound anti-CD3 and anti-CD28, whole UV-inactivated TMEV (UV-BeAn), or 
media for 72 hours and supernatants were measured for Th1, Th2 and Th17 cytokines.   
CNS-IL from I/NR mice appeared to produce more IFN-γ when stimulated with 
antibodies to both CD3 and CD28 than any other group, possibly indicating a higher 
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number of Th1 clones (Fig. 3-7A).  When stimulated with UV-BeAn, CNS-IL from 
I/NR mice produced statistically more IFN-γ than CNS-IL isolated from I/R mice 
(Student’s t-test; p < 0.05; Fig. 3-7A).  I/NR mice secreted significantly higher levels of 
IL-17A, a marker of Th17 cell effector function, when stimulated with UV-BeAn, than 
I/R (Student’s t-test; p < 0.05; Fig. 3-7B).  Moreover, I/NR mice were also found to 
produce statistically more IL-2 when stimulated with UV-BeAn than I/R mice (Fig. 3-
7C; Student’s t-test; p < 0.05).  Generally, the same trend existed for the Th2 cytokines 
IL-5 and IL-10, when stimulated with either anti-CD3 and anti-CD28 antibodies or UV-
BeAn, but these effects were not statistically significant (data not shown).  These results 
indicate that at day 8 p.i., infected mice possess increased levels of virus-specific pro-
inflammatory T-cells within the CNS, and that stress decreases these responses. 
In the spleen, stressed mice (I/R, NI/R) groups appeared to have fewer Th1 and 
Th2 clones when compared to their non-stressed counterparts (I/NR, NI/R) as indicated 
by a general reduction in IFN-γ, IL-4 and IL-10 secretion following anti-CD3 and anti-
CD28 stimulation (Fig. 3-8A-B, D).  Importantly, infected animals produced more IFN-
γ, Il-17A, IL-4 and IL-10 following stimulation with UV-BeAn than non-infected mice 
(ps < 0.05).  With the exception of IL-17A, comparisons between I/NR and I/R mice 
groups confirmed that stress decreased these virus specific immune responses (ps < 
0.05).  Taken together these results suggest that restraint stress administered during acute 
infection with TMEV inhibits virus-specific Th1 and Th2 cytokine production from cells 





















































Figure 3-7.  RS decreases virus-specific proinflammatory responses occurring in the CNS at day 
8 p.i. with TMEV.  CNS-IL were extracted from mice at day 8 p.i.  CNS-IL (5.0 x 104) were 
combined with 1.0 x 106 sygeneic irradiated feeders and cultured with plate-bound α-CD3 
(10µg/ml) and α-CD28 (2µg/ml), purified UV-inactivated BeAn, or media for 72 hours.  
Supernatants were used to measure cytokine production by luminex or ELISA. A-C.  I/NR mice 
produced increased amounts of the pro-inflammatory cytokines IFN-γ (A), IL-17A (B) and IL-2 
(C) when re-stimulated with whole UV-BeAn compared to media controls.  I/R mice produced 
significantly less of these cytokines than infected/non-stressed mice.  Significant effects are 
shown.  Results are combined means ± SEM of 3 separate experiments, and are representative of 
4-6 mice per group.  Student’s t-tests were used to test significance. * P < 0.05, ** P < 0.01, *** 































































Figure 3-8.  Restraint stress decreases both virus-specific pro-inflammatory and anti-
inflammatory responses occurring in the spleen at day 8 p.i. with TMEV.  Splenocytes (1.0 x 
106) were isolated from I/NR, I/R, NI/NR, NI/R mice at day 8 p.i. and cultured with plate-bound 
α-CD3 (10µg/ml) and α-CD28 (2µg/ml), purified UV-inactivated BeAn (1.0 µg), or media for 72 
hours at 37 C and 5.0% CO2.  Supernatants were used to measure cytokine production by 
luminex or ELISA.  A-D.  Splenocytes produced increased amounts of the pro-inflammatory 
cytokines IFN- γ (A), IL-17A (C) and IL-4 (B) and IL-10 (D) when re-stimulated with whole 




To explore the effects of stress on type 1 and type 2 responses further, we 
questioned whether stress altered the polarization of T-cells.  We hypothesized that if RS 
caused Th1 and Th2 immunosuppression rather than just decreased cytokine secretion, 
then T-bet and GATA-3, the transcription factors for Th1 and Th2 polarization 
respectively, would also be decreased.  Therefore, we first measured mRNA levels of 
both T-bet and GATA-3 by quantitative RT-PCR from RNA isolated from unstimulated 
splenocytes. We found that at day 8 p.i., mice in the I/NR group had significantly 
increased mRNA levels of T-bet (p < 0.05), when compared to other groups, and that RS 
significantly decreased mRNA levels of T-bet (Fig. 3-9A, top; p < 0.01).  Although not 
as robust, the same effects of infection and stress were demonstrated for GATA-3 
mRNA levels, such that the I/NR group possessed higher expression levels of GATA-3 
than any other group, and that RS significantly decreased GATA-3 expression (Fig 3-
9A, bottom; p’s < 0.05).  To determine if these effects of stress indeed translated into 
decreased protein levels, and to ensure the validity of our findings, we repeated the 
experiment, but measured T-bet and GATA-3 protein levels by immunoblots from 
nuclear extracts of splenocytes at day 8 p.i., following stimulation plate-bound anti-CD3 
and anti-CD28 antibodies, VP274-86, VP3159-166 or NS peptides for 5 and 24 hours.  
Regardless of the stimulus, prior infection with TMEV increased only T-bet relative to 
β-actin controls in non-stressed mice after 5 hours of stimulation (Fig. 3-9B; top).  
Contrary to the results demonstrated by RT-PCR, GATA-3 nuclear protein levels were 
not affected by RS (Fig. 3-9B; top).  While not as pronounced, the same trend existed 
following 24 hours of stimulation (Fig. 3-9; bottom).  Densitometry quantification of 
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protein levels at 5 hours of stimulation resembled results obtained from mRNA fold 
induction by RT-PCR, insofar as stress was appeared to decrease T-bet nuclear protein 
levels, but did not appear to have influenced GATA-3 protein (Fig. 3-9C).   
 
 





























































































































































































Figure 3-9.   Restraint stress decreased T-bet, and causes decreased virus specific IFN-γ 
secretion from stimulated splenocytes isolated at day 8 p.i.  A.  RNA isolated from splenocytes 
of mice at day 8 p.i. was reversed transcribed into cDNA.  mRNA expression of T-bet and 
GATA-3 tested by RT-PCR.  Data represent fold induction relative to β-actin and normalize to 
NI/NR group.  B.  In separate experiments splenocytes (1.0 x 106) were cultured with plate-
bound α-CD3 (10µg/ml) and α-CD28 (2µg/ml), VP274-86 (2.0 μM), VP3155-166 (2.0 μM), or non-
specific peptide (NS; 2.0 μM) or for 5 or 24 h at 37°C and 5.0% CO2.  Nuclear extracts were 
subjected to immunoblots specific for T-bet (B; top row); or GATA-3 (B; middle row) or β-actin 
(B; bottom row).  C.  Densitometric analysis at of T-bet relative to β-actin was normalized to the 
NI/NR group at 5 h stimulation.  D. Supernatants were used to measure IFN-γ production by 
ELISA.  A and D results represent means ± SEM of 3 separate experiments comprising 5-7 mice 
per group.  B represent pooled samples from 2 mice per group; this experiment was repeated 
with similar results (not shown).  C are mean densitometric analysis of results obtained of both 



































































































































































































Figure 3-9, continued. 
 
In order to determine if these effects of stress correlated with decreases in IFN-γ, 
a known target of T-bet, we measured IFN-γ secretion from previously stimulated 
splenocyte cultures taken from infected (I/NR, I/R), or non-infected (NI/NR, NI/R) 
groups at day 8 p.i.  Figure 3-9D shows that infection resulted in increased IFN-γ 
production by 24 hours following stimulation anti-CD3 and anti-CD28, or viral peptides 
(VP274-86, VP3159-166), but not the NS peptide.  Restraint stress was found to significantly 
decrease both virus-specific CD4 (VP274-86) and CD8 (VP3159-166) responses by 
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approximately 21% and 66% respectively (Students t-test; ps < 0.05). These results are 
highly reminiscent of our ELISPOT data at this time, and indicate that RS results in a 
decrease in IFN-γ secretion as well as the number of IFN-γ producing cells (Fig. 3-4).   
 
3.2.5 Restraint stress modestly alters CD4+ and CD8+ T-cell percentages at days 8 and 
16 p.i. 
The possibility that RS was mediating its actions in the periphery (spleen) by 
decreasing the total percentages of CD4+ and CD8+ T-cells, either by trafficking or cell 
death, could account for our observed reductions in T-cell responses.  In order to 
investigate this possibility, we measured T-cell percentages in isolated spenocytes from 
I/NR and I/R mice by flow cytometry at days 8 and 16 p.i.  At day 8 p.i. we found that 
RS resulted in a very slight (64.5% vs. 62%), but highly significant (Student’s t test; p < 
0.01), decrease in the percentage of CD4+ T-cells (Fig. 3-10A).  The effect of RS on 
CD4+ percentage was found to persist until day 16 p.i. (63.5% vs. 57.5%) despite the 
secession of RS (Student’s t test; p < 0.001).   
The percentages of CD8+ T-cells in the spleens were higher at day 8 than day 16 
p.i.  In contrast to that observed for CD4+ T-cells, RS resulted in a moderate, but highly 
significant increase in the percentages of CD8+ T-cells at both day 8 (31% vs. 35%) and 
day 16 (20% vs. 25%) (Fig. 3-10B; Student’s t test; ps < 0.01).  These results indicate 
that RS is capable of modifying peripheral CD4+ and CD8+ T-cell percentages.  
However, while statistically significant, these effects account for up to only 5% 
alteration, and thus are unlikely to fully account for our observed RS-induced 
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immunosuppression of virus specific CD4+ (VP274-86) effector function.  Additionally, as 
stress resulted in an increased percentage of CD8+ T-cells, the observed decrease in 









































Figure 3-10.  Restraint stress differentially alters CD4+ and CD8+ T-cell percentages at days 8 
and 16 p.i.  Female SJL mice aged 4-5 weeks were assigned to either infected/non-restrained 
(I/NR), or infected/restrained (I/R), groups.  Beginning at day -1 post infection (p.i.) mice in the 
restrained groups were subjected to 8 hours nightly restraint sessions which lasted until day 8 p.i.  
At day 8 or 16 p.i. percentages of CD4+ (A) and CD8+ (B) T-cells from isolated splenocytes (1.0 
x 106) was determined by flow cytometry.  For each time point n = 7 per group. 




3.2.6 Effects of glucocorticoids on adaptive immune responses to TMEV at day 8 p.i. 
As restraint stress has been previously demonstrated to increase serum 
corticosterone in SJL mice infected with TMEV (Sieve et al., 2004), glucocorticoids 
could be responsible for our observed immunosuppression.  To test the hypothesis that 
glucocorticoids mediate stress-induced immunosuppression, we infected mice and 
treated them with dexamethasone (DEX), RU486 or respective vehicle controls, and 
measured virus-specific immune responses during their peak at day 8 p.i.  Analysis of 
change in body weight percentages indicated that our treatments were successful because 
as seen before, (Fig. 3-4B) stress caused a decrease in body weight which was reversed 
by concurrent administration of RU486 (Fig. 3-11A).  At the same time administration 
of DEX mimicked the effect of RS (Fig. 3-11A).  The effects of these treatments became 
statistically significant by day 4 p.i.  Additionally, we found that the total number of 
isolated splenocytes were still reduced in stressed mice treated the RU486 (Fig. 3-11B).  
In contrast, the effects of RS on T-cell percentages in the spleens were entirely mediated 
by glucocorticoids as these effects were completely reversed when RU486 was 
aministered to I/R mice, but were reestablished in I/NR mice when administered DEX 
(Fig. 3-12A-B).  As before, stress decreased the number of VP274-86 and VP3155-169 
specific IFN-γ producing cells in the spleen, and DEX treatment mimicked these effects 
(Fig. 3-12B-C).  However, unlike T-cell percentages, RU486 treatment during 
concurrent RS did not completely alleviate the effects of RS (Fig. 3-12D).  In agreement 
with our previous data, almost no VP274-86 reactive IFN-γ producing cells were detected 
in the CNS of infected animals, while a robust VP3155-169 response was evident (Fig. 3-
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12E).      Compared to the spleen, the responses in the CNS exhibited similar effects of 
RU486 and DEX treatments on the number of VP3155-169 reactive IFN-γ producing cells 
although the effects failed to reach statistical significance; possibly attributable to a low 























































Figure 3-11.  Restraint stress induced weight loss is mediated by the actions of glucocorticoids.  
Female SJL mice aged 4-5 weeks were assigned to either infected/non-restrained PBS treated 
(I/NR-PBS), infected/non-restrained DEX treated (I/NR-DEX), infected/restrained PEG treated 
(I/R-PEG), or infected/restrained RU486 treated (I/R-RU486).  Beginning at day -1 post 
infection (p.i.) mice in the restrained groups were subjected to 8 hours nightly restraint sessions 
which lasted until day 8 p.i.  Treatments with DEX (1.0 mg/kg) and RU486 (25mg/kg) or vehicle 
control (PBS or PEG400 respectively) were administered nightly 1 h prior to each stress session 
by i.p. or s.c. injection in a total volume of 0.1ml.  A.  Body weight was recorded nightly before 
injections and is presented as percent change from baseline (day -1 p.i.).  B.  At the termination 
of the experiment the total number of spleen cells were determined by trypan blue exclusion.   























































Figure 3-12.  Effects of RS on T-cell number and virus-specific effector function are partly due 
to the actions of glucocorticoids.   Female SJL mice aged 4-5 weeks were assigned to either 
infected/non-restrained PBS treated (I/NR-PBS), infected/non-restrained DEX treated (I/NR-
DEX), infected/restrained PEG treated (I/R-PEG), or infected/restrained RU486 treated (I/R-
RU486).  Beginning at day -1 post infection (p.i.), mice in the restrained groups were subjected 
to 8 hours nightly restraint sessions which lasted until day 8 p.i.  Treatments with DEX (1.0 
mg/kg) and RU486 (25mg/kg) or vehicle control (PBS or PEG400 respectively) were 
administered nightly 1 h prior to each stress session by i.p. or s.c. injection in a total volume of 
0.1ml.  A.  Effects of glucocorticoids on percentage of CD4+ and CD8+ (B) cells in the spleens of 
infected  mice.  C.  The effects of RS, DEX and RU486 treatment on the number of IFN-γ 
producing CD4+ restricted (VP274-86) cells in the spleen.  D.  The effects of RS, DEX and RU486 
treatment on the number of  IFN-γ producing CD8+ restricted (VP3155-169) cells in the spleens.  E.  
The effects of RS, DEX and RU486 treatment on the number of IFN-γ producing CD4+ 
restricted (VP274-86) cells in the CNS.  F.  The effects of RS, DEX and RU486 treatment on the 
numbers of CD8 restricted (VP3155-169) IFN-γ producing cells in the CNS.  Results are combined 






























































































































Figure 3-12, continued. 
 
Unlike T-cell effector function, the effects of glucocorticoids on serum antibody 
levels were not as straightforward.  At day 8 p.i., DEX treatment appeared to reduce 
serum antibody levels in I/NR mice (Fig. 3-13), indicating a potential role for 
glucocorticoids in inhibiting antibody levels.  I/R mice treated with the glucocorticoid 
receptor antagonist RU486 also appeared in decreased TMEV specific antibody levels 
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Figure 3-13.  Restraint stress induced increase in TMEV-specific serum antibody levels does not 
appear to be attributable to the actions of glucocorticoids.  Mice were assigned to either 
infected/non-restrained PBS treated (I/NR-PBS), infected/non-restrained DEX treated (I/NR-
DEX), infected/restrained PEG treated (I/R-PEG), or infected/restrained RU486 treated (I/R-
RU486).  At day -1p.i. mice in the restrained groups were subjected to 8 h nightly restraint 
sessions which lasted until day 8 p.i.  Treatments with DEX (1.0 mg/kg), RU486 (25mg/kg) or 
vehicle control (PBS or PEG400 respectively) were given nightly 1 h prior to each stress session 
by i.p. or s.c. injection in a total volume of 0.1ml.  Virus-specific antibody levels were measured 
from serum taken at day 8 p.i. by ELISA.  Results are means ± SEM of 10 mice per group from 





3.2.7 Effect of glucocorticoids on the functions of IFN-γ production 
 In the above experiments glucocorticoid-induced immunosuppression could have 
been brought about by suppressing the function of antigen presenting cells, essentially 
inhibiting the generation of TMEV-specific immunity.  To more closely examine the 
effects of glucocorticoids on the effector functions in T-cells, we first stimulated 
splenocytes isolated from I/NR mice with VP274-86, VP3155-169 , or NS peptides in the 
presence of varying concentrations of DEX for 24 hours, and then determined IFN-γ 
concentrations from the culture supernatants.  DEX treatment of cells resulted in a dose 
dependent reduction in IFN-γ production for both VP274-86, and VP3155-169  stimulated 
splenocytes (Fig. 3-14A), indicating that either IFN-γ production is inhibited by DEX 
treatment or that DEX treatment causes cell death.  To investigate the latter possibility 
we stimulated splenocytes isolated from a I/NR mouse with either viral peptides, control 
peptides, media alone or varying concentrations of DEX.  Utilizing an MTT assay, the 
viability of the splenocytes were determined at 24 hours post stimulation.  Increasing 
concentrations of DEX resulted in a dose dependent reduction of viability (Fig. 3-14B).  
At 100nM concentration of DEX there was approximately 32% reduction in viability.  
While it seems unlikely that this reduction in viability reflected exclusive death of IFN-γ 
production T-cells in our culture system, we cannot rule out this possibility.  Taken 
together, these results may support a role for glucocorticoid induced inhibition of TMEV 



















































































Figure 3-14.   Glucocorticoids decrease virus specific IFN-γ production.  Non-restrained female 
SJL mice (n = 2) were infected with TMEV.  A.  At day 8 p.i. 1.0 x 106 spleen cells were 
stimulated with 2μM VP274-86 (VP2), VP3155-169 (VP3) or non-specific (NS) peptide for 24 h in 
presents of varying concentrations of dexamethasone (DEX) or media.  Concentrations of IFN-γ 
from supernatants were determined by ELISA. B.  At day 8 p.i. splenocytes from a I/NR SJL 
mouse were isolated and simulated as described.  After 24 h of stimulation MTT was used to 
check viability of cells.  Samples from all conditions were run in duplicate with the exception of 
the NS stimulated cells from the MTT assay (B), which is representative of only one sample per 
condition.  Results are combined means ± SEM. *P < 0.05, **P <0.01, ***P < 0.001.  
 
 115
4.  Discussion 
In multiple sclerosis, the production of proinflammatory cytokines, particularly 
IFN-γ, within the CNS by CD4+ or CD8+ T-cells is generally perceived as a negative 
event (Sospedra and Martin, 2005).  In fact, when administered as a therapy to MS 
patients, IFN-γ was associated with increased frequency of relapses (Panitch et al., 
1987).  Experimentally, IFN-γ has been shown to directly induce neurotoxicity by 
resulting in the phosphorylation of the AMPA receptor GLuR1, a process dependent on 
the direct association with the IFN-γR and its activation (Mizuno et al., 2008).  In 
addition, it has been demonstrated that induced IFN-γ expression within the CNS can 
inhibit re-myelination by a process dependent on ER stress (Lin et al., 2006).  IFN-γ may 
also modulate MS through its ability to induce MHC class II expression on astrocytes 
(Wong et al., 1984) as well as through its ability to induce MHC class I expression on 
electrically silent neurons (Neumann et al., 1995).  The later would expose neurons to a 
potential cytolytic attack by CD8+ T-cells, which have been shown to be oligoclonally 
expanded in MS patients and outnumber CD4+ T-cells within the lesions by 3:1 (Bebbe 
et al., 2000).  In support of the deleterious effects of type 1 immune responses in MS, T-
bet and phosphorylated STAT1 levels have recently been shown to be elevated in 
peripheral blood mononuclear cells taken from patients during relapses compared to 
those in remission or healthy controls.  Furthermore, treatment with oral glucocorticoids 
inhibited this effect (Frisullo et al., 2007). 
 Another proinflammatory cytokine that has recently received considerable 
attention in the realm of autoimmune diseases is IL-17.  While T-cells and neutrophils 
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are capable of producting IL-17, the major source of IL-17 is the Th17 cell, which in 
humans have been shown to also be capable of producing IFN-γ (Annunziato et al., 
2007).  Supporting a role for Th17 cells in the pathogenesis of MS, patients have 
increased IL-17 mRNA expression in their brain and CSF (Witowskiet et al., 2004).  
Additionally, Vaknin-Dembinsky et al., (2006), have demonstrated that IL-23, a 
cytokine responsible for Th17 cell proliferation,  is increased in dendritic cells isolated 
from MS patients, and that isolated CD4+ T-cells stimulated with α-CD3 antibodies 
produce more IL-17 than healthy controls (2006). Mechanistically, it is thought that 
these Th17 polarizing dendritic cells arise from the differentiation of circulating 
monocytes by activated cerebrovascular endothelial cells at the site of the lesion (Ifergan 
et al., 2007).  Finally, involvement of Th17 cells in the pathogenesis of MS is supported 
by the findings that IL-17R is expressed on human endothelial cells of MS patients but 
not patients with other neurological diseases; that IL-17 is capable of incurring BBB 
breakdown and Th17 cells can kill neurons in a granzyme dependent fashion (Kebir et 
al., 2007). 
 Even though proinflammatory cytokine secretion can have devastating effects 
within the CNS, animal models of MS have shown that proinflammatory cytokine 
secretion can potentiate some protection.  For instance, EAE is exacerbated in IFN-γ-/- 
mice (Krakowski and Owens, 1996; Ferber et al., 1996; Willenborg et al., 1996).   In 
Theiler’s virus infection, IFN-γ is thought to assume a protective role.  During early 
infection it is beneficial as illustrated by the fact that it has potent in vitro anti-viral 
activity against TMEV (Welsh et al., 1995) and has been demonstrated to be  required 
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for neuronal viral clearance from the CNS, as IFN-γ-/- mice display decreased survival 
rates following infection with TMEV (Rodriguez et al., 2003; Murray et al., 2002).  
Additionally, both IFN-γ-/- and IFN-γR-/- mice on a normally demyelination-resistant 
background develop severe demyelination (Rodriguez et al., 1995; Johnston et al., 2001; 
Murray et al., 2002).  While many studies have investigated the role of IFN-γ in TMEV 
infection, to date, virtually nothing is known about the involvement of Th17 cells in the 
pathogenesis of Theiler’s virus infection.  However, some studies indirectly implicated 
these cells in the disease process.  For instance, deletion of IL-12(p40), a subunit 
required for the formation of both active IL-12 and IL-23 heterodimers, by antibody 
administration given during early infection with TMEV delays the onset of 
demyelination in susceptible mice (Inoue et al., 1998).  In constrast, deletion of STAT4, 
a transcription factor responsible for IFN-γ transcription, in mice on a normally TMEV-
IDD resistant background, are rendered susceptible to demyelination (Rodriguez et al., 
2006).  Also, the TMEV susceptibility gene tmevp3 is suspected of coding for IL-22, an 
additional product of Th17 cells (Liang et al., 2006), and that this loci limits viral titers 
within the CNS controlling mortality due to encephalitis in SJL mice during early 
infection (Levillayer et al., 2007). 
In the current study re-stimulation with either the immunodominant CD4+ 
(VP274-86) or CD8+ (VP3155-169) peptides demonstrated that RS severely impairs the 
number of virus specific IFN-γ producing T-cells in the periphery, as well as the number 
of virus specific IFN-γ producing CD8+ cells in the CNS of infected animals.  Moreover, 
the absence of the type 1 immune response in the serum, periphery, and CNS was 
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coupled with reductions in virus specific type 2 responses.  In isolated splenocytes Th1 
and Th2 cytokine reduction was mirrored by decreases in T-bet at the mRNA and 
protein levels, as well as a slight decrease in GATA-3 mRNA, strongly suggesting a 
globalized suppressive response to stress. As such, our results are supported by those of 
Dobbs et al., (1996) which show that RS causes a globalized immunosuppression during 
acute viral infection.  Additionally, we have, to our knowledge demonstrated for the first 
time, a suppressive effect of stress on virus specific IL-17 production within the CNS; 
which interestingly were not duplicated in the periphery, a finding that is currently under 
investigation.  In contrast, the numbers of virus-specific CD8+ T-cells as determined by 
IFN-γ ELISPOTs were correlated between the CNS and spleens of infected mice, and 
cytokine profiles exhibited following stimulation of CNS-ILs or splenocytes with UV-
inactivated virus were in agreement, which may indicate the development of virus-
specific immunity in the periphery and subsequent trafficking to the CNS.  Alternatively, 
reductions in virus-specific responses by stress could have been brought about by 
reductions in lymophocyte proliferation, increased cell death within both the spleen and 
CNS, or enhanced efflux of cells from the CNS back into the periphery, mechanisms that 
are currently being investigated.  Moreover, glucocorticoids were found to contribute to 
this RS-induced suppression as the antagonist RU486 resulted in partial restoration of T-
cell effector function in both the CNS and the spleen, whereas administration of the 
synthetic glucococorticoid, dexamethasone mimicked the effects of stress. 
The observed suppressive effects of stress and glucocorticoids on T-cell effector 
function, particularly virus-specific IFN-γ producing cells, could have been a byproduct 
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of suppressive effects directed toward antigen presenting cells, especially macrophages 
and dendritic cells, resulting in decreased numbers of virus specific T-cell clones.  This 
possibility is supported by the fact that corticosterone can inhibit processing and 
presentation of MHC class I molecules on DCs (Truckenmiller et al., 2005), as well as 
decrease CD80/CD86 transcription, cause MHC class II retention and reduce IL-6, IL-12 
and TNF-α production in DCs activated with LPS (Elftman et al., 2007).  In support of 
this mechanism of immunosuppression, T-cells from stressed mice stimulated with α-
CD3/ α-CD28 antibodies tended to produce less type 1 and type2 cytokines than T-cells 
from non-stressed mice, a finding that may indicate an overall reduction on the number 
of Th1/Tc1 and Th2/Tc2 clones present within the CNS and the spleen (Figs. 3-4 and 3-
5).  Alternatively, the increase in corticosterone by stress in our model (Sieve et al., 
2004) could also act directly at the level of the T-cell by inhibiting the functions of the 
transcription factors responsible for mediating effector function.  To date, 
glucocorticoids have been shown to inhibit the actions of AP-1, NFkB and GATA-3 
(reviewed in Webster et al., 2002; Jee et al., 2005).  Recently, the actions of 
glucocorticoids, specifically dexamethasone,  have been demonstrated to inhibit the 
binding of T-bet to the IFN-γ promoter, possibly providing a mechanism for defective 
IFN-γ transcription and production in previously polarized Th1 or Tc1 effector T-cells 
(Liberman et al., 2007). 
The transcription factor T-box expressed in T-cells (T-bet) brings about 
polarization of naive Th0 cells to the functional Th1 phenotype, and is required for 
optimal trafficking of this subtype into inflamed tissue (Szabo et al., 2000; Lord et al., 
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2005).  Additionally, T-bet has been implicated in the development of functionally 
active NK cells (Szabo et al., 2002) and NKT cells (Townsend et al., 2004), as well as 
the optimal production of IFN-γ from dendritic cells (Lugo-Villarino et al., 2003).  T-bet 
is also reported to play a role in class switching in B-cells (Peng et al., 2002; Xu and 
Zhang, 2005).  Early in vitro experiments indicated that T-bet was not solely responsible 
for the production of IFN-γ production by CD8+ T-cells (Szabo et al., 2002), which was 
later shown to be under the cooperative control of another T-box transcription factor, 
Eomesodermin (Eomes; Pearce et al., 2003).  However, more recent studies indicate that 
T-bet is important for antigen specific cytotoxicity in CD8+ T-cells (Sullivan et al., 
2003), and has most recently been shown to be required for the secretion of IFN-γ from 
CD8+ T-cells during infection (Mayer et al., 2008).  Therefore, it is not surprising that T-
bet-/- mice have been shown to be more susceptible to HSV-2 and Vaccinia Virus 
(Svensson et al., 2005; Matsui et al., 2005) infections than wild-type controls.  
Interestingly, the immunologic phenotype of restraint stressed mice compares with that 
of the T-bet-/-, as RS mice are known to display reduced NK cell function (Welsh et al., 
2004; Teng et al., 2005), decreased CD4+ and CD8+ T-cell responses to viral infections 
(Sheridan et al., 1991; Dobbs et al., 1996; Freeman et al., 2007; current study), decreased 
T-cell trafficking (Zhang et al., 1998; Ottaway and Husband, 1994; Mizobe et al., 1997), 
and display greater susceptibility to TMEV (Campbell et al., 2001), and HSV-1 infection 
(DeLano, and, Mallery, 1998; Anglen et al., 2003).   
To explore a possible connection between the immunosuppressive effects of RS 
and T-bet, we first demonstrated that RS reduced mRNA and protein levels of the 
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transcription factor T-bet isolated from primary splenocyte cultures.  These stress effects 
were not entirely attributable to altered T-cell populations, as stress only moderately 
affected CD4+ and CD8+ T-cell percentages.  The mechanisms by which stress results in 
a decrease in nuclear levels of T-bet is not currently understood, although several 
explanations exist.  For instance, T-bet is known to be induced by IFN-γ dependent 
activation of STAT1 (Afkrian et al., 2002), a process that glucocorticoids have been 
shown to inhibit (Hu et al., 2002).  Alternatively, it has been shown that the polarization 
of Th1 cells is dependent on the binding of IL-12(p70) to its receptor and the subsequent 
phosphorylation of STAT4 (Usui et al., 2006; Wurster et al., 2000).  As mentioned 
previously, glucocorticoids can inhibit IL-12 production and secretion at the DC level 
which, in turn would conceivably reduce the number of T-bet positive cells.  Supporting 
this hypothesis is the fact that RS caused significant decreases in both circulating serum 
IL-12(p40) and IL-12(p70) concentrations (Table 3-2).  This process could also be 
ablated downstream of the signaling pathway, as dexamethasone has also been shown to 
inhibit the phosphorylation of STAT4 by a mechanism that was independent of IL-12R 
activation (Franchimont et al., 2000). 
Additionally, we were able to demonstrate that DEX decreased virus peptide- 
specific IFN-γ secretion from splenocytes isolated from I/NR mice in a dose-dependent 
fashion.  This effect did not appear to be entirely due to decreases in cell viability as 
determined by an MTT assay.  As such, these results may indicate that the effects of 
DEX were acting on a molecular level rather than cellular.  This effect was seen in both 
virus-specific CD4+ T-cells and CD8+ T-cells, directly indicating potential roles for 
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glucocorticoids in modulating the functions of either IL-12-induced STAT4, T-bet, 
Eomes or all of these factors at the ifng promoter.  These possibilities are the subject of 
current investigation.  However, it is likely that glucocorticoids exert their 
immunosuppressive properties concurrently at both the innate and adaptive levels of 
immunity. 
Antibodies generated against Theiler’s virus play an important role in viral 
clearance, as demonstrated by the fact that CD4+ T-cell depleted mice can be “rescued” 
by passive transfer of anti-viral antibodies (Borrow et al., 1993).  Immunization of SJL 
mice with the immunodominant antibody epitope (VP112-25) prior to infection with 
TMEV delays the onset of demyelination (Yahikozawa et al., 1997).  In C57BL/6 mice 
antibodies are able to convey resistance in the absence of a CD8+ T-cell response (Kang 
et al., 2005).   Additionally, deletion of B-cells by administration of anti-IgM antibody to 
SJL mice during acute TMEV infection results in a more severe demyelinating disease 
(Rodriguez et al., 1990).  Together, these studies illustrate the contribution of anti-
TMEV antibodies in controlling early viral replication.  Unlike virus-specific cellular 
responses, virus-specific humoral responses were found to be increased as a 
consequence of restraint stress, an unexpected finding given the nature of RS on virus-
specific T-cell responses.  Nonetheless, these effects were most readily illustrated by the 
increased virus specific Ig in the serum at days 8 and 16 p.i., although not producing 
statistically significant effects, the results from our virus-specific ELISPOT assays 
seemed to agree with this finding.  Importantly however, no virus-specific antibody 
secreting cells were detected in the CNS of infected mice at either time point, a finding 
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that is supported by others (Pachner et al., 2007).  This is in contrast to the results 
obtained for virus-specific CD8+ T-cells which were abundantly present in the CNS of 
infected animals at both day 8 and 16 p.i.  The mechanism by which stress affects the 
humoral response is not completely understood, and much conflicting evidence exists.  
For instance, our findings that stress results in increased virus-specific antibody levels 
are supported by the findings of (Brenner and Moynihan, 1997) demonstrating that in 
HSV-1 infection, uncontrollable footshock increased virus-specific serum IgM.  
Additionally, restraint stress also resulted in increased antigen specific IgM and IgG 
levels following immunization with KLH (Karp et al., 2000).    However, our study is in 
contrast to studies conducted by others indicating that chronic stress decreases antigen 
specific antibody levels (Fukui et al., 1997; Houri-Haddad et al., 2003; Silberman et al., 
2003), as well as with other studies that indicate stress has no effect on antibody levels 
(Sheridan et al., 1991; Feng et al., 1991; Karp et al., 1997; Cao et al., 2003).  While we 
demonstrate significantly increased serum antibody levels, we acknowledge that the 
relevance of these findings remain obscured, as we have yet to measure the effects of 
stress on neutralizing levels of anti-virus antibodies. 
There is little doubt about the occurrence of inflammatory processes within the 
CNS during the natural progression of MS.  However, when considering that post 
mortem examination of  newly developing lesions, indicate death of oligodendrocytes by 
apoptosis in the absence of inflammation (Barnett and Prineas, 2004), it seems pertinent 
to investigate the early event(s) leading to the manifestation of this disease.  To this end, 
there is some evidence supporting the involvement of an infectious trigger in MS.  For 
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instance, many chronic demyelinating diseases in animals are brought about by viral 
infection including canine distemper in dogs (Wisniewski et al., 1972); visna virus in 
Icelandic sheep (Sigurdsson et al., 1957) as well as MHV and Semliki Forest virus in 
mice (Weiner, 1973).  In man the autoimmune demyelinating diseases transverse 
myelitis, acute disseminating encephalomyelitis and Guillan Barre syndrome, occur after 
infection or vaccination.  Taken together, this indicates that overactive immune 
responses in response to viral infection or challenge can lead to demyelination and 
autoimmune-mediated myelin destruction. 
Complicating matters, stress which results in the release of immunosuppressive 
steroids into the circulation, has been associated with both onset and exacerbation of the 
disease (Li et al., 2004; Grant et al., 1989; Mohr et al., 2004).  If MS adheres strictly to 
an autoimmune pathogenesis then the effects of stress on the natural history of the 
disease are paradoxical.  This is best illustrated by the effects of RS on the progression 
of EAE (Krakowski and Owens, 1996; Ferber et al., 1996; Willenborg et al., 1996).  
However if an infectious, perhaps a persistent agent, is involved in the initiation and 
progression of MS, then the immunosuppressive effects of stress, as occurs in Theiler’s 
virus infection, will favor the pathogen and, after the resolution of the stressful stimuli, 
may expediate the autoimmune process, possibly through the attraction of naturally 
occurring autoreactive cells into the CNS from the periphery or by molecular mimicry 
and subsequent epitope spreading.  The recent finding that bone marrow reconstitution in 
a chronic myelogenous leukemia patient with MS was unable to alter disease course may 
support the above concept (Jeffery, 2007).  
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Alternatively, it is known that viral infections, particularly upper respiratory 
infections, precipitate MS exacerbation (Buljevac et al., 2002).  Through 
immunosuppressive properties, stress may increase the risk of MS exacerbation by 
indirectly increasing the risk of acquiring an infection.  Supporting this hypothesis is the 
fact that experimental stress in humans followed by rhinovirus infection resulted in 
increased disease severity (Cohen et al., 1991).  Nevertheless, our results indicate that 
stress results in immunosuppression of both TMEV specific T-cell responses, 
particularly protective IFN-γ, and provides a sound mechanism for observed increased 














IV  RESTRAINT STRESS FAILS TO RENDER C57BL/6 MICE SUSCEPTIBLE 
TO THEILER’S VIRUS INDUCED DEMYELINATION 
 
1.  Introduction 
Multiple sclerosis (MS) is a chronic idiopathic demyelinating and 
neurodegenerative disease of the central nervous system.  As such, both the onset and 
exacerbation of MS are currently thought to be heavily influenced by multiple factors 
including infectious, genetic and environmental (Hauser and Oksenberg, 2006).  
Evidence suggesting a viral involvement in the etiology of MS includes the association 
of multiple viral infections with MS (Cermelli and Jacobson, 2000), the precedence of 
relapses by infection (Sibley et al., 1985; Panitch, 1994) and epidemiological studies 
demonstrating MS outbreaks in areas with no previous history of the disease, 
particularity those conducted on the Faroe Islands (Kurtzke and Heltberg, 2001).  
Additionally, human viral infections are known to cause demyelination both through 
direct lysis of oligodendrocytes, as occurs in progressive multifocal 
leukoencephalopathy brought on by JC virus infection, and indirectly, as is the case in 
post infectious acute disseminated encephalomyelitis initiated by vaccination or 
infection (Tenembaum et al., 2007) and subacute sclerosing panencephalitis caused by 
measles virus infection (Sips et al., 2007).  In addition, virus-induced demyelination is 
demonstratable in animals as well.  For instance, infection of Icelandic sheep with visna 
virus (Sigurdsson et al., 1957), dogs with canine distemper virus (Wisniewski et al., 
1972), and mice with Semliki forest virus, the JHM strain of murine hepatitis virus, or 
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Theiler’s murine encephalomyelitis virus (Weiner, 1973; Daniels et al., 1952; Lipton, 
1975) all induce demyelinating diseases of the CNS that pathologically resemble human 
MS.    
Aside from evidence supporting an infectious trigger for MS onset and 
exacerbation, genetic predisposition to the disease is also likely to play a role in the 
pathogenesis of MS.  This is illustrated by studies conducted on twins that demonstrate 
an approximate 30% concordance rate among monozygotic twins but only a 3-5% rate 
among dizygotic twins (Ebers et al., 1986; Willer et al., 2003; Hansen et al., 2005a; 
Hansen et al., 2005b).  Indeed, multiple loci representing nearly every chromosome have 
been associated with MS (Dyment et al., 2004).  However, to date, the strongest and 
most reproducible genetic link, accounting for an estimated 17-60% of the genetic 
association with MS, is the HLA gene HLA-DRB1 (Haines et al., 1998; Hauser and 
Oksenberg, 2006). 
Other environmental stimuli, such as psychological stress, have also been 
implicated in the involvement of MS.  Interestingly, stress has been repeatedly 
associated with both onset (Warren et al., 1982; Grant et al., 1989; Li et al., 2004) and 
exacerbation (Mohr et al., 2004; Brown et al., 2006a; Brown et al., 2006b) of the 
disease, although the mechanism(s) behind these effects of stress on MS are currently 
poorly understood. 
Theiler’s murine encephalomyelitis virus (TMEV) is a member of the family 
Picornaviridae. TMEV infection of mice provides an excellent model in which to study 
human MS because it is endemic in mice although, in nature, rarely causes 
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demyelinating disease (Theiler, 1934).  Moreover, the development of Theiler’s virus 
induced demyelinating disease (TVIDD), the chronic progressive immune-mediated 
demyelinating and neurodegenerative disease, has been shown to depend on viral 
persistence within the CNS.  This persistence is genetically influenced by multiple loci 
both within and outside the murine H-2 (Brahic et al., 2005).  As such, mice that are H-2 
d,b,k are able to effectively clear the virus from the CNS and do not develop TVIDD, 
mice that are H-2 s,v,q,r,f do not clear the virus from the CNS and eventually develop 
TVIDD, and congenic strains such as B10.S demonstrate reduced severity of TVIDD 
(Azoulay-Cayla et al., 2000; Rodriguez et al., 1986) 
It is for these reasons that we have been interested in the mechanisms by which 
stress can influence the pathogenesis of TMEV infection.  We have previously found 
that psychological stress administered during early infection of TMEV in susceptible 
SJL mice results in an earlier and exacerbated demyelinating disease (Sieve et al., 2004).  
We hypothesized that immunosuppression during acute infection, resulted in higher viral 
titers in the CNS, which in turn, contributed to earlier onset and exacerbation of TVIDD.   
Because adaptive immunity, specifically virus specific CD8 T cells responses, are 
required for viral clearance from the CNS of non-susceptible C57BL/6 mice (Mendez-
Fernandez et al., 2003), we questioned whether chronic stress during early infection 





2.  Methods and materials 
2.1  Mice  
Female C57BL/6 mice were purchased from Jackson Laboratories (Bar Harbor, 
Maine).  The animals were housed 3-4 per cage, and kept on a constant 12 hour light-
dark cycle (0500/1700 h).  Food and water was available to all mice ad libitum.  Upon 
arrival mice were equally distributed into cages based on body mass.  Before the onset of 
each experiment, all mice were divided into groups corresponding to infection and 
stress, allowed to acclimate for 1 week prior to the onset of the experiment.  To 
determine the effects of RS on infection during the acute infection with TMEV infected 
non-restained mice (I/NR) were compared to infected restrained mice (I/R).  To test the 
effects of stress on susceptibility to chronic demyelination I/NR, I/R and sham infected 
restrained (NI/R) mice groups were used. 
 
 2.2  Virus and infection   
All mice were anesthetized with isoflourane prior to the infection.  Mice in the 
infected groups were then injected intracerebrally (i.c.) with approximately 5.0 x 105 
p.f.u. of the BeAn strain of TMEV (kindly provided by Dr Lipton), and mice in the non-
infected groups were sham infected (i.c.) with sterile phosphate buffered saline. 
 
2.3  Restraint stress procedure   
Restraint stress was carried out as described previously (Mi et al., 2006a).  
Briefly, mice in the restraint group were restrained starting 1 day prior to infection for 8 
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hours a session (1200-0800).  For acute phase experiments, mice were restrained nightly 
for 7 consecutive days.  For chronic phase experiments, mice received a total of 20 
restraint sessions consisting of 5 consecutive nights of stress followed by 2 nights with 
no stress (Sieve et al., 2004). 
 
2.4  Physiological indices of stress and infection 
The degree of ruffling, an indicator of stress, as well as body mass were recorded 
daily during the acute phase experiments (day 7 or 16 p.i.), and biweekly during the 
chronic phase experiments.  The degree of ruffling was scored as 0 = no ruffling, 1 = 
ruffling of the head, 2 = ruffling of the head, and 50% of the body, 3 = ruffling of the 
head and entire body. 
 
2.5  Blood collection for RIA 
Prior to restraint, and 48 hours post-restraint, all mice were bled from the 
saphaneous vein as previously described during the hours of 0800 and 1000 (Sieve et al., 
2004).  Immediately following collection, plasma was removed after centrifuging at 
3000 x g for 10 minutes at 4°C, and stored at -80˚C until corticosterone levels could be 
determined by radioimmunoassay (RIA; Keith et al., 1978). 
   
2.6  Corticosterone assay 
All plasma were assayed for corticosterone at baseline (before restraint) and 48 
hours post restraint using RIA kits obtained from MP biomedicals (Morgan Irvine, CA) 
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according to the manufacturers’ instructions (Keith et al., 1978).  Corticosterone levels 
are expressed in ng/ml.  
 
2.7  Measurement of serum amyloid a levels 
 Serum Amyloid A (SAA) levels were measured from serum by ELISA according 
to manufacturers’ instructions (Biosource). 
 
2.8  NK cell assay 
NK cell activity was assessed using a standard 51Cr release assay as previously 
described using splenocytes as effectors and YAC cells as targets (Welsh et al., 2004). 
Total 51Cr release was determined by incubating targets with 10% Triton-X 100.  
Spontaneous release was determined by counting the amount of 51Cr released after 
incubation of targets in complete RPMI-1640 media.  Total lysis of experimental 
samples were calculated using the following equation:  [(experimental release – 
spontaneous release)/(total release – spontaneous release)] x 100.  All samples were run 
in triplicate. 
  
2.9  Antibody levels 
TMEV-specific antibody levels from serum of mice taken from days 7, 16, 73, 
155, and 193 p.i. were determined using ELISAs developed in our lab as described 
previously (see above). 
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2.10  CTL assay 
Cytotoxic T lymphocyte activity was assessed on days 7 and 16 using a 
chromium release assay.  Here, previously isolated syngeneic cerebrovascular 
endothelial (CVE) cells (Sapatino et al., 1993) were infected with the BeAn strain of 
TMEV at a multiplicity of infection (m.o.i.) of 1 for 24 hours.  The cells were then 
radiolabelled with 100μCi/2.0 x 106 cells with Na51CrO for 2 hours at 37° C and 5.0% 
CO2.   Meanwhile, single cell suspensions of spleen cells were made as described 
previously (Welsh et al., 2004), and added to sterile round-bottomed 96-well polystyrene 
plates at a concentration of 1.0 x 106 cells/well in a total volume of 100μl media.  
Doubling dilutions were made of effectors, and 1.0 x 104 radiolabelled CVE cells per 
100μl media were added to all wells.  The cells were then brought together by 
centrifugation at 500 x g for 1 minute.  The plate was incubated at 37° C and 5.0% CO2 
for 4 hours.  The cells were pelleted by centrifugation at 2000 x g for 20 minutes, and 
100 μl of the supernatant was removed and counted using a gamma counter.  Total 51Cr 
release was determined by adding 100 μl of 10% Triton-X to wells containing 
radiolabelled CVE cells only.  Spontaneous release was determined by measuring 100 μl 
of supernatant containing only radiolabelled CVE cells.  Percent lysis was calculated 
using the following formula:  [(experimental release – spontaneous release)/(total release 





2.11  Plaque assays 
Plaque assays were used to determine viral levels in the brains of mice at days 7 
and 16 post infection as described previously (Mi et al., 2006b). 
 
2.12  Rotarod analysis 
 Rotarod analysis can serve as an indicator of motor dysfunction as a result of 
Theiler’s virus induced demyelinating disease, if measured during the chronic phase of 
TMEV infection (McGavern, et a., 1999).  Therefore, all groups were tested for 
performance on rotarod starting at day 77 p.i. using a Ugo Basile Model 7650 
accelerating rotarod treadmill.  The time on the rod comprised 1 session and was 
recorded for each animal.  Each animal completed two sessions on each test date.  Scores 
were taken biweekly, and results were expressed as the means of two sessions per date.  
 
2.13  Histology   
 Mice in the chronic phase experiment were sacrificed at day 195 p.i., and 
perfused with 10% formalin.  The brains and spinal cords were isolated, grossly 
sectioned, dehydrated, embedded in paraffin, sectioned into 5μm sections and stained 
with hematoxylin and eosin (H+E).  Sections were then examined for inflammation and 





2.14  Statistics 
Data are presented as mean ± SEM.  Data were analyzed using analysis of 
variance (ANOVA) and repeated measures ANOVA.  When appropriate, Fisher’s 
protected least significant difference model was used for post hoc comparison of means.  
In all cases significance was set at p ≤ 0.05.   
 
3.  Results 
3.1  Experiment 1:  Early infection 
3.1.1 Indices of stress 
Mice that have undergone restraint stress typically display ruffled fur and 
decreased body weight (Sieve et al., 2004).  As seen in Figure 4-1, stress caused a 
significant decrease in body weight which corresponded to the period in which mice 
were receiving nightly restraint sessions p < 0.01(days 1-7 p.i.) (Fig. 4-1A).  This effect 
was immediately diminished following the termination of these sessions and no 
differences between I/NR vs I/R mice were seen for the duration of the experiment (days 
8-16 p.i.) p = 0.815 (Fig. 4-1A).  In contrast, mice in the I/R group displayed 
significantly increased ruffling scores when compared to I/NR mice (Fig. 4-1B).  This 
effect was more significant at days 1-7 p.i., corresponding to the time in which I/R mice 
were being stressed p < 0.0001.  However, I/R mice remained more ruffled than I/NR 
mice even after stress sessions had ceased (days 8-16 p.i.) p < 0.01 (Fig. 4-1B).  These 





































Figure 4-1.   Restraint stress decreases body weight and causes ruffling in TMEV-infected 
C57BL/6 mice.  During the restraint stress (RS) period (solid black line), infected/restrained 
(I/R) mice showed significant weight loss compared to infected/non-restrained (I/NR) mice (p < 
0.01) (A). RS significantly increase ruffling scores in I/R vs. I/NR mice during the restraint 




3.1.2 Innate immune function 
Natural killer (NK) cells play an important role in the early limitation of viral 
infection through both the direct lysis of viral infected cells as well as the secretion of 
IFN-γ.  In C57BL/10 mice, the depletion of NK cells by antibody during early infection 
with Theiler’s virus resulted in increased gray matter disease (Paya et al., 1989).  As we 
have demonstrated that RS decreases NK cell activity in susceptible CBA mice (Welsh 
et al., 2004), we questioned if stress could also decrease the NK cell response in 
C57BL/6 mice.  Previous pilot experiments indicated day 1 p.i. as having the most 
significant virus-specific increases in NK cell lysis (not shown).  Therefore, this time-
point was used to determine the effects of stress on NK cell effector function. As seen in 
Figure 4-2, stressed mice displayed significantly decreased overall NK cell responses 
when compared to their non-stressed counterparts, and infected mice had higher overall 
NK cell responses compared to non-infected mice (Fig. 4-2A; ps < 0.001).  We found 
that the effect of stress was most significant at the effector to target ratio of 100:1 while 
not statistically significant, NK cell lysis of YAC-1 target cells appeared to be modestly 
decreased from 36% in I/NR mice to approximately 25% in I/R mice accounting for a 
reduction of about 11% (p = 0.068; Fig. 4-2B).  This result may demonstrate a stress 
induced decrease in innate immune processes which has shown to protect against gray 
matter disease (Paya et al., 1989). 
 Alternatively, at day 1 p.i., both infection with TMEV and stress were found to 
significantly increase circulating levels of the acute phase reactant serum amyloid A, a 
protein typically used as a marker of innate inflammation following viral and bacterial 
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infections (Fig. 4-2C; both p’s > 0.001).  Together these results indicate that only 
selective aspects of innate immunity are reduced by chronic stress, and that stress may 
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Figure 4-2.  Restraint stress differentially affects markers of innate immune function at day 1 p.i. 
Mice were stressed by restraint one day prior to infection with TMEV.  At day 1 p.i. splenic NK 
cell effector function was measured by chromium release assay using YAC-1 cells as targets. At 
an effector:target ratio of 100:1 (B)  I/R mice (n = 5) displayed a strong trend towards reduced 
capacity to lyse targets than I/NR mice (n = 4; p = 0.068).  NI/R mice (n = 4) had significantly 
lower NK cell activity than NI/NR mice (n = 4; p < 0.001).  Serum SAA levels from mice at day 
1p.i. were tested by ELISA (C) and indicated that both infection and stress drastically increased 














































Figure 4-2, continued. 
 
3.1.3 Effects of RS on adaptive immune responses to TMEV at days 7 and 16 p.i. 
The resistance of C57BL/6 mice to Theiler’s virus induced demyelination is due 
to their ability to effectively clear TMEV from the CNS during early infection.  In fact, 
practically all virus is eliminated from these mice by day 16 p.i. after i.c. inoculation 
(Dethlefs et al., 1997).  Early viral clearance in C57BL/6 mice has been attributed to the 
generation of a robust adaptive immune response, which utilizes both cellular and 
humoral immunity (Kang et al., 2005).  We determined the effects of RS on these 
responses at days 7 and 16 p.i.  Interestingly, at day 7 p.i. no differences were detected 
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between groups although it appeared that I/R mice had reduced spleen mass (106 ± 23 
mg) compared to I/NR mice (158 ± 14 mg), but this effect was not statistically 
significant p = 0.095 (Fig. 4-3A).  Likewise, at day 16 p.i, no differences between I/R 
and I/NR groups were found to exist (Fig. 4-3A).  This was in sharp contrast to the 
effects of stress on CBA mice (Welsh et al., 2004). 
The cytotoxic T-lymphocyte (CTL) response plays a major role in TMEV 
clearance and resistance to demyelination in C57BL/6 mice (Mendez-Fernandez et al., 
2003).  In these mice, the CTL response is detectable as early as 5 days post infection, 
peaks between days 7-10 p.i. and resolves with viral clearance by day 16 p.i. (Dethlefs et 
al., 1997a).  Using infected cloned syngeneic CVE cells as targets in a chromium release 
assay, we observed no differences between I/NR and I/R groups (Fig. 4-3B; p = 0.2588) 
at day 7 p.i..  By day 16 p.i., the CTL response had resolved and was undetectable in 
I/NR and I/R mice groups (Fig. 4-3C).   
Antibody responses directed toward TMEV have also been shown to limit viral 
persistence in the CNS in the absence of a CD8+ T-cell response, illustrating their 
importance in viral neutralization during early infection and protection from encephalitis 
(Kang et al., 2005).  Therefore, we measured the effects of stress on virus-specific IgM 
and IgG responses by ELISA at both day 7 and day 8 p.i.  We found no stress-induced 
differences in IgM responses at either day 7 or day 16 p.i. both (both ps > 0.05). 
Additionally, the virus-specific IgM response was not found to differ between day 7 and 
16 p.i. (Fig. 4-3D-E; p > 0.05).  In contrast to the IgM response, the virus specific IgG 
was almost undetectable at day 7 p.i., but was substantially increased by day 16 p.i. (Fig. 
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4-3F-G; p < 0.0001).  However, RS was not found to significantly influence the level of 
circulating virus-specific IgG at either time-point (Fig. 4-3F-G; p > 0.05).  Together 
these results indicate that RS did not significantly alter virus-specific immune responses 
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Figure 4-3.  Effects of RS on adaptive immune responses to TMEV at days 7 and 16 p.i. A.  
Spleen weight at day 7 p.i. and at day 16 p.i.  B-C. Splenic CTL responses against infected  CVE 
cells at day 7 p.i. (B) and at day 16 p.i. (C).  D-E. Anti-TMEV IgM levels from serum at day 7 
(D) and day 16 p.i. (E).  F-G.  Serum IgG levels to TMEV, at day 7 (F), and day 16 (G).      









































































Figure 4-3, continued. 
 
3.1.4 Effects of RS on brain viral titers 
In order to determine the effects of RS on viral persistence within the CNS, we 
used plaque assays to measure viral titers from brains at days 7 and 16 p.i. Figure 4-4 
illustrates the effect of RS on brain viral titers.  Collectively, viral titers were highest on 
day 7 p.i. compared to day 16 p.i. (Fig. 4-4).  It appeared that I/R mice had slightly 
higher viral titers than I/NR mice at day 7 p.i., but this finding was not statistically 
significant (p > 0.05).  The same was true at day 16 p.i., insofar as there were no 
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significant differences between I/R vs. I/NR groups (Fig. 4-4).   These results indicate 














































Figure 4-4.  Effects of RS on brain viral titers at day 7 and 16 p.i. Brain viral titers were 
measured by plaque assay on days 7 and 16 p.i.  I/R mice had slightly higher levels of virus at 
day 7 p.i. (left) than I/NR, but the effect was not significant.  By day 16 p.i. (right) both I/R and 
I/NR mice had low or undetectable levels of virus in the brain, and no effects of RS were noted. 
 
3.2   Experiment 2:  Late infection  
Results from our first experiment indicated that 8 consecutive RS sessions each 
lasting 8 hours did not significantly alter either virus specific adaptive immunity or viral 
persistence in the early phases of TMEV infection.  Due to the age of our mice (3-5 
weeks old) we could not increase the length of each stress session without expecting 
high mortality rates (Campbell et al., 2001).  Therefore, we altered the number of RS 
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sessions such that mice received 5 consecutive nights of RS with 2 night rest in between, 
for a total of 15 RS sessions rather than 8 (Sieve et al., 2004).  To ensure that 8 hours of 
RS was acting as a stressor to our C57BL/6 mice, we measured serum corticosterone 
before and immediately after the second RS session as an indicator of hypothalamic-
pituitary-adrenal (HPA) axis activation (Sieve et al., 2004).  C57BL/6 mice do not 
develop demyelination following infection with TMEV.  However, in order to determine 
the effects of RS on altered susceptibility to TMEV, we included NI/R mice as a control 
group. 
 
3.2.1 Effects of stress on body weights, ruffling, and plasma corticosterone 
concentration 
As in experiment 1, we found that RS significantly decreased body weights of 
mice in the restrained groups (I/R and NI/R) during the period in which the mice were 
receiving nightly RS sessions (days 0-21p.i.) (Fig. 4-5A; p < 0.0001).  Body weights 
were found to quickly returned to levels comparable of I/NR mice immediately 
following RS sessions, and were not found to differ again for the duration of the 
experiment (days 22-193) (Fig. 4-5A; p > 0.05).  However, infection with TMEV had no 
effect on body weights at any time-point p’s > 0.1 (Fig. 4-5A).   
Also, we found that ruffling scores were significantly increased during days 0-21 
p.i. in both I/R as well as NI/R groups compared to the I/NR group (Fig. 4-5B; p < 
0.0001).  These scores remained significantly increased following the restraint period 
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(days 22-193 p.i.) for mice in the restrained groups (Fig. 4-5B; p < 0.0001).  Once again, 
infection did not alter signs of ruffling at any time-point (Fig. 4-5B; p’s < 0.05). 
As illustrated in Figure 4-5C, we found that restraint stress significantly 
increased plasma corticosterone in I/R, and NI/R mice compared to I/NR mice (p < 
0.0001), while infection had no influence on plasma corticosterone (Fig. 4-5C; p > 0.05) 
demonstrating HPA axis activation following stress.  Taken together, the above data 


























Figure 4-5.  Effects of infection and RS on weight, ruffling and plasma corticosterone.  A-B.  As 
in the acute phase study, restrained mice displayed decreased body weight (A.) and ruffling 
scores (B) compared to non-restrained mice during the RS period (solid black line) (p < 0.001), 
but this effect quickly subsided following the RS period (A-B).  C.  Plasma CORT levels were 
not different between groups prior to restraint, but RS increased CORT at 48 hours after the first 
restraint session (day 1 p.i.) (p < 0.0001) (C). Results are means ± S.E.M.  *P < 0.05, ***P < 












































































3.2.2 Effects of stress on TMEV-specific antibody levels at days 74, 127, and 193 p.i. 
Virus-specific IgG antibody levels were used as indicators of the effects of 
chronic stress occurring during early disease on adaptive immunity during the late phase 
of TMEV infection.  Therefore, virus-specific circulating antibody levels were 
determined by ELISA.  Infection with TMEV resulted in substantially increased 
antibody levels at days 74, 127 and 193 p.i. when compared to non-infected mice groups 
(I/NR and I/R vs. NI/R; Fig. 4-6A-C).  However, as occurred during early infection 
(days 7 and 16 p.i.; Fig. 4-3F-G) previous restraint stress was not found to alter the 
humoral response, as measured by serum IgG levels to TMEV at any of these time-
points post infection (Fig. 4-6A-C).  These results indicate that despite 15 sessions of 
restraint stress occurring during early infection with TMEV the mice in the I/R group 
were still able to mount an effective, and robust antibody mediated immune response 



















































































Figure 4-6.  Effects of RS on serum virus-specific IgG responses to TMEV at days 74, 155, and 
193 p.i.  Infected mice had higher antibody levels than non-infected controls at days 74 (A), 155 
(B) and 195 (C) p.i.  RS had no effect on antibody levels at these time points (A-C).  Results are 
means ± S.E.M. 
 148
3.2.3 Effects of stress on indices of demyelination 
Susceptible mice infected with TMEV, such as the SJL strain, display clinical 
symptoms of demyelination which include a wobbly gait, abnormal righting reflex, a 
hunched posture, and ruffling of the fur.  The onset of these symptoms typically begins 
around 40-55 days post-infection and progressively worsens as the animal ages.  
However, as hunched posture and ruffled fur can also be used to assess degree of stress 
(Figs. 4-1B and 4-5B), we focused primarily on gait score as an indication of disease 
onset.  Additionally, we tested motor responses by rotarod bi-weekly.  No mice 
developed signs of gait abnormality at any time during the experiment (Not shown).  
Moreover, as seen in Figure 4-7A, neither infection nor restraint stress altered the degree 
of motor capability as determined by rotarod analysis (both ps > .05).  Finally, 
histological analysis of spinal cords from I/R mice demonstrated no inflammation or 

















Figure 4-7.  Effects of RS on indices of demyelination.  No differences were detected between 
I/R, I/NR or NI/R groups by rotarod (A).  H+E staining of CNS tissue isolated at day 193 p.i. 


























4.  Discussion 
Restraint stress immediately preceding and following influenza infection has 
been reported to decrease NK cell activity (Tseng et al., 2005; Hunzeker et al., 2004), 
decrease CTL responses (Sheridan et al., 1998) mononuclear cell infiltrates into the 
lungs (Hermann et al., 1995) and decrease IL-2 production in the lungs (Sheridan et al., 
1991).  Likewise, RS has also been shown to downregulate CTL, NK and IL-2 responses 
to experimental herpes virus infection (Bonneau et al., 1991), leading to increases in 
HSV induced encephalitis (Anglen et al., 2003), as well as cause viral reactivation from 
the trigeminal nerves of infected mice (Freeman et al., 2007). 
During early infection with TMEV, 12 hour sessions of RS in CBA mice has 
been shown to decrease NK cell activity (Welsh et al., 2004), chemokine, and cytokine 
expression in the brains and spleens, as well as alter viral dissemination and viral load 
(Mi et al., 2004; 2006a; 2006b).  Additionally, 8 hour sessions of RS in SJL mice causes 
suppression of virus specific T-cell responses, in the CNS as well as the periphery 
(Steelman et al., unpublished observation) which may result in an exacerbated late 
disease (Sieve et al., 2004). 
Based on our previous findings, as well as those of others, we hypothesized that 
12 hour RS sessions would cause suppression of innate and adaptive immune responses 
toward TMEV in C57BL/6 mice – responses that are needed for viral clearance and 
inhibition of viral persistence from the CNS in this prototypical TMEV resistant inbred 
strain (Brahic et al., 1981; Rodriguez et al., 1995).  Therefore, as occurs in susceptible 
strains of mice, we hypothesized that this immunosuppression would result in increased 
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viral load in the CNS, possibly leading to persistence and the subsequent development of 
TVIDD.  Our results overwhelmingly demonstrate that 12 hours RS sessions of 
C57BL/6 mice do not alter susceptibility to TMEV, and failed to significantly suppress 
the development of both antibody and CTL responses directed toward TMEV (Fig. 4-3).  
These findings mirror the inability of RS to significantly influence viral load within the 
CNS of our infected mice (Fig. 4-4).  While these data are in agreement with studies 
conducted on the effects of repeated 16 hour sessions of RS on virus specific humoral 
responses to influenza (Sheridan et al., 1991; Feng et al., 1991), they are in contrast to 
the findings of others that clearly demonstrate suppressive effects of repeated RS on 
CTL effector function (Bonneau et al., 1991; Sheridan et al., 1998; Freeman et al., 
2007).  One reason for the discrepancy between our data and those of others may be 
attributable to the subtle differences in the assays used to test the CTL response.  While 
others have successfully used radiolabelled splenocytes as target cells, we chose to 
employ the use of cloned cerebrovascular endothelial cells, a suspected target of in vivo 
infection of TMEV and possibly persistence (Sapatino et al., 1995).  While the degree of 
our percent lysis are low compared to conventional assays we believe that they 
accurately reflect the events occurring in vivo as illustrated which is illustrated by the 
fact that CNS viral load did not significantly differ between I/NR and I/R groups during 
the same timeframe. On the other hand, despite obvious differences in body weight and 
the increases in ruffling scores due to RS, we have also entertained the possibility that 
our mice were not stressed.  However, RS clearly resulted in the release of 
corticosterone into the blood (Figure 4-5C) which is an accepted marker of HPA axis 
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activation.  Moreover, these concentrations have been shown to correlate with 
immunosuppression in other strains of mice (Sieve et al., 2004). 
Alternatively, this paradox may be explained in several ways.  First, while our 
mice were certainly stressed, their allostatic load may not have been increased enough to 
cause immunologic distress (McEwen, 2007).  This concept is supported by findings of 
others that demonstrate how the timing and duration of a stressor as well as the influence 
of the genetic background on the immune response (Harizi et al., 2007).  As mentioned 
previously, C57BL/6 mice are capable of generating a very effective early immune 
response toward TMEV (Oleszak et al., 2004).  Therefore, it could be possible that the 
antigenic stimulus alters the allostatic set point for when stress becomes distress.  In this 
scenario, an equivalent amount of stress is likely to differentially affect the immunologic 
outcome of any given pathogenic stimuli based on its degree of immunogenicity.  This 
could explain why the same dose of stress (12 hours) differentially affects viral titers in 
inbred mouse strains of varying susceptibility to TMEV (Mi et al., 2004; present data).   
The onset of mulitple sclerosis is thought to be influenced by multiple factors 
(Hauser and Oksenberg, 2006).  Of these, psychological stress has been repeatedly 
associated with MS since around the time of its initial characterization by Charcot 
(Charcot, 1877).  However, while most studies support a role of stress in the 
pathogenesis of MS, some studies have demonstrated a lack of association between 
stressful life events and exacerbation of MS (Mohr et al., 2004).  Using TMEV as a 
model for human MS, we have now demonstrated the ability of C57BL/6 mice to 
prevent persistent viral infection of the CNS despite being subjected to a chronic stressor 
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during a critical time in the determination of viral persistence (Oleszack et al., 2004).  As 
such, this study may have important implications when considering the effects of stress 
on human diseases such as MS.  For instance, different populations may vary in response 
to stress or have different allostatic set points, such that the perception of a similar 
stressor may not necessarily trigger a uniform distress in different individuals.  This 
could explain why chronic stressors in certain populations are strongly linked to MS 
onset (Li et al., 2004) and exacerbations (Grant et al., 1989), whereas, other chronic 
stressors occurring in different populations, are not linked to MS exacerbations 
(Nisipeanu and Korczyn, 1993). 
In conclusion, RS did not alter susceptibility to TMEV-induced demyelination of 
C57BL/6 mice.  However, the data herein begin to elucidate a role for how genetic, 
immunologic and environmental factors contribute to virus-induced demyelination, in a 
sense validating the use of RS and TMEV infection as a model of human MS.  At the 
very least, this study emphasizes the importance of using different inbred strains of mice 















V DISCUSSION AND CONCLUSIONS 
 
1.  General summary 
The results of the studies herein demonstrate the effects of stress-induced 
immunosuppressive responses directed toward TMEV.  Specifically, we were able to 
demonstrate early suppression of infection-induced splenic NK cell-mediated 
cytotoxicity which was paralleled by increased CNS viral titers in both CBA and 
BALB/c mice.  In SJL mice, which are highly susceptible to TMEV-IDD, we were able 
to demonstrate alterations in virus-specific adaptive immune responses at a time in 
which viral clearance for this disease is paramount.  In this regard, we found that the 
numbers of virus specific IFN-γ producing CD4+ and CD8+ T-cells were decreased in 
the spleens, and in the case of virus specific CD8+ T-cells, the CNS.  Importantly, this 
suppression by restraint stress was not restricted to type 1 immune responses, but also 
extended to type 2 responses as illustrated by reduced IL-10 and IL-4, and in the CNS, 
IL-17 responses as indicated by responses to UV-inactivated whole virus.  By treating 
mice with dexamethasone alone or RU486 administered concurrently during stress, we 
were able to demonstrate a partial role for glucocorticoids in the inhibition of virus 
specific type 1 immunity.  Finally, we showed that in TMEV-infected non-stressed SJL 
mice, virus-specific IFN-γ production was inhibited in a dose dependent fashion by co-
culture with dexamethasone.  In spite of the immunosuppressive effects on virus-specific 
T-cell responses, we found that restraint stress increased anti-viral serum Ig levels.  
Finally, we demonstrated that restraint stress does not have the same immuno-
modulatory actions on C57BL/6 mice, as immune responses in these mice were hardly 
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affected by restraint stress.  As a result, CNS viral clearance was not significantly 
delayed in this mouse strain, and stress did not overcome genetic predisposition to 
resistance.  Taken together, these results support the conclusions of other studies that 
were suggestive of restraint-stress induced suppression of T-cell effector function, (Mi et 
al., 2004; 2006b), and are strongly suggestive of a mechanism for the observed increases 
in viral titers and dissemination (Mi et al., 2006a). 
 
2.  RS suppresses NK cell responses in both susceptible and resistant strains of mice 
 We demonstrated that two sessions of RS were sufficient to cause overall 
reductions in NK cell cytotoxicity and result in increased in CNS viral titers in both 
CBA and BALB/c mice.  Given the differences in NK cell responses that have been 
shown to exist between C57BL/10 and SJL strains of mice, we had hypothesized that the 
degree of cytolysis by splenic NK cells would correlate with susceptibility (Paya et al., 
1989).  This was not the case as we found that CBA mice displayed more cytolytic 
reactivity than BALB/c mice.  In contrast, SJL mice displayed almost no detectable NK 
activity.  
 Our findings support those of others who have shown a negative effect of chronic 
stress on the NK cell response in both mice (Sheridan et al., 1998; Hunzeker et al., 2004; 
Welsh et al., 2004; Tseng et al., 2005) and humans (Herbert and Cohen, 1993; Cohen et 
al., 2007).  The mechanism by which RS reduces NK cell function has been partially 
explained in mice, and involves both the SNS and the HPA axis.  For instance, during 
influenza infection, the actions of the SNS were shown to mediate the effects of RS on 
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cytotoxicity, whereas the HPA axis caused decreased NK cell trafficking (Tseng et al., 
2005). 
Despite these effects, we failed to find a significant correlation between 
decreased function in the spleen and increased CNS viral titers, which may suggest 
differences in NK numbers or responsiveness between the site of infection (CNS) and 
the periphery (spleen).  Alternatively, this finding could implicate other innate immune 
functions in limiting replication of TMEV within the CNS during early infection that are 
suppressed by RS. 
 One possible mechanism by which viral replication could be limited at 24 hours 
post infection is through the production of the type 1 interferons, IFN-α and IFN-β.  The 
type 1 interferons are rapidly induced following infection, and almost all cells are 
capable of their production, including cells within the CNS.  For instance, in TMEV as 
well as Le Crosse virus infection, it has been shown that both IFN-β and some forms of 
IFN-α (particularly the α5 and α2 isoforms) can be secreted by neurons (Delhaye et al., 
2006).  Additionally, type 1 interferon mRNA expression has been shown to be up-
regulated following infection of microglia with TMEV in vitro (Olson et al., 2001).  
Importantly, these proteins increase expression of MHC class I in the CNS of TMEV-
infected mice as early as 6 hours post infection, which may facilitate clearance of virus 
by CD8+ T-cell mediated processes that occur at later time points (Njenga et al., 1997).  
Finally, the importance of IFN-α/β production in protection from TMEV as well as other 
encephalogenic viral infections, has been demonstrated in IFN-α/β-/- mice (van den 
Broek et al., 1995).   
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It is conceivable that the inhibition of such an early response within the CNS by 
stress could account for increased viral titers demonstrated at this time point.  Contrary 
to this hypothesis, RS was not found to decrease either mRNA expression of IFN-α or 
IFN-β at day 1 p.i., but was shown to augment type 1 interferon mRNA expression of 
both the lung during at day 3, 5 and 7 p.i. with influenza virus infection (Hunzeker et al., 
2004).  Similarly, Mi et al., (2006) found that while neither stress nor infection 
significantly altered mRNA expression of IFN-β in the CNS at day 2 p.i., within infected 
mice, RS resulted in a significant increase in this interferon by day 7 p.i.  Thus, RS may 
lead to increases in type 1 interferon production as a compensatory mechanism for 
protection against viral infection (Hunzeker et al., 2004).  Alternatively, the RS induced 
increase in type 1 interferons could mirror increased viral titers by stress demonstrated at 
these times (Mi et al., 2006a).   Taken together, these studies suggest a requirement for 
type 1 interferon production in limiting TMEV infection, but they strongly indicate that 
the mechanism by which RS causes increased viral titers in our experiment was not due 
to a decrease in this innate response because the association with an NK cell-mediated 
effect on viral clearance was best observed in susceptible SJL mice which have a 
defective development of NK cells (Fig. 2-3A; Kaminsky et al., 1987).  Important to this 
argument is the fact that viral titers were not influenced by RS in this mouse strain (Fig. 
2-3C). 
 Given the protective effects of IFN-γ in TMEV clearance from neurons within 
the CNS (Rodriguez et al., 2003), and our inability to detect IFN-γ in the serum of mice 
at day 1 p.i., it becomes important to investigate further the effects of RS on the role of 
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NK-cell mediated IFN-γ secretion and number of IFN-γ producing NK-cells within the 
CNS, and its relation to TMEV viral titers.  To our knowledge the effects of RS on this 
important aspect of NK-cell effector function has yet to be investigated in a viral model 
of disease.  However, Mi et al., (2006) have produced some indirect evidence that 
suggest a stress-induced decrease in this response.   Specifically, they were able to 
demonstrate that at day 2 p.i. with TMEV, mRNA expression of IFN-γ was increased in 
the CNS of infected animals, and that this appeared to be slightly decreased in stressed 
mice (Mi et al., 2006b).  In addition, analysis of mRNA expression of IFN-γ from spleen 
cells taken at day 2 p.i., was found to be decreased by RS (Mi et al., 2006a).  Because 
NK cells, CD4+, and CD8+ T-cells are the major producers of IFN-γ, the time-frame of 
this effect is suggestive of a RS-mediated decrease in NK cell production of IFN-γ.   
However, in these studies it is impossible to rule out DC, or NKT cells as the effector 
cell(s). 
 
3.  Effects of RS on T-cell mediated immunity toward TMEV 
Although innate immunity contributes to viral limitation during early disease, it 
is the abrupt generation of a robust virus-specific adaptive immune response that 
impedes TMEV persistence and subsequent demyelination.  Thus, functional CD4+ T-
cell (Welsh et al., 1987; Lin et al., 2004; Karls et al., 2002), CD8+ T-cell (Mendez-
Fernandez et al., 2003; Begolka et al., 2001; Delthefs et al., 1997), and antibody 
responses (Kang et al., 2005) are an absolute necessity for TMEV clearance.  Indeed, 
Mohindru et al., (2006) have recently demonstrated that prior immunization of 
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susceptible SJL mice with the CD4+ T-cell immunodominant peptides (VP1233-250, 
VP274-86, and VP324-37) results in delayed disease onset.  Alternatively, susceptible CBA 
mice depleted of CD4+ T-cells by thymectomy and antibody die shortly after infection 
(Welsh et al., 1987).   
The effects of CD8+ T-cells on TMEV clearance are best illustrated by the results 
of Delethfs, Mendez-Fernandez, and Lyman wherein they show that an early (Delethfs et 
al., 1997), but robust (Lyman et al., 2004) CD8+ CTL response to a single 
immunodominant epitope is required (Mendez-Fernandez et al., 2003).  Interestingly, it 
has also been hypothesized that the CD8+ T-cell response can account for the differences 
in the severity of DA versus BeAn strains of TMEV infection in SJL mice, as DA, 
produces a more severe form of early disease and contains one CD8+ T-cell dominant 
epitope, whereas the BeAn strain contains three CD8+ T-cell immunodominant epitopes 
and produces a less severe form of acute disease (Kang et al., 2002b).   
The above studies show that in SJL mice, the virus-specific cellular response is 
compromised by stress.  Specifically, we demonstrated that the number of IFN-γ 
producing cells in the CNS of I/R mice was reduced by nearly 60% when compared to 
I/NR mice.  These cells were determined to be almost exclusively CD8+ T-cells as 
indicated by their ability to recognize the MHC class I restricted peptide VP3155-166, and 
their inability to recognize the MHC class II restricted immunodominant peptide VP274-
86, a finding that confirms those of Mohindru et al., (2006).   
Moreover, we also found that the amount of IFN-γ secreted in response to 
stimulation with whole UV-irradiated virus, was severely diminished in stressed mice. 
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This finding was observed in the spleen as well as the CNS.  In addition, cytokine 
measurements from CNS-IL isolated at day 8 p.i., revealed increases in virus-specific 
IL-17A.  This finding is important as it may indicate that the majority of CD4+ T-cells 
present in the CNS during early infection with TMEV are virus-specific IL-17A 
producing cells.  These findings are also the first to suggest that restraint stress can 
decrease IL-17A responses within the CNS. 
The observed immunosuppressive effects of stress, particularly IFN-γ responses 
within the CNS, are likely the cause of increased viral titers observed during this time-
frame (Mi et al., 2006b).  The mechanism by which stress ameliorated TMEV-specific 
T-cell responses was partially attributable to the actions of glucocorticoids on virus 
responsive CD8+ T-cell numbers.  Indeed IFN-γ producing CD8+ T-cell numbers were 
significantly restored in the spleen and showed a strong trend toward restoration within 
the CNS following concurrent RU486 treatment.  This finding differed from studies 
investigating the effects of restraint stress on influenza pathogenesis that demonstrated 
complete restoration of IFN-γ production after stimulation with whole influenza virus 
(Dobbs et al., 1996). 
These discrepancies may be explained by the fact that the above study utilized 
viable virus as a stimulus over the course of 72 hours which is likely to have resulted in 
IFN-γ production from NK cells present in their cultures (Dobbs et al., 1996).  In 
contrast, we used viral peptides designed to specifically target either CD4+ or CD8+ T-
cells.  Furthermore, SJL mice lack functional NK cells (Fig. 2-3A), thus ruling out the 
possibility that NK cells would be the source of IFN-γ.  In support of this hypothesis, 
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levels of IL-2, a cytokine not produced by NK cells, was not completely restored in mice 
that received restraint stress and concurrent administration of RU486 (Dobbs et al., 
1996).  Nevertheless, these studies together indicate a role for glucocorticoids in 
mediating suppression of type 1 immune responses during viral infection.  However, due 
to the partial restoration of cytokine production seen in our studies, the role that the SNS 
plays in cytokine production in stressed mice should also be considered. 
 In general, stress-induced increases in glucocorticoids may have caused 
decreased immunity behind the BBB in several ways.  For instance, stress may have 
caused T-cell induced apoptosis, possibly resulting in substantially decreased T-cell 
numbers.  Alternatively, stress-induced glucocorticoids may have caused decreased 
trafficking of T-cells to the CNS, or stress may have had a direct effect on effector 
function at the T-cell level.  Finally, stress may have affected the generation of T-cell 
responses through the actions of glucocorticoids on antigen presenting cells.   
 
3.1  Suppression through lymphopenia 
The hypothesis that stress caused T-cell induced apoptosis is supported by the 
reduction of both thymus and spleen mass following restraint stress (Campbell et al., 
2001).  This finding was replicated in our studies by the observed reductions in the total 
number of cells isolated from the spleens restrained mice (Fig. 3-11B).  While this is a 
legitimate hypothesis, it does not explain the reductions in effector function that we 
observed when we normalized for cell number in our cultures.  A reduction in T-cells 
would have supported the hypothesis that many of our effects were attributable to 
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differences in cell population.  Flow cytometric analysis of T-cell percentages, 
demonstrated only small effects of stress on CD4+ and CD8+ T-cell populations, and 
while there was a significant decrease in CD4+ T-cell percentage, stress the CD8+ T-cell 
percentages actually increased.  As such, these small alterations are not likely account 
for our observed effects. 
 
3.2  Suppression through altered trafficking 
Suppression of virus-specific immune responses within the CNS of stressed mice 
could have been brought about by decreases in local proliferation, increased efflux from 
the CNS, increased cell death within the CNS or decreased trafficking to the CNS.  The 
suppression of IL-2 production by virus-stimulated CNS-ILs taken from infected 
stressed mice may suggest decreases in local proliferative responses.  While stress may 
have caused increased T-cell efflux or cell death, the evidence that stress could have 
caused decreases in T-cell trafficking to the CNS is noteworthy for several reasons:  first 
and foremost, we observed decreased numbers of virus-specific cells within the CNS of 
stressed mice.  Secondly, stimulation of CNS-ILs using α-CD3/CD28 antibodies 
demonstrated suppression in nearly all cytokines within the CNS, possibly reflecting 
fewer T-cells numbers.  Thirdly, these findings are supported by reductions in 
lymphocytes in the blood of stressed mice (Campbell et al., 2001; Zhang et al., 1998; 
Ottaway and Husband, 1994; Mizobe et al., 1997).  Finally, the influence of restraint 
stress on lymphocyte trafficking is suggested by studies investigating the effects of stress 
on chemokines (Mi et al., 2004).   
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The chemokines RANTES and MCP-1 are important in the chemoattraction of 
both memory T-cells and monocytes, respectively to the site of infection.  In TMEV 
infection, these chemokines have been proposed to aid in early viral clearance from the 
CNS, but are also thought to contribute to the pathogenesis of demyelination in the 
chronic stages of infection by sequestering autoreactive lymphocytes behind the blood-
brain barrier (Murray et al., 2000; Ransohoff et al., 2002; Kim et al., 2005).  Our results 
agree with those of Mi et al., (2004) which indicate that restraint stress decreases 
circulating levels of these chemokines at a time when cellular trafficking into the CNS is 
critical for viral clearance.  Mechanistically, these effects could be, in part, due to 
decreases in IFN-γ, which has been shown to stimulate the production of RANTES and 
MCP-1 (Valente et al., 1998).  To this end, it is important to mention that in our study, 
serum concentrations of IFN-γ were positively correlated with those of RANTES and 
MCP-1 (not shown).  
While RS decreased the serum concentrations of most cytokines and chemokines, 
this was not the case for the chemokine KC (CXCL1) and growth factor G-CSF.    Both 
KC and MIP-2 (CXCL2) are thought to function as mouse homologs of human IL-8.  As 
such, these CXC chemokines play a major role in the trafficking of neutrophils.  The 
hematopoetic factor G-CSF is, in part, responsible for the maturation of neutrophils from 
the bone marrow, and indeed is used clinically to bolster circulating neutrophils in 
patients undergoing chemotherapy.  RS dramatically increased serum concentrations of 
these proteins (Table 3-3).  These results build on our previous findings (Campbell et al., 
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2001; Welsh et al., 2004) by suggesting that it is the modulation of KC and G-CSF by 
RS that contribute to RS-induced neutrophilia.   
Unlike RANTES and MCP-1, KC gene transcription is down regulated by IFN-γ 
(Ellis and Beaman, 2004).  While IFN-γ concentrations did not significantly correlate 
with either KC or G-CSF concentrations in this study, we showed that TMEV infection 
decreased serum levels of KC, but not G-CSF.  These results, obtained from the 
periphery, are in contrast to what is observed in the CNS of susceptible mice as it has 
been shown that TMEV infection can increase both KC and MIP-2 expression in 
primary astrocytes from susceptible mice and humans (Rubio et al., 2006).  A study by 
Rubio et al. (2006) suggests that MIP-2 may contribute to the pathogenesis of TMEV-
induced demyelination, as astrocytes from susceptible (SJL) but not resistant mice 
(BALB/c) secrete MIP-2. Interestingly, roles for KC and G-CSF in the pathogenesis of 
demyelinating disease have also been illustrated in the experimental allergic 
encephalomyelitis (EAE) model of human multiple sclerosis (Tran et al., 2000; Verda et 
al., 2006).  Specifically, Tran et al. (2000) demonstrated that IFN-γ-/- or IFNγR-/- 
BALB/c mice are rendered susceptible to MBP-induced EAE and produce high levels of 
KC.  Pathologically, the inflammatory infiltrate in the CNS was comprised of mostly 
neutrophils and was localized to areas of demyelination (Tran et al., 2000).  While these 
results suggest that neutrophils are actively involved in the demyelination process of 
both animal models of MS, a subsequent study using the EAE model suggested that 
infiltrating neutrophils serve a regulatory role through the secretion of nitric oxide, and 
that this regulatory function is in part dependent on IFN-γ (Zehntner et al., 2005).  
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Additionally, Verda et al. (2006) have recently demonstrated that G-CSF administration 
causes exacerbation of EAE (Verda et al., 2006).  Alternatively, the increases in serum 
KC and G-CSF could be in part due to IL-17 production from T-cells (Witowski et al., 
2004).  In regards to the latter, it is interesting that while stress reduced the amount of 
IL-17A production within the CNS, antibody stimulation of T-cells in the spleen 
revealed NI/R mice produced more IL-17 than other groups, a finding that needs to be 
substantiated. 
 
3.3  Suppression by direct action on T-cells 
  In general, cellular immune responses (Th1) are characterized by the secretion of 
IFN-γ and IL-2 from CD4+ T-cells (Abbas et al., 1996).  The generation of Th1 
responses occurs through the presentation of antigen, costimulation, and secondary 
stimulation of naive T-cells with proinflammatory cytokines, particularly IL-12.  
Binding of active IL-12(p70), composed of the p35 and p40 subunits, to its receptor, 
stimulates activation of the Janus family of tyrosine kinase2 (JAK2) and TYK2 (Agnello 
et al., 2003; Bacon et al., 1995) which directly activates the signal transducer and 
activator of transcription (STAT)4 to translocate to the nucleus and induce the 
transcription of IFN-γ (Usui et al., 2006; Wurster et al., 2000).  Upon secretion, IFN-γ 
can act in an autocrine or paracrine fashion.  Binding of IFN-γ to its receptor causes 
phosphorylation and subsequent activation of STAT1, which results in the transcription 
of the T-box expressed in T cells (T-bet) transcription factor, the master driver of Th1 
polarization (Afkarian et al., 2002; Szabo et al., 2000).   
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T-bet, a member of the family of T-box transcription factors, is expressed in 
CD4+ and CD8+ T-cells, NK cells, B-cells and DCs.  The actions of T-bet have been 
discussed (Section III), but it should be reiterated that this transcription factor plays a 
critical role in the development of the Th1 response (Szabo et al., 2000).  While ectopic 
expression of T-bet has been demonstrated to drive Th1 expression in cells that had been 
biased toward Th2 (Szabo et al., 2000), the effects of T-bet on the generation of a type 1 
immune response is best illustrated by the phenotype of T-bet-/- mice.   T-bet-/- mice 
produced sub-optimal amounts of IFN-γ (Lugo-Villarino et al., 2003; Szabo et al., 2002), 
have reduced NK cell cytotoxicity (Szabo et al., 2002), diminished T-cell activation by 
dendritic cells (Lugo-Villarino et al., 2003) decreased IL-12R expression (Afkarian et 
al., 2002), diminished antigen-specific CD8+ T-cell-mediated CTL response (Sullivan et 
al., 2003), and reduced proinflammatory CD4+ T-cell trafficking (Lord et al., 2005).  The 
actions of T-bet on Th1 polarization, and IFN-γ gene transcription have recently been 
attributed to its direct binding (Hwang et al., 2005) and inhibition of the transcription 
factor GATA-3 (Usui et al., 2006). 
Unlike Th1 immunity, Th2 immunity is characterized by the secretion of 
cytokines IL-4, IL-5, IL-10 and IL-13 from CD4+ T-cells and by promoting the 
generation of antibody responses that are effective at reducing helminthic infections 
(Agnello et al., 2003).  The generation of a Th2 response is dependent on IL-4 binding 
its receptor and the subsequent phosphorylation of STAT6 (Hou et al., 1994; Agnello et 
al., 2003).  Active STAT6 can then translocate to the nucleus and induce the expression 
of GATA-3.  Importantly, the transcription of the Gata3 gene has recently been shown 
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to require both Notch 1 and 2 signaling and subsequent activation of RBP-J on the Gata3 
promotor leading to Th2 polarization by processes independent of IL-4 and STAT6 
(Amsen et al., 2007).  The actions of GATA-3 are opposite of T-bet, as it is necessary 
and sufficient for Th2 polarization (Zheng and Flavell, 1997).  Once activated, GATA-3 
can increase the gene transcription of Th2 cytokines by acetylating histones within their 
promotor regions (Avni et al., 2002).  In addition, Usui et al., (2006) have recently 
demonstrated that GATA-3 activation inhibits STAT4 induced transcription of the IFNG 
gene.  Therefore, the functions of the transcription factors T-bet and GATA-3 provide a 
molecular framework for understanding the Th1/Th2 paradigm as well as the generation 
of an effective immune response.   
  Recently, there has been described a new pro-inflammatory lineage of T helper 
cells, designated Th17, that plays an important role in the induction of EAE (Harrington 
et al., 2005; Park et al., 2005; Komiyama et al., 2006).  The polarization of these cells is 
dependent on the synergistic actions of IL-6 and TGF-β on naïve T-cells, the 
phosphorylation of STAT3, (Chen et al., 2006; Yang et al., 2007) and the subsequent 
activation of the transcription factors RORγt and RORα (Ivanov et al., 2006; Yang et al., 
2008).  However, their propagation is dependent on IL-23 stimulation (Bettelli et al., 
2006; Veldhoen et al., 2006; Mangan et al., 2006).  In mice, IFN-γ acts to suppress both 
the induction and actions of these cells after mycobacterial infection indicating a 
regulatory role for IFN-γ on the effector function of these cells (Cruz et al., 2006).  The 
knowledge of these molecular events is imperative for understanding how stress can 
effect the generation of Th1, Th2 and Th17 immunity to TMEV. 
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The ability of stress to inhibit effector function is supported by the fact that 
glucocorticoids have been shown to inhibit IFN-γ production of CD8+ T-cells in HSV-1 
infection, without influencing the number of CD8+ cells within the CNS (Freedman et 
al., 2007).  Similarily, we showed that glucocorticoid treatment inhibited both CD4+ and 
CD8+ specific IFN-γ secretion in splenocytes taken from I/NR mice.  It is possible that 
these effects are due to the inhibitory actions of glucocorticoids on T-bet which has been 
shown to occur by direct binding of the activated glucocorticoid receptor to T-bet, 
resulting in decreased binding of this transcription factor to the Ifng promoter (Liberman 
et al., 2007).  Glucocorticoids have also been demonstrated to inhibit the actions of 
STAT1 (Hu et al., 2003), STAT4 (Franchimont et al., 2000), GATA-3 (Jee et al., 2005), 
NFkB and AP-1 (Webster et al., 2002), strongly indicating a suppressive role at the T-
cell level. 
 
3.4  Suppression through decreased generation of T-cell responses 
Our findings can also be explained by the failure to generate an immune response 
to TMEV, which may reflect a stress-induced impairment of antigen presenting cell 
function.  Supporting this hypothesis are data that clearly indicate suppressive effects of 
glucocorticoids on dendritic cells (DCs).  In these studies, it was found that DC treated 
with glucocorticoids  had altered processing and presentation of MHC class I and class II 
molecules as well as decreased costimulatory molecule, particularily CD80/CD86, 
expression on their cell surface, as well as decreased IL-6, IL-12 and TNF-α production 
after activation with LPS (Truckenmiller et al., 2005; Elftman et al., 2007).  This 
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mechanism for immunosuppression is supported by the decreased circulating serum 
levels of IL-12 (p40) and IL-12 (p70) in stressed mice.  Additionally, the decreased 
responses to the T-cell stimulatory antibodies could also be perceived as supportive of 
this concept as they may indicate fewer T-cell clones rather than total number of cells.  
In this regard, the reductions in T-cell responses were also observed in the spleens of 
stressed mice. 
 
3.5  Failure of stress to effect C57BL/6 immunity 
 Taken together, we demonstrate that in SJL mice, restraint stress greatly 
decreases both CD4+ and CD8+ T-cell responses within the CNS regardless of the 
mechanism.  However, it is worth mentioning that in C57BL/6 mice this was not found 
to be the case.  In fact, there were no readily observed effects of RS on the CTL 
responses to TMEV infected CVE cells.  The inability for stress to alter CD8 responses 
to TMEV was reflected in both the viral titers and the unaltered susceptibility to the late 
demyelinating disease, as indicated by histological analysis (Fig. 4-7B). 
 The reason for the discrepancies in the ability of restraint stress to alter immune 
responses to TMEV between SJL and C57BL/6 mice remains unknown, however several 
possibilities exist, most of which have received attention (Section IV).  One previously 
unmentioned, but particularly interesting, possibility is the fact that different responses 
to chronic stress have been shown to exist between individual mice within the C57BL/6 
strain (Krishnan et al., 2007).  Using social defeat stress as a model, these authors were 
able to show that increased brain-derived neurotropic factor (BDNF) resulting from 
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hyperactive ventral tegmental area (VTA) neurons resulted in susceptibility to social 
defeat.  Susceptibility to defeat was indicated by decreased sucrose preference, 
hypothermia, body mass, and circadian amplitude (among others) compared to controls, 
but was not reflected by altered serum glucocorticoids levels (Krishnan et al., 2007).  
Given the relatively small number of mice used in our study, the above study raises the 
possibility, although unlikely, that all of the mice in the stressed group were non-
suseptible to stress.  Noteworthy, is our observed reduction in body mass within our 
stressed mice, which in the above study was an indicator of susceptibility (Krishnan et 
al., 2007).  A more probable explanation is that the immune response toward TMEV 
requires longer lasting restraint sessions to achieve immunosuppression (Sheridan et al., 
1998), a procedure that, due to age restrictions of TMEV infection, resulted in high 
incidence of morbidity and mortality in preliminary studies making it unfeasible. 
 
4.  RS differentially affects humoral immune responses to early TMEV infection 
The observation that stress raised virus-specific serum antibody levels in SJL 
mice was unexpected given the degree of virus -specific CD4+ T-cell 
immunosuppression that was demonstrated in the spleens of infected mice (Fig 3-5).  
Importantly, this infliction by stress was not attributed to a shift towards Th2 immune 
responses as suggested by many (for review see Webster et al., 2002; Elenkov, 2004; 
Calcagni and Elenkov, 2006).  Indeed, both type 1 and type 2 responses were 
suppressed, but not all cytokines were suppressed. In fact, despite decreases in serum 
levels of IL-4, and IL-5 by restraint stress, IL-6 levels, which have potent B-cell 
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stimulatory properties, were increased in the serum by stress (Tables 3-1 and 3-2).   
Given the overall immunosuppressive action of restraint stress on stimulated T-cells, it is 
likely that the increase in serum IL-6 was derived from an alternate source.  The 
demonstration of increased serum levels may implicate hepatocytes as the culprit, but 
none of the other many cellular sources of IL-6 should be ruled out.  While the 
mechanism for stress- induced antibody production is not yet clear, it is very likely to be 
under genetic control, as C57BL/6 mice that underwent similar restraint stress sessions 
displayed slightly reduced, but non-significant decreases in virus specific antibody levels 
(Fig. 4-3).  Interestingly, a recent study by Hou et al., (2007), has indicated that DCs 
from SJL mice produce much higher levels of IL-6 then DCs from C57BL/6 mice when 
infected with TMEV.   This finding however, cannot be applied directly to the current 
studies, as we demonstrated a strong trend for infection to reduce the augmented effects 
of stress on IL-6 levels, which indicate a suppressive role for infection.  To this end, the 
differential effects of stress on IL-6 production in SJL and C57BL/6 strains have not yet 
been compared.  However it is interesting that the administration of recombinant IL-6 to 
TMEV-infected SJL mice has been shown to result in increases in TMEV-specific 
anitbody production, which is protective upon transfer to infected mice (Rodriguez et al., 
1994), and suggests that IL-6 is capable of playing a mechanistic role in the upregulation 
of TMEV-specific antibody responses that are protective against early encephalitis.  
 Interestingly, stress-induced increases in TMEV-specific antibodies did not 
appear to be attributable to the actions of glucocorticoids, as administration of 
dexamethasone was found to decrease antibody levels while treatment with RU486 did 
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not reverse this effect.  These results contrast with those of early in vitro studies that 
indicate a necessity and sufficiency of the suppressive actions of glucocorticoid on 
production of antibody to both T-cell independent (P-PAA) and T-cell dependent 
(SRBC) antigens (Emilie et al., 1984).   This strongly implies that other mechanisms, 
such as those mediated by the SNS, are involved.  With respect to this hypothesis, it is 
interesting that B-cells, DCs and Th1 cells, but not Th2 cells, have been demonstrated to 
posses β2-adrenergic receptors (ARs), indicating that both epinephrine and 
norepinepherine can directly influence these cell types (Elenkov et al., 1996; Johnson et 
al., 2005; Kavelaars et al., 1997; Mohamed-Ali et al., 2001). 
The studies herein are not the first to report altered T-cell responses coupled to 
unaltered virus-specific serum antibody levels (Sheridan et al., 1991).  Moreover, the 
increases in antibody levels in the serum are not necessarily indicative of increased 
ability to clear viral infections (neutralizing).  For instance, caretakers of dementia 
patients have been shown to have increased circulating levels of anti-HSV-1 antibodies, 
when compared to non-caretakers, but at the same time did not reflect an increase in 
neutralizing titers (Glaser and Kiecolt-Glaser, 1997).  Furthermore, even if the increased 
TMEV-specific antibody levels in SJL mice were neutralizing, their circulation in the 
serum is not beneficial to limiting viral spread behind the blood-brain barrier between 
neurons.  In this regard, it is important to reiterate that we could not detect any virus-
specific-antibody-secreting cells within the CNS at either days 8 or 16 p.i.  In contrast, 
we observed copious numbers of virus-specific antibody-secreting cells within the CNS 
of infected mice during late infection, but relatively few in the spleens of these mice (Fig 
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5-1).  The latter findings are supported by recent studies which more thoroughly 
characterize the production of intrathecal antibody (Pachner et al., 2007a; 2007b).  
Nevertheless, if these antibodies are found to be neutralizing, a means of entry into the 
CNS must be considered as circulating antibody are unable to cross the BBB.   
Entry of circulating anti-viral antibodies into the parenchyma of the CNS could 
be facilitated in several ways:  First, viral infection of either cerebrovascular endothelial 
cells or astrocytes, the cells which comprise the BBB, would be expected to compromise 
the integrity of the BBB allowing leakage of antibody.  Secondly, stress may actually aid 
in the diffusion of antibody from the circulation into the CNS by opening the BBB.  In 
support of this mechanism, acute restraint stress in rats has been shown to open the BBB, 
a process that was dependent on activation of mast cells and subsequent degranulation 
and histamine release in response to exposure of CRH (Esposito et al., 2001; Esposito et 
al., 2002).  While the effects of chronic restraint stress on this occurrence has not been 
thoroughly investigated, it has been shown repeatedly to increase serum corticosterone 
(Sieve et al., 2004; 2006; Fig. 4-5C) , a down stream product of HPA axis activation, and 
preliminary studies from our laboratory suggests that the BBB is, in fact, compromised 
following chronic restraint stress.  These possibilities should be the subject of future 
investigation. 
 The increase in virus-specific antibody levels by stress in SJL mice may also play 
a role in the pathogenesis of demyelination, a possibility that should not be readily 
dismissed.  For instance, as occurs in MS, TMEV infection has recently been shown to 
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result in intrathecal antibody production (Pachner et al., 2007a) that begins around the 
time of demyelination, and is in fact correlated with disability and viral titers (Pachner et  
al., 2007b).  The percentage of antibody-secreting cells specific for TMEV in the CNS 
during late disease is suspected to be around 54% compared to 8% in the spleen 
(Pachner et al., 2007b and Fig 5-1).  Even though T-cells obviously play a role in 
clearance of TMEV from the CNS, they are also facilitators of demyelination in late 
disease (Lipton, and Dal Conto, 1976; Welsh et al., 1987; Rodriguez et al., 1986).  This 
T-cell mediated destruction of myelin in the late disease, may be enhanced by humoral 
responses behind the BBB.  One mechanism by which this could occur is through 
complement-mediated lysis of oligodendrocytes.  Indeed, while the CNS is considered 
immunoprivileged, it possesses all of the components of the complement cascade.    
Alternatively, autoantibody binding to myelin could opsonize oligodendrocytes allowing 
microglia or infiltrating monocytes to destroy the tissue by phagocytosis. Finally, 
antibody could cause direct lysis of cells by antibody-induced cellular cytotoxicity 
(Antel and Bar-Or, 2006).  
The fact that only 54% of antibody producing cells during chronic disease are 
TMEV specific, indicates that roughly 40-50% recognize alternate antigens.  
Importantly, several studies have demonstrated the presence of anti-myelin antibodies in 
the serum of TMEV-infected mice during late disease (Rauch et al., 1987; Sieve et al., 
2004; Sieve et al., 2006).  Of particular interest is the development of antibodies directed 
against the protein myelin oligodendrocyte glycoprotein (MOG), a small tansmembrane 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































content in myelin, MOG is a relevant target for antibody binding and subsequently the 
subjection of much study in human MS (Reindl et al., 2006).  This is because MOG 
contains an Ig domain that is completely exposed to the extracellular environment.  In 
fact, MOG peptides have been shown to be encephalogenic, causing EAE in rats, mice, 
rhesus monkeys, and marmosets (Iglesia et al., 2001).  Moreover, EAE induction in both 
rats and marmosets requires the presence of specific B-cells, strongly indicating a role 
for antimyelin responses in the development of EAE (Iglesia et al., 2001).  Importantly, 
the presence of circulating anti-MOG (MOG35-55) antibodies during the chronic phase of 
TMEV infection of SJL mice has also been demonstrated possibly indicating a parallel 
mechanism of tissue destruction between animal models and human disease (Sieve et al., 
2004).  Our results, in SJL mice, present the possibility that stress, either by increasing 
the overall humoral response, or by allowing entry of autoreactive antibody into the CNS 
by disruption of the BBB could modulate the demyelination process. 
 
5.   Conclusion 
Pathologically, the hallmark of MS is demyelination, which occurs in the white 
matter of the CNS, usually in a perivascular fashion around post-capillary venules and 
veins and is thought to result from immune-mediated destruction of myelin.  The 
demyelinated ‘plaque’ displays heterogeneity, and has been sub-typed to fit one of four 
categories based on the pattern of demyelination (Lucchinetti et al., 2000).  All four 
types of plaques (I-IV) contain T-cells and macrophages.  However,  Lucchinetti et al., 
(1999;2000) describe the type I lesion as being macrophage associated as it resembles 
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the models of demyelination resulting from TNF-α and reactive oxygen species; the type 
II lesion is also macrophage associated but additionally contains deposition of 
immunoglobulin and activated complement; the type III lesion resembles demyelination 
mediated by apoptosis and is reminiscent of demyelination that occurs following some 
viral infections of oligodendrocytes; the type IV lesion represented non-apoptosis 
associated primary oligodendropathy  (Lucchinetti et al., 1999; 2000). This 
heterogeneity along with additional studies conducted in both MS patients as well as in 
animal models of MS, particularly experimental autoimmune encephalomyelitis (EAE), 
suggests that T-cells are responsible for the pathogenesis of MS (Chitnis, 2007).   
Historically, MS has been considered the prototypical Th1-mediated autoimmune 
disease which is mediated by trafficking of autoreactive cells from the periphery into the 
CNS (Sospedra and Martin, 2005).  Reasons to suspect autoimmune CD4+ T-cells in the 
pathogenesis of MS include, but are not limited to: the presence of CD4+ T-cells in all 
four types of lesions (Lucchinetti et al., 1999; 2000); the increased  prevalence of active 
MBP specific T-cells in the periphery and cerebrospinal fluid of MS patients vs. controls 
(Zhang et al., 1994); the exacerbation of disease in patients following treatment with  
altered peptide ligand mimicking MBP (Bielekova et al., 2000) the unfavorable response 
following treatment of patients with IFN-γ (Panitch et al., 1987); the robust genetic 
association with the HLA-DR locus (Hafler et al., 2007); the occurance of 
polymorphisms in genes involved in immunoregulation of T-cells in MS patients 
(Chitnis, 2007); marked decrease in disease activity following treatment with a 
humanized monoclonal targeting α4β1integrin (natalizumab; Miller et al., 2003); the 
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spontaneous development of EAE in transgenic mice on Rag2-/- made to express  both 
the human HLA-DR*1501 as well as TCR isolated from T-cell clone of an MS patient  
(Madsen et al., 1999); and the ability of myelin specific CD4+ T-cells to induce EAE 
following adoptive transfer into naive mice.  However, Th1 cells may not be as 
exclusively involved in MS pathogenesis as once thought since Th17 cells have recently 
been implicated.  In light of this evidence, it is still imperative to consider other 
mechanisms of demyelination as anti-CD4 therapy in MS patients was demonstrated to 
effectively delete CD4+ T-cells, but was not able to effectively alter disease course (von 
Oosten et al., 1997). 
 Other immune cells are also thought to play a role in the pathogenesis of MS, 
although the mechanisms have not been as intensively researched.  Supporting evidence 
for a CD8+ T-cell involvement includes, but is not limited to: the fact that CD8 T-cells 
consistently outnumber CD4+ T-cells within the lesion by at least 2:1; CD8 memory T-
cells have been shown to be clonally expanded in the CNS of MS patients (Bebbe et al., 
2000); class I MHC can be expressed on electrically silent neurons or functionally 
impaired neurons (Neumann et al., 1995); the transfer of myelin specific CD8+ T-cells 
into naive mice can induce EAE (Huseby et al., 2001);  and there is an association 
between HLA-A0201 and MS (Fogdell-Hahn et al., 2000).  However, the involvement 
of HLA-A0201 in the pathogenesis of MS is somewhat controversial as both protective 
and detrimental effects have been described (Sospedra and Martin, 2005; Fogdell-Hahn 
et al., 2000).  Additionally, B-cells are thought to play a role in the pathogenesis of MS.  
The importance of B-cell involvement in MS is illustrated by the deposition of antibody 
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and complement in the type II lesion described above; the prevalence of oligoclonal 
bands in the CSF of most MS patients indicating intrathecal antibody production and 
clonal expansion; the suspected correlation between circulating anti-MOG and anti-MBP 
Ig at onset with disease exacerbation as determined by MRI (Berger et al., 2003). Also, 
treatment with monoclonal antibodies (rituximab) directed against the B-cell marker 
CD20 provides some promising therapeutic results in the ability to MS patients (Muraro 
and Bielekova, 2007). 
Innate immune responses, other those associated with macrophages and dendritic 
cells, are also thought to influence the pathogenesis of MS.  For instance, the activation 
and degranulation of mast cells, which have been identified within the MS plaque, could 
result in opening the BBB; the abundant production of IFN-γ by NKT cells in MS 
patients could influence macrophage and microglia activation as well as MHC class I 
expression on glial cells; γδ T-cells are present in chronic lesions of MS patients, and 
have  demonstrated the capacity to lyse oligodendrocytes in a perforin-dependent fashion  
(reviewed in Sospedra and Martin, 2005).  In terms of the latter, it is interesting that one 
study indicated the capacity of γδ T-cells to act as professional antigen presenting cells 
(Brandes et al., 2005).  Therefore, upon activation these cells may transverse the BBB 
and act as APCs within the CNS parachyma.  On the other hand NK cells, especially 
those displaying the CD56 bright or CD95+ phenotype, appear to be regulatory and are 
thought to confer protection against the pro-inflammatory anti-myelin T-cell responses 
occurring in MS (Bielekova et al., 2006; Takahashi et al., 2004).  
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 If stress is immunosuppressive then it should protect against autoimmunity.  For 
instance, in EAE, the prototypical autoimmune disease, chronic stress is invariably 
beneficial, as illustrated by its delay of onset (Levine et al., 1962; Correa et al., 1998; 
Griffin et al., 1993).  In fact, in some models of relapsing-remitting EAE, it has been 
suggested that the stress of paralysis on the animal is partially responsible for remissions 
(Levine and Saltznan, 1987).  
 Translationally, the effects of stress on human multiple sclerosis should also be 
beneficial.  To this end, glucocorticoids are substantially beneficial when administered to 
patients during relapse, and speed recovery (Frohman et al., 2006).  However, Li et al. 
(2004), convincingly demonstrate that chronic stress significantly increases the risk for 
acquiring MS.  This conundrum may be explained by separating the events that occur 
during onset of MS and those that are occurring during relapse.  Even though MS is 
idiopathic, much evidence points to an infectious agent as an initiating event.  If the 
disease process in MS is caused and perhaps perpetuated by a viral agent, then chronic 
stress, through immunosuppression, might modulate the susceptibility to the disease.   
In humans, the prototypical example of immunosuppression leading to 
demyelination is the disease progressive multifocal leucoencephalopathy (PML) which 
is caused by the ubiquitous JC virus.  While approximately 80% of the population is 
seropositive for JC virus, immunosuppression is thought to be a key prerequisite for the 
development of PML, allowing uncontrolled viral infection of oligodendrocytes, which 
results in rapidly progressing virus-mediated demyelination (Sabath and Major, 2002).  
Similar to JC virus, Theiler’s virus is a widespread infectious agent in mice (Lipton et 
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al., 2001), but in nature, rarely results in demyelination (Sabin and Olitsky, 1938).  Most 
importantly, demyelination in TMEV is immune-mediated, but completely dependent on 
the ability of the virus establish a persistent infection. 
Our results on the effects of stress during early Theiler’s virus infection begin to 
establish a conceptual framework for how chronic stress can influence the onset of MS.  
If the autoimmune nature of MS is initially brought on by an infectious trigger, the 
translation of our results suggests that stressful life events in genetically susceptible 
individuals may heighten the risk for developing MS.  At the same time, our results 
indicate that in genetically resistant individuals, chronic stress may not alter the risk for 
developing the disease.   
 
6.  Future Studies 
6.1  Determine the influence of stress on the ability of NK cells to modulate early 
       immune responses to TMEV  
6.1.1 Determine the role and mechanism of stress on NK cell cytokine secretion 
The effects of both acute and chronic stress on NK cell cytotoxicity has been 
extensively investigated in both humans and mice.  In mice, the suppression of 
cytotoxicity is mediated through the SNS.  However, cytokine production, in particular 
the production of IFN-γ, from purified NK cells has not been investigated.  Importantly, 
the induction of cytotoxcity and cytokine production in NK cells has been attributed to 
two separate signaling pathways (Vivier et al., 2004).  As such, it is conceivable that 
while RS may act via the SNS to inhibit cytotoxicity, stress could inhibit cytokine 
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production (IFN-γ) by similar means, through the HPA axis, or not at all.  Studies 
employing the use of HPA agonist (corticosterone or dexamethasone) and antagonist 
(RU486) as well as catecholamine agonist (epinephrine or norepinepherin) and 
antagonist (propranolol) as treatments to address IFN-γ secretion from purified NK cells 
isolated from stressed or non-stressed mice, should begin to address this issue.  Follow-
up in vitro experiments using infected, non-stressed mice should be conducted that are 
intended to assess the phosphorylation status of proteins such as ZAP70, SHP1/2, as well 
as transcription factors known to induce IFN-γ transcription, which should be 
determined by qRT-PCR over a time course.  In these experiments it will be important to 
utilize neutralizing antibodies to IL-15, IL-18, and IL-12 as these have been shown to 
induce IFN-γ transcription in NK cells and may influence the interpretation of the data. 
 
6.1.2 Determine the effects of stress on the trafficking of NK cells to the CNS during 
TMEV infection 
The demonstration of NK cells within the CNS during TMEV infection has been 
implicated by one particular study investigating the effects of CTL responses on viral 
clearance, whereby the investigators were able to demonstrate that percent cell lysis 
using CNS-IL from day 7 p.i. was decreased when NK cells were previously depleted 
(Lindsley et al., 1991).   However, the amount of IFN-γ production from these cells was 
not determined.   As such, the degree by which NK cells influence the development of 
type 1 immune responses in the periphery, as well as IFN-γ-mediated viral clearance in 
the CNS during early infection, and the potential compromise of this function by stress-
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induced inhibition of NK cell trafficking to the CNS, has yet to successfully be 
demonstrated.  While FACS analysis utilizing intracellular cytokine staining techniques 
would specifically indicate the number of NK cells producing IFN- γ cells in the CNS, 
the numbers of mice required to obtain enough cells would present a problem, especially 
when considering the need to counter balance across groups during the experiment (N = 
20 per day for at least 3 days per time point).  The use of IFN-γ ELISPOT assays 
incorporating YAC-1 cells as stimulators may aid in the detection of small numbers of 
NK cells isolated from the CNS during early infection, and may provide a more practical 
approach, providing that preliminary studies would result in IFN-γ production that is NK 
cell specific.   Additionally, restraint stress could cause decreases in IFN- γ production 
from NK cells in a variety of different fashions.  For instance, RS has been shown to 
decrease mRNA levels of IL-15, and IL-12 (Hunzeker et al., 2004) potentially 
influencing both the survival and proliferation of NK cells as well as the transcription 
and secretion of IFN-γ.  These effects should also be addressed. 
 
6.2  Determine the immunological relevance of restraint stress induced increases in 
       antibody titer and its influence on the pathogenesis of TMEV infection 
6.2.1     Immunologic relevance of increased antibody in stressed and non-stressed mice 
 As mentioned, increases in virus-specific antibody levels are not always 
indications of increased immunity (Glaser and Kiecolt-Glaser, 1997).  Therefore, the 
level of neutralizing titers of serum antibody should first be determined in order to 
speculate on the potential of antibody to limit viral spread within the CNS.   Because 
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there is no guarantee that circulating antibody will reach the site of infection (CNS 
parenchyma) experiments should be conducted in I/NR, I/R, NI/NR, and NI/R mice to 
determine the degree of antibody allowed entry into the CNS of these mice, as stress 
may result in a compromised BBB.  The amount of antibody reaching the CNS could be 
measured in several fashions.  One potential way would be to inject (i.v.) a pre-
determined amount of radiolabelled (125I) mouse IgG or IgG + IgM either during or prior 
to stress.  At different time points, after injection, the animals should be thoroughly 
perfused with PBS, their brain and spinal cord extracted and placed into tubes to be 
counted by a gamma counter.  The percent of antibody that entered the parenchyma 
could be calculated by dividing the measured counts per minute (cpm) by the injected 
cpm and multiplied by 100.  To determine where the antibody was most likely to cross, 
the above experiments should be repeated, tissue processed for sectioning and the 
sections subjected to autoradiography (injection of peroxidase labeled antibody rather 
than radiolabelled antibody and development with horseradish peroxidase may give 
similar results).  Additionally, these experiments should be repeated using antagonists 
and agonist specific for the HPA axis and the SNS.  Due to the negative feedback control 
of the HPA axis results obtained with corticosterone or dexamethasone administration 
should be take with caution as these steroids would expect to limit production of CRH 
from the hypothalamus, a hormone potentially implicated in BBB disruption.  
Collectively these studies should determine if stress increases neutralizing titers of 
TMEV specific antibody in the circulation, if circulating antibody levels are allowed 
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entry across the BBB in stressed and non-stressed mice, and provide a potential 
mechanism for altered entry of these antibodies. 
 
6.2.2 The influence of stress-induced increase in antibody on the pathogenesis of  
TMEV infection 
 Because stress may alter the pathogenesis of Theiler’s virus-induced 
demyelination by increasing intrathecal antibody production, studies should be devised 
to address this issue.  These studies should follow the design of Sieve et al., (2004), and 
test for TMEV-specific antibody production in the brains and spinal cords of mice 
groups at days 30, 50, 100, 150 and 200 p.i. by ELISPOT.  Additionally, ELISPOT 
assays should be designed to specifically determine subclass of antibody being produced 
behind the BBB, as those that are complement fixing would be seen as potentially 
detrimental.  Moreover, the numbers of myelin-reactive antibody producing cells should 
also be determined in the same fashion.  Finally, the pathogenic potential of CNS 
antibody producing cells should be determined by transfer experiments into naive mice.  
Finally, because B-cells are, in fact, professional antigen presenting cells, capacity of 
CNS-isolated B-cells to present both viral and myelin epitopes to T-cells should be 






6.3  Determine the immunological relevance of RS on the polarization of different 
       TMEV-specific T-cell subtypes 
6.3.1 To characterize the effects of RS on Theiler’s virus specific Th1, Th2, and Th17 
responses from CD4+ T cells as well as CD11c+ dendritic cells ex vivo in SJL 
mice   
 During acute TMEV infection, virus specific CD4+ T helper (Th) cells are 
protective as illustrated by the fact that the majority of CD4+ deficient mice will die 
within days following injection.  Restraint stress (RS) has been shown to limit immune 
responses to several viral infections including influenza and herpes simplex.  
Mechanistically, this effect is thought to stem from a Th1/Th2 shift in immunity.  
However, our data suggests that RS results in an overall immunosuppression that is 
reversible following the secession of RS.  As such, we propose that over the course of 8 
days of RS both dendritic cell function and CD4+ Th responses (Th1, Th2 and Th17) 
will be decreased at days 4, and 8 p.i., but will recover and be comparable to those of 
non-stressed animals by day 16 and 24 p.i.  The effects of RS on TMEV induced Th 
polarization in these experiments should be determined using purified CD11c+ dendritic 
cells isolated from the spleen, as well as CD4+ T-cells isolated from the CNS and the 
spleen.  The effects of stress on the polarization of CD4+ T-cells should be demonstrated 
using, intracellular cytokine staining and flow cytometry, mRNA expression and 
western blotting of transcription factors, and by cytokine secretion.  Moreover, the 
demonstration of virus induced activation of transcription factors responsible for T-cell 
polarization should be determined by ChIP assays. 
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6.3.2   To determine the roles of glucocorticoids and catecholamines on Theiler’s virus 
induced APC activation and function in vitro 
 Antigen presenting cells (APCs) including macrophages and dendritic cells (DC) 
are not only required for the generation of adaptive immune responses, but are also 
thought to influence T helper cell polarization – thus making them essential components 
of the immune system.  Dendritic cells, in particular, play an imperative role in uptake of 
antigen, and subsequent presentation, activation and polarization of naive CD4+ T cells 
into effector CD4+ T cells.  Stress influences immunity through the activation of both the 
sympathetic nervous system (SNS) leading to the release of norepinephrine (NE), 
epinephrine (EPI) as wells as the hypothalamic-pituitary-adrenal axis resulting in the 
release of glucocorticoids.  As APCs have been shown to express receptors for NE (β2-
AR), EPI (β1-AR) as well as glucocorticoids (GR), studies should be designed to 
investigate the effects of these stress-induced molecules on the functional responses of 
these cells to Theiler’s virus. Specifically, peritoneal macrophages or bone marrow 
derived DCs from SJL mice should be cultured with or without EPI, NE or DEX. These 
cells should then be sham infected with PBS or infected with TMEV at various 
multiplicities of inefection.  At 5, 24 and 48 hours post infection (p.i.), APC function 
will be assessed by mRNA expression, cytokine secretion (IL-23(p19), IL-12(p70), IL-6, 
and IL-10), and presence of activation markers (MHC class II, CD80, CD8α).  
Additionally, the function of these APCs should also be assessed by their ability to 





6.4  Determine the relevance of T-bet in the demyelination disease of TMEV 
While many studies have addressed the effects of IFN-γ on Theiler’s virus-
induced demyelination (TMEV-IDD) as well as its activator STAT4, no studies have 
elucidated the role of T-bet in TMEV-IDD.  While T-bet is responsible for Th1 
polarization and IFN-γ secretion it as so controls the regulation of IL-23R expression, 
indicating an involvement in propagating Th17 cells.  In fact, while IFN-γ-/- mice 
developed more severe EAE, T-bet-/- mice on the same background are resistant.  Given 
the requirement for Th17 cells in the facilitation of EAE it is tempting to speculate that 
these cells may be required for the induction of TVID.  There is evidence that supports 
such a hypothesis: IFN-γ-/- mice on a normally TVID-resistant background are rendered 
susceptible to demyelination (Rodriguez et al., 1995), but TMEV infection cannot be 
confined to inducing either Th1 or Th2 immune responses (Monteyne et al., 1999).  
Also, macrophages from the highly susceptible SJL mouse strain have been shown to 
secrete high amounts of IL-12(p40), but low amounts of IL-12(p35) whereas the 
macrophages from resistant mice secrete low amounts of IL-12(p40) (Petro, 2005a).  
Moreover, TMEV infection of the macrophage cell line, RAW264.7, induces expression 
of IL-23 (Petro, 2005b). Additionally, we have found that TMEV infection increases 
serum concentrations of IL-12(p40), but has no effect on IL-12(p70) concentrations, and 
mice possess Th17 cells in the CNS  at day 8 p.i. in SJL mice as well as high quantities 
of IL-17A producting cells in the spleens during chronic disease (not shown).  
 189
Furthermore, both IL-6 mRNA expression (Mi et al., 2006b) as well as protein 
concentration (Johnson et al., 2006; Steelman unpublished observation) is increased 
following infection with the BeAn strain of TMEV, and MIP-2 (CXCL2), a protein 
induced by IL-17, is also found to be increased during the demyelinating phase, and 
maybe involved in susceptibility (Rubio et al., 2006).  Finally, the abolition of IL-
12(p40) via monoclonal antibody administration during acute infection delays 
demyelination, but STAT4-/- mice on a normally TVID-resistant background are 
rendered susceptible to demyelination (Inoune et al., 1998; Rodriguez et al., 2006).   
Therefore, it will be interesting to determine the effects of T-bet on the pathogenesis of 
TMEV infection.  Studies utilizing T-bet-/- mice on a resistant C57BL/6 background 
should be used to examine the course of TMEV infection.  The effect of virus specific 
immune responses in T-bet-/- mice on other T-cell subsets should also be explored.  
Subsequent studies should be used to determine the mechanism of observed effects (i.e. 
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Appendix A.  The number of IFN-γ producting virus specific CD8+ T-cells were correlated 






















































































































































































Appendix B.  Elispot Raw Data.  A-D.  Number of IFN-γ producing cells counted from the CNS 
(top) or spleens (bottom) of infected/non-restrained (I/NR), infected/restrained (I/R), non-
infected/non-restrained (NI/NR), and non-infected/restrained (NI/R) mice at days 8 p.i. (A,C) or 
16 p.i. (B,D).  To ensure CD4+ and CD8+ T-cell specific IFN-γ production, the background 
spots, determined by incubation with a non-specific peptide sequence (NS), were subtracted 
from the numbers generated by incubation with both CD4+ and CD8+ immunodominant peptides 
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